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Abstract  
Background: In 2009 the Department of Health introduced a national cardiovascular 
risk assessment, management, and reduction programme – the NHS Health Check. 
The programme aimed to reduce premature morbidity and mortality for those aged 
40-74. Individuals who are identified to be at high risk (>20%) of cardiovascular 
disease are offered lifestyle advice and/or prophylactic medication to reduce their 
risk. This study aimed to understand the factors that influence individuals’ 
engagement with the programme. Normalisation Process Theory was used as a 
theoretical lens to underpin the study and make sense of the findings. 
Methods: A secondary analysis of data collected through 26 semi-structured 
interviews was conducted. Purposive sampling was undertaken of patients who had 
previously been identified, through the NHS Health Check Programme, as being at 
increased cardiovascular risk. Participants had been identified as high-risk, been 
offered lifestyle advice, lipid lowering medications, and had attended at least one 
annual review. Data were initially analysed thematically. Themes were then 
compared to Normalisation Process Theory constructs to assess if they could provide 
insight into engagement with the programme. 
Findings: Findings explore the work undertaken by participants to engage with (or 
not) each stage of the NHS Health Check journey. Focus is on four main areas, 
which relate to Normalisation Process Theory constructs; the sense making and 
working out participation work undertaken to decide to attend the check and 
understand what it means to be identified as at increased cardiovascular risk, and the 
doing it and reflecting on it work undertaken to implement lifestyle changes, adhere 
to medication regimens and engage in surveillance and monitoring activity.  
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Conclusions: Normalisation Process Theory helped to surface important aspects of 
the NHSHC programme that influence participants’ engagement with the NHSHC 
and their subsequent journey throughout the process from: attending the assessment, 
being identified as at-risk, making sense of this ‘diagnosis’, and engaging in lifestyle 
changes and/or a pharmaceutically aided journey. Evidence from this study suggests 
that the at-risk individual should be viewed as a participant in a social system, and 
that this wider social system is integral to engagement, both positively and 
negatively, with all aspects of the programme. 
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1 Introduction 
This thesis presents work undertaken to explore the experiences of individuals who 
had been identified as at increased risk of suffering an adverse cardiovascular event 
through the National Health Service Health Check (NHSHC) programme in four 
localities in the North East of England. This work is nested within a collection of 
projects that were undertaken between 2008 and 2014 that initially explored the roll 
out of the NHSHC programme in general practices, community pharmacies, 
community settings, and workplaces (Oswald et al., 2010, McNaughton et al., 2011, 
McNaughton and Shucksmith, 2014). The initial phase of evaluation was 
commissioned by a collaborative of four Primary Care Trusts (PCTs) and focussed 
on the barriers and facilitators experienced by those organisations tasked with 
providing the NHSHC in the early stages of roll out, in order to inform the 
commissioning process and development of the programme locally. 
 
The second commissioned phase of work consisted of two linked projects. Firstly, a 
cost effectiveness analysis of local uptake data and recommended treatment 
pathways was undertaken to build a case for the continuation of the local NHSHC 
programme (McNaughton et al., 2013). The second linked project was a qualitative 
study commissioned to provide insight into the experience of those people invited to 
attend the NHSHC. It was acknowledged locally that it was essential to explore how 
individuals felt about the NHSHC assessment and subsequent intervention pathways, 
in order to inform the NHSHC offer through local providers (McNaughton et al., 
2013, McNaughton and Shucksmith, 2015).  
 
8 
 
The commissioning of the qualitative evaluation element presented an opportunity to 
undertake this PhD study. The evaluation required that the experiences of ‘at-risk’ 
individuals be explored and reported to inform the local programme. However, it 
also provided the opportunity to explore this in a much more theoretically driven way 
than required by the commissioning PCTs. It was agreed that the data should be 
analysed and presented initially for evaluation purposes of the commissioners 
(McNaughton et al., 2013) but that a theoretically driven secondary analysis was to 
be undertaken for the purposes of the PhD. This theoretically driven analysis was 
designed to focus on how NPT could illuminate the processes ‘at-risk’ individuals 
went through to make sense of being at increased CVR and also to analyse their 
engagement with aspects of the programme.  
 
As this decision to pursue a PhD was agreed at the outset of the evaluation work it 
allowed the study to be designed to serve both purposes; that of the commissioned 
evaluation and the PhD study. The academic focus and identification and use of 
Normalisation Process Theory, the theoretical lens described in chapter 4, to inform 
the study design, analysis, and interpretation is what sets this PhD study apart from 
the evaluation work and is my original contribution. 
  
1.1 Reflection on the [contemporary] context 
The project was carried out against a backdrop of political change and both national 
and local reorganisation of the PCTs. The NHSHC programme was conceived under 
a Labour Government in 2008 and rolled out nationally in 2009. The programme was 
still in its infancy when, in 2010, the Conservative/ Liberal Democrat Coalition came 
into Government in England. There were many uncertainties about the future shape 
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of the NHS generally and, specifically, the future of the national commissioning of 
the NHSHC assessment. As described in Chapter 2, responsibility for the 
commissioning of the NHSHC assessment stage was given to Local Authorities (LA) 
whilst the responsibility for commissioning the annual review became the 
responsibility of NHS England, meaning that the assessment, intervention, and 
follow-up became disjointed. Public Health England became concerned with 
conversion of invitation for a NHSHC into assessment, rather than being concerned 
with the longer-term outcomes of intervening. This meant that focus shifted away 
from the longer term outcomes of the programme and is reflected in the national 
evaluation work that was commissioned and undertaken (Chapter 2). Nationally 
funded evaluation work focussed on assessing population level effects and cost 
effectiveness of the programme as it was rolled out nationally. However less focus 
was put on the individuals who were part of the programme and the success (or not) 
with which they engaged with the programme, embraced (or not) the interventions, 
and managed to sustain (or not) their engagement over the longer term.   
 
1.2 Research questions, aims, and objectives 
The primary concern of this thesis is to explore the factors that influence the 
experience of those people identified as at increased risk of adverse cardiovascular 
events through the NHSHC programme. Therefore, I set out to explore the journey 
that individuals embark on from invitation to attend an NHSHC through their 
diagnosis of risk, adherence (or not) to lifestyle advice and lipid lowering 
medication, to their experience of annual review. Normalisation Process Theory 
(NPT) was used as a theoretical lens to view and illuminate the processes that people 
go through to implement, embed, and integrate the practices of the NHSHC 
10 
 
programme and any recommended medication or lifestyle changes in the context of 
their lives. An explanation of this theoretical choice is provided in chapter 4. There 
were two primary research questions, which are outlined on the following pages. 
 
 
Research question one 
What factors influence high-risk individuals’ engagement with the NHSHC 
programme? 
Aim To understand and explore at-risk individual’s 
experience of engaging with the NHSHC programme 
in order to identify factors that promote or inhibit 
engagement with assessment, risk identification, 
intervention, and sustained engagement over the 
longer term (1year+). 
Objectives 1. To examine how individuals make sense of the 
NHSHC programme 
2. To understand how individuals interpret being at-
risk of a cardiovascular event 
3. To explore how individuals make sense of lifestyle 
advice and/or intervention 
4. To catalogue how individuals make sense of the 
prescription of prophylactic medications 
5. To discover how individuals integrate and sustain 
lifestyle changes and/or prophylactic medications 
6. To determine how individuals engage with ongoing 
monitoring of risk 
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Research question two 
Can NPT provide insight into engagement with the NHSHC programme? 
Aim To utilise the constructs of NPT to unpack and explore 
reported engagement with the NHSHC programme. 
Objectives; 
to explore NPT’s 
appropriateness to 
explain experience of: 
To explore the appropriateness of NPT to explain 
people’s understanding of and engagement with 
various stages of the patient journey towards living 
with a diagnosis of risk, i.e. 
1. Invitation to attend assessment 
2. Receiving a diagnosis of cardiovascular risk 
3. Engagement with lifestyle advice and/or 
intervention 
4. Engagement with prophylactic medication 
5. Engagement with ongoing monitoring over the 
longer term 
 
 
To answer these questions the thesis begins, in chapter 2, by providing contextual 
information about the introduction and implementation of the NHSHC. Chapter 3 
then presents an overview of what is known about the experience of becoming and 
being a patient, before introducing, in chapter 4, the core theory – NPT – which has 
been used to structure the study design and to analyse the results. In chapter 5 I 
discuss the method employed to undertake this study. Study findings are presented in 
chapters 6 and 7, and these are followed by a discussion of findings (chapter 8) in 
relation to the theoretical framework provided by NPT. Finally, conclusions and 
implications for theory, policy and practice, training, support, and education, and 
research are presented in chapter 9. In the following pages, an overview of each 
chapter is presented to provide a roadmap of the thesis. 
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1.3 A roadmap of the thesis 
Chapter 1 has situated the research in terms of how the project came about, has 
discussed the rationale for undertaking the study and presented the research 
questions, aims, and objectives.  
 
In Chapter 2 I move on to explore cardiovascular disease and its impacts both 
globally and in the United Kingdom (UK) before turning attention to the 
development of a national cardiovascular risk assessment programme – the NHSHC. 
The structure of the national programme is described alongside how the programme 
is delivered in the local context.  Evidence about uptake and engagement from the 
first few years of roll out is explored. 
 
Chapter 3 turns to the sociological literature about what is known about ‘being a 
patient’. Here the focus is on the concept and process of diagnosis, adopting a sick 
role, embodying illness and the work involved in being a patient. 
 
In Chapter 4 Normalisation Process Theory is presented as the theoretical lens that 
underpins the study. The theory is described and explored, alongside literature about 
how it has been used in other studies. An interpretation of the core constructs of the 
theory is presented as well as a description of how those concepts have been 
interpreted and applied across the research process for this study. 
 
Chapter 5 presents the methodology of the study, beginning with a discussion of the 
underpinning philosophical and theoretical foundations of the study before turning to 
the procedural methods employed to collect and analyse the data. 
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Chapters 6 and 7 present the findings from the study. Chapter 6 is concerned with 
participants’ accounts of considering participation with the NHSHC and their 
experiences of being identified as at high risk of cardiovascular disease. Chapter 7 is 
concerned with levels of participation and adherence with lifestyle changes, 
prophylactic medications, and the annual review process. 
 
Chapter 8 presents the synthesis of the findings chapters, using NPT as a framework 
to structure discussion. 
 
Finally in Chapter 9, implications from the findings are presented. Implications for 
theory; policy and practice; training, support, and education; and research are 
discussed.  
 
References and appendices complete the thesis. Peer reviewed journal articles that 
have been published by the PhD candidate arising from this study are presented as 
Appendix 11.1.  
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2 The NHS Health Check Programme 
The primary concern of the thesis is not the NHS Health Check (NHSHC) 
programme itself, or its effectiveness (or otherwise), but rather the novel application 
of Normalisation Process Theory (Chapter 4), to explore the process of becoming a 
patient with a chronic condition. Chapter 2 provides background information. It is 
important to understand the wider context from which this data was collected – 
namely from patients participating in a novel but wide scale (and somewhat 
controversial) intervention who had undergone an NHSHC assessment and been 
identified as being at high risk of suffering a cardiovascular event in the next ten 
years. 
 
To understand why and how the NHSHC programme came into being, this chapter 
starts by outlining the rates of cardiovascular diseases (CVD) both at a global level 
and at a national level in the United Kingdom (UK) and the global burden of the 
disease. This acts in part as a frame of reference which explains why CVD reduction 
and prevention in the population has become such a targeted priority. Following on 
from that, the development of a national systematic cardiovascular risk assessment, 
reduction and management programme is described, as well as the Tees Valley’s 
specific response to this programme. Moving on from this rather descriptive 
background to the development of the CVD risk assessment programme, the more 
contentious aspects of the programme are explored alongside academic literature 
pertaining to the medicalisation of health and illness, the classification of illness, and 
the rise of the risk factor concept in surveillance medicine. 
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2.1 Cardiovascular diseases 
2.1.1 The global burden of cardiovascular disease 
Globally, the burden of non-communicable diseases such as diseases of the 
cardiovascular system,  cancer, and chronic respiratory diseases is huge and they are 
a major cause of morbidity and mortality (World Health Organization, 2011c). These 
diseases collectively account for around 63% of deaths each year (World Health 
Organization, 2011c, World Health Organization, 2011b), which equated to 
approximately 57 million deaths in 2008  (World Health Organization, 2007, World 
Health Organization, 2011c).  
 
In particular, CVDs and their consequences; heart attack, stroke, vascular 
complications of hypertension (high blood pressure), hyperlipidaemia (high 
cholesterol), and diabetes mellitus - cause  around 17 million deaths each year, 
equating to 1/3 of all recorded deaths (World Health Organization, 2013). 
Hypertension alone accounts for 9.4 million deaths and approximately 40% of the 
world’s adult population has been clinically diagnosed (World Health Organization, 
2013). The number of people with a clinical diagnosis of hypertension has risen 
sharply over the past few decades from 600 million in 1980 to 1 billion in 2008 and 
has been attributed to an aging population and lifestyle factors such as poor diet and 
decreased physical activity (World Health Organization, 2013).  
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2.1.2 Cardiovascular disease in the United Kingdom 
In the UK, cardiovascular diseases were the leading cause of avoidable mortality 
between 2001 and 2006. However, over that time period the death rate fell by 29%, 
meaning that by 2007 neoplasms (cancerous and non-cancerous growths) had 
overtaken CVD as the leading cause of mortality (Office for National Statistics, 
2013), potentially as a consequence of diagnostic and surgical improvements. In the 
latest data, to 2015, CVDs remained the second highest cause of mortality with 
Alzheimer’s and dementia taking the first place (Office for National Statistics, 2016). 
In 2008 cardiovascular diseases accounted for 34% of deaths in the UK, despite 
downward trends for metabolic risk factors, systolic blood pressure and total 
cholesterol over the time period to 2008 (World Health Organization, 2011c). In 
2009, 180,000 people died from CVD, again  representing one third of all deaths that 
year (Townsend et al., 2012). Treatment of CVD in 2014 cost the National Health 
Service (NHS) around £15 billion, a figure that is projected to rise to £18 billion by 
2020, and thus representing a huge financial burden on the UK health system (British 
Heart Foundation, 2014).  
 
The prevalence of CVD has been attributed to worldwide population growth, aging, 
and behavioural risk factors such as unhealthy diets, physical inactivity, overweight 
and obesity, smoking, and harmful levels of alcohol use, as well as persistent 
exposure to stress (World Health Organization, 2013) and this is mirrored in the UK 
experience. Risk factors for CVD are, for the most part, modifiable, which has led to 
increased efforts to change the behavioural habits of the population. It has become 
widely accepted that around 80% of these premature deaths could be prevented 
through the modification of behavioural risk factors such as poor diet, low levels of 
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physical activity, tobacco and alcohol use, and also through the identification of 
underlying physiological conditions such as increased cholesterol and high blood 
pressure (World Health Organization, 2011a, World Health Organization, 2007, 
World Health Organization, 2011b, Department of Health, 2008c, Department of 
Health, 2009).  Alone, each individual risk factor may not be damaging, but the 
adverse effects are often compounded because individuals present with multiple risk 
factors (World Health Organization, 2011a, World Health Organization, 2007, World 
Health Organization, 2011c, World Health Organization, 2013). In order to tackle the 
growing problems related to the effects of behavioural risk factors on the individual 
and society, a mix of population-based approaches to risk reduction is recommended 
by WHO. For example:  
 raising of taxes on tobacco and alcohol 
 promotion of policies on smoke-free workplaces and public areas 
 banning or restricting the advertising of products such as tobacco, alcohol, 
and high fat foods 
 mass health promotion advertising about reducing the intake of salt, and 
 awareness programmes about physical activity and diet (World Health 
Organization, 2013, Barton et al., 2011, Jørgensen et al., 2013)  
 
In the UK, the burden of CVD is felt disproportionately in disadvantaged 
communities, not least because modifiable risk factors such as poor diet, smoking 
and low levels of physical activity contribute significantly to the prevalence of CVD 
(Capewell and Graham, 2010, Department of Health, 2008c, Department of Health, 
2009, Bajekal et al., 2012, Stafford et al., 2012). Cardiovascular disease mortality 
18 
 
rates within the population as a whole have been falling by around 6% per year. 
However, this reduction is experienced differently between socio-economic groups, 
meaning that, as overall mortality rates fall, health inequalities are increasing 
(Bajekal et al., 2012). Structural conditions of class and poverty play a role in the 
engagement with ‘risk behaviours’ and subsequent development of CVD (Raphael, 
2003) meaning that people in low income groups might have worse diets, engage in 
less physical activity, consume more alcohol, and are more likely to smoke tobacco 
products. Traditionally, as a society, we have looked towards health services to 
attend to concerns about heath and illness. However, much of the burden of ill health 
and disease can be attributed to structural conditions around where people are born, 
grow up, live their lives, go to work, and grow old (Marmot et al., 2008). The effects 
of social policy and socioeconomic constraints on health and illness have been 
recognised for centuries (Marmot, 2001). However, the Black Report (Black, 1980) 
demonstrated the unequal distribution of morbidity and mortality in the British 
population and suggested that the gap in these health inequalities was widening, 
rather than shrinking (McIntosh-Gray, 1982). Despite efforts to recognise and tackle 
the structural and social impacts on the experience of health and illness within the 
population since the publication of the Black Report, similar findings were 
demonstrated in the Acheson Report of the 1990s (Acheson, 1998) and Marmot 
Review of 2010 (Marmot, 2010).      
 
In spite of calls to tackle the incidence of CVD through population level intervention 
programmes such as the NHSHC – though national in scope - focus on finding 
individual (potential) cases for ill health and changing individual behaviour to reduce 
this risk, thus placing responsibility for CVR reduction at the door of the individual, 
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rather than attending to the structural and social determinants of health and illness. 
Moreover, it could be argued that an integrated approach to prevent ill health that 
reduces or eliminates the impact of structural and social forces on health and 
addresses individual behaviours would likely be most beneficial. 
 
2.2 The NHS Health Check Programme 
In the following section the NHSHC programme is described. The Template for 
Intervention Description and Replication (TIDieR) framework is used to organise the 
description of the NHSHC intervention (Hoffmann et al., 2014). The TIDieR 
framework is made up of 12 items as presented in Table 1. 
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Table 1: TIDieR framework description 
Item Description 
1.  Brief name National Health Service Health check (NHSHC) 
 
The NHSHC is a cardiovascular risk assessment, management and reduction programme. It offers systematic 
identification of individuals, aged 40-74 years old, within the English population who are at increased risk 
(>20%) of suffering an adverse cardiovascular event in the next ten years. For those identified as at increased 
risk of CVD, the intervention is offered through lifestyle modification advice and prophylactic lipid lowering 
medication 
 
2.  Why In April 2008, under a Labour Government, the Department of Health (DH) announced plans to introduce a 
national vascular assessment programme. In light of the prevalence of CVD in the UK population (section 
2.1.2), the number of deaths attributed to it per annum (section 2.1.2), and the associated costs of treatment 
(section 2.1.2), reducing cardiovascular disease risk (CVR) and burden of illnesses attributed to CVD became 
a priority for the UK government. The NHSHC programme was formally launched in April 2009 (Department 
of Health, 2008d, Department of Health, 2008c, Department of Health, 2009).  
 
The NHSHC was introduced to facilitate the identification of individuals who were displaying early warning 
signs of CVD and to provide intervention consisting of  lifestyle advice and prophylactic medication in order 
to reduce CVR (Department of Health, 2008c, Department of Health, 2009). 
 
Economic rationale for the programme: Projections prior to implementation of the NHSHC programme 
indicated that, once fully implemented, the programme was estimated to cost £332m per annum – a significant 
sum – however, the annual benefits of the programme were projected to be £3.7bn (Department of Health, 
2008a). Importantly, this model was built upon the assumption of a 75% uptake of invitation to attend 
assessment (Department of Health, 2008a).  
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Health gain as rationale for the programme: The NHSHC programme aspired to make an impact on both 
morbidity and mortality occasioned by CVD. In initial guidance documents, it was claimed that huge savings 
could be made to the healthcare system and many lives could be saved, through the introduction of a CVR 
assessment and management programme. Programme aspirations included: 
1. prevention of at least 9,500 heart attacks and strokes a year (2,000 of which would be fatal) 
2. prevention of at least 4, 000 people a year developing diabetes 
3. earlier detection of at least 25,000 people a year with diabetes or kidney disease  (Department of 
Health, 2008c) (p9). 
 
This was to be achieved through the identification of those at increased risk and intervention through lifestyle 
modification. 
 
Intervention provision: Guidance produced by the Department of Health recommended that, for those 
identified as high risk of CVR, intervention should be offered in line with current National Institute for Health 
and Clinical Excellence (NICE) guidelines, as those interventions were evidence based and deemed cost 
effective. These interventions are presented in Table 2 and are reproduced from Department of Health 
(2008d). 
 
3.  What (materials) Providers: Provider organisations were offered the opportunity to attend several training events and away 
days hosted by the PCT (as was) to offer opportunity to discuss the terms of the Local Enhanced Service 
agreement, aspects of programme delivery, and be updated about local programme progress. Specific training 
was offered to those delivering the checks in GP practices to develop skills in motivational interviewing to 
foster behaviour change in those identified as at high risk of CVD. 
Each GP practice delivering the NHSHC in Tees was provided with two separate lists of patients, generated 
by Primary Care Informatics (as was), on a quarterly basis. The first list identified all eligible patients that 
were registered with the GP practice (>40 years old not previously diagnosed with diabetes or hypertension). 
The second list was termed the ‘indicative list’ (Chamnan et al., 2010a, Marshall, 2008) and identified those 
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patients registered with the GP practice who were predicted to be at the greatest risk for CVD based upon an 
assessment of routinely collected data (age, height, weight, blood pressure).  
 
Participants: Each patient who was invited by their GP practice, through a targeted approach (i.e. the eligible 
or indicative lists) was sent a formal invitation letter by their GP practice. The letters were devised by each 
individual GP practice making the provision of invitation content inconsistent. However, more recently work 
has been undertaken to develop a national NHSHC template letter (Public Health England et al., 2015) to 
standardise the invitation process using principles developed by the Behavioural Insights Team (Service et al., 
2014).  
 
During the second CVR assessment appointment, when the individual’s risk score has been calculated and 
delivered (figure 1, appendix 11.3) generic health promotional literature may have been offered to facilitate 
discussions about healthy diet, physical activity, smoking cessation and alcohol reduction. The materials 
provided were at the discretion of the individual health providers 
 
4.  What (procedures Those eligible for an NHSHC are provided with a CVR risk assessment through the collection and synthesis 
of lifestyle information, anthropometric measurements, and family history. Using this information, a personal 
calculation of CVR is attained using an approved risk equation (discussed later in this chapter), and, for those 
who are identified as being at increased risk, there is an offer of intervention through lifestyle advice, 
provision of prophylactic medication (statins), and ongoing monitoring of CVR into the future (annual 
review). 
During the initial appointment, individuals were often asked to fast before they attend, so that they could have 
a blood test to assess their blood lipid levels – a cholesterol test. In fact, guidance changed over the course of 
this study and fasting lipid tests are now not required under best practice guidance. Details about age, sex, 
smoking status, physical activity, alcohol intake, family history, ethnicity, Body Mass Index, cholesterol test, 
blood pressure, blood glucose are collected for risk calculation. At the second appointment, the individual’s 
risk is discussed, this provides an opportunity for brief motivational interviewing, discussion about lifestyle 
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changes that could have a positive effect on projected risk of CVD and, if necessary, the prescription of 
prophylactic lipid lowering medications (Department of Health, 2009).  
 
Everyone who attends an NHSHC assessment, regardless of their risk score outcome, are entered into a recall 
system so they can have their risk reassessed as per best practice guidance. Individuals identified as low or 
medium risk (<10% and <19% respectively) are entered into a 5 year recall for reassessment. Individuals 
identified as at right CVR (>20%) are entered into an annual recall for monitoring (see figure 1 and appendix 
11.3). 
 
Risk management: regardless of identified risk score, all individuals who have received an NHSHC should 
be offered information about smoking cessation, exercise on prescription/ physical activity intervention, 
weight management on referral, lifestyle management advice that is appropriate to their needs. In addition, 
those at high risk are offered lipid lowering medications regardless of their cholesterol levels, for the purposes 
of prevention and/ or antihypertensives as appropriate (figure 1 and appendix 11.3) 
 
5.  Who Provided Provider(s): GP practices, Pharmacy, community venues (outreach/ workplaces) (see item 7) this section 
describes provision within GP practices. 
 
Expertise: The initial risk assessment is split into 2 appointments (item 8). Delivery model varies between 
GP practices (item 9).  
 
Initial clinical testing (appointment 1) may be carried out by a trained and competent member of GP staff i.e. 
a Healthcare Assistant, Practice Nurse, General Practitioner.  
 
24 
 
Delivery of risk assessment (appointment 2) is normally carried out by an appropriately trained Practice Nurse 
or General Practitioner.  
 
Specific training: appropriate medical competencies to carry out clinical aspects of the assessment (i.e. 
anthropometric measurements, blood pressure etc…). 
 
Training on use of risk calculator (item 6) risk delivery and motivational interviewing was provided by the 
PCT. 
 
6.  How The NHSHC is provided on a face to face basis with each patient seen individually. Intervention may be 
offered in a group setting (e.g. exercise on prescription) 
 
7.  Where The NHSHC is offered in a variety of settings. Nationally, the NHSHC is offered primarily through General 
Practitioner (GP) practices, but best practice guidance from DH suggests that, in order to provide this equity 
of access and to reach those members of the public who are reluctant to access GP services, the NHSHC 
should also be delivered through a variety of other settings, for example community pharmacy and 
community venues (Department of Health, 2008c, Department of Health, 2009).  
 
8.  When and how much The NHSHC is broken down into two main components. Firstly the CVR assessment and then the annual 
monitoring. 
 
Cardiovascular risk assessment: two separate appointments with the health professional each lasting around 
10 minutes and spaced two weeks apart to allow for blood results to be processed in the laboratory. The first 
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appointment is for collection of information about risk factors and clinical testing; the second appointment is 
for delivery of results and provision of intervention. 
 
Annual monitoring: one ten minute appointment annually. 
 
9.  Tailoring The delivery of the NHSHC across the UK is varied. Primary Care Trusts were initially tasked with 
developing a programme that was relevant to their individual population, giving the local commissioning 
bodies’ scope to design and deliver the NHSHC programme in whatever way they deemed best for their 
population, whilst adhering to national standards to provide quality assurance (Artac et al., 2013a, Graley et 
al., 2011). Primary Care Trusts also had to be mindful of providing equity of access to their local population 
to avoid inadvertently increasing health inequalities (Capewell and Graham, 2010, Department of Health, 
2009).  
 
Invitation: Indicative list: GP practices used this list to identify and target those individuals who could gain 
most benefit from the NHSHC assessment and intervention. These individuals are invited to attend a NHSHC 
assessment, normally in ‘waves’, dependent on the GP practice’s policy. However, GP practice engagement 
with the indicative list is variable across practices, with some practices engaging much more than others 
(Oswald et al., 2010). Alongside a targeted approach, calling individuals in from the indicative list, many GP 
practices have also adopted an opportunistic method of inviting people for a NHSHC assessment when they 
become eligible by age, or attend a new patient check. In some GP practices new patients that fall within the 
target age range are offered an assessment at their new patient check (Oswald et al., 2010). 
 
The invitation letter that was sent to patients of each practice was developed ‘in house’ by each GP practice. 
There was guidance offered from the PCT, however, this was not compulsory. 
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Risk assessment: The advice, provision of medications, and subsequent recall for review of CVD risk is 
tailored to the individual, based on their CVR calculation (discussed later in this chapter) 
 
Intervention: Provision if intervention – lifestyle advice and/or prophylactic medication could be tailored to 
the individual’s needs, whist complying with programme pathway (figure 1 and appendix 11.3). Access to 
lifestyle management services is dependent on local service availability. 
 
10.  Modifications Following the healthcare reforms in 2013 which abolished the Primary Care Trusts, the responsibility for the 
commissioning of NHSHCs was moved from the NHS to Local Authorities (LA), despite the fact that the 
majority of the checks are carried out in GP surgeries, which remain part of the National Health Service. The 
way in which the NHSHC is commissioned has changed dramatically since its inception and it is perhaps 
worthy of a brief note at this point. Initially, Primary Care Trusts (PCT) commissioned providers of the 
NHSHC to deliver both the initial assessment of risk and subsequent intervention and follow-up reviews for 
those at high risk on an annual basis. However, in February 2013 the NHSHC became a statutory programme, 
mandated in legislation (Secretary of State, 2013). In this legislation, the commissioning of the initial 
assessment became mandatory for LAs, and is commissioned by local public health teams as part of their 
population level prevention work. However, the provision of intervention for those discovered to be at high 
risk is not covered by the same legislation. NHS England is responsible for commissioning any intervention 
required and annual review of the NHSHC (NHS England, 2014). Since the fragmentation of the NHSHC 
assessment, intervention and follow up, attention from Public Health England (PHE) has shifted from 
monitoring outcomes of the NHSHC and focussed on monitoring the conversion of invitations to assessment. 
Since its inception, the NHSHC has also become a vehicle for delivering other health promotion information 
e.g. about dementia (NHS Health Check, 2014).  
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Programme level aspirations (item 2) were substantially revised in 2013, 4 years after the introduction of the 
NHSHC programme to: 
1. the NHSHC programme could save 650 lives per year by preventing 1,600 heart attacks 
2. prevent development of diabetes in over 4,000 people per year 
3. aid in the early detection of at least 20,000 cases of kidney disease and diabetes  (Public Health 
England, 2013).  
 
11.  How well (planned) Monitoring of uptake of the NHSHC is monitored locally through Local Enhanced Service Agreements and 
nationally through PHE. 
 
12.  How well (actual) Early evidence from local evaluation work suggests that the actual uptake figure was between 29% to 45% 
(Artac et al., 2013b, Dalton et al., 2011, Cochrane et al., 2013, Richardson et al., 2008), well below initial 
estimates. 
 
Like Tees, some other areas in the UK have been offering NHSHC assessments both opportunistically and 
through a targeted approach, utilising previously held patient data to ‘pre-assess’ patients and offer screening 
appointments. Kumar et al. (2011) reported learning from the Stoke-on-Trent roll out of the NHSHC. They 
suggested that developing both a targeted and opportunistic strategy to offer the check coupled with the 
opportunity for patients to utilise a drop-in clinic for assessment was both an effective and cost effective way 
of delivering the check. Targeted approaches are, however, dependent on the quality of the existing patient 
data used, to pre-assess patients to indicate those at highest risk. 
 
National NHSHC programme figures, as of January 2016 show that 51.7% of the eligible population have 
been offered an NHSHC assessment since PHE took over responsibility for the programme in 2013. A total of 
25% of the eligible population have received an assessment in that same time period (NHS Health Check, 
2016). Table 3 shows national figures to January 2016. This demonstrates much lower than expected uptake 
of the NHSHC. 
 
Aspirational targets of covering 20% of the eligible population each year, until total coverage of the eligible 
population was achieved by 2013 were put forward by DH in 2008. It was then intended that, subsequently, 
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the programme would focus on those people who became eligible by entering into the eligible age cohort each 
year (Department of Health, 2008b). Again, this was based on an assumed uptake of invitation of 75% 
(Department of Health, 2008a). Evidently, these targets have still to be met.   Artac et al. (2013a) reported that 
national coverage of NHSHC was, on average 8.2% in 2012 with great variation between PCT areas, ranging 
from 0%-29.8%. Still in 2015 that figure stands at just 25% of the population receiving an assessment (NHS 
Health Check, 2016). Cochrane et al. (2013) suggest that such low uptake demonstrates a lack of interest for 
this assessment in the population. Early evidence does, however, suggest that the NHSHC has been effective 
in engaging Black and Minority Ethnic (BME) groups (Cochrane et al., 2013, Artac et al., 2013b, Lambert et 
al., 2012). 
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Table 2: Recommended Interventions 
Intervention offered Existing guidance 
Brief exercise intervention NICE guidance PHI002 Four commonly used 
methods 
to increase physical activity, March 2006 
 
Multi-component weight 
loss programmes 
 
NICE clinical guideline CG43 Obesity, December 
2006 
Impaired glucose 
regulation (IGR) intensive 
lifestyle management 
 
NICE clinical guideline CG43 Obesity, December 
2006 
Stop smoking services NICE guidance PHI001 Brief interventions and 
referral 
for smoking cessation in primary care and other 
settings, March 2006 
 
Antihypertensives for 
those with hypertension 
NICE clinical guideline 34 Management of 
hypertension 
in adults in primary care: partial update, June 2006 
 
Statins for primary 
prevention 
NICE technology appraisal 94 Statins for the 
prevention 
of cardiovascular events, January 2006 
 
Renin angiotensin system 
blockers for those with 
proteinuria 
 
NICE guidance on chronic kidney disease 
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Figure 1: NHS Health Check pathway1 2 
 
Table 3: National NHS Health Check offers and assessments 
 Number (%) 
Eligible population 15579278 
 
Number offered NHSHC 8053495    (51.7%) 
 
Number accepted offer and received NHSHC 
 
3887937    (25%) 
% of those offered a check who accepted 
 
48.3% 
% uptake expected (2008 modelling) 
 
75% 
                                                          
1 Source: Department of Health (2009), Best Practice Guidance, p4 
2 Figure 1 shows the pathway presented in the national guidance. Appendix 11.3 shows the 
local pathway that was developed for the Tees roll out of the programme, there is a slight 
variation to the Tees pathway as it includes assessment of alcohol intake. The decision to 
include assessment of alcohol within the local rollout of the NHSHC was taken by the PCT 
to tailor the check to their local population, discussion of this tailoring can be found in Item 
9 of the TIDieR framework 
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Figured taken from NHS Health Check (2016) 
 
2.3 Evidence from the first years of roll-out 
The majority of published work, to date, from local and national evaluations of the 
NHSHC programme have focussed on coverage, uptake and conversion of 
invitations to appointments. Little has been published concerning patient reactions to 
their CVR assessment and their subsequent journey through making changes to 
lifestyle, adherence to medication, and engagement with annual review. The NHSHC 
has been suggested as a catalyst for change, especially in relation to making and 
sustaining dietary changes. These changes have been noted as being prioritised over 
engagement with physical activity as they are perceived to be easier to implement 
and sustain (Alford and Perry, 2010, Krska et al., 2014, Perry et al., 2014). Whilst in 
the Tees evaluation work with ‘at-risk’ individuals we found that dietary changes 
were the most common of the lifestyle changes to be adopted, many people were 
reluctant to make substantial changes in the belief that guidance about healthy eating 
was changeable. Instead patients opted to make small but sustainable changes such as 
reducing salt intake or limiting saturated fat consumption (McNaughton and 
Shucksmith, 2015). In this same sample, discussion about lifestyle changes were 
broached variably with participants with intervention via statins being the most 
common route of action to reduce CVR (McNaughton and Shucksmith, 2015).  
 
It would seem evident that in order for people to instigate lifestyle changes or 
embark on medical regimens they must process the information about CVR and 
afford value to investing time, effort, and resources into change. The process of 
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understanding CVR is not made in a rational way, as will be explored later in the 
findings section, Perry et al. (2014) suggest an interplay between emotional 
responses, cognitive responses and analytical understanding of risk. It has been 
proposed that the provision of clear and personalised information about CVR (Krska 
et al., 2014, McNaughton et al., 2013), and the utilisation of visual aids (Shaw et al., 
2015, McNaughton et al., 2013) could positively influence cognitive understanding 
of CVR. 
 
Findings from the early years of the NHSHC roll out indicate that provision of health 
checks through non-traditional providers, for example, community pharmacy and 
community outreach in places such as supermarkets, workplaces, and libraries are 
well received by those eligible for the checks (Perry et al., 2014). Outreach services 
based in the community have been observed as an effective mechanism to attract and 
recruit harder to reach populations such as younger (under 50 years old) men 
(Visram et al., 2014), the BME community (Hunt et al., 2013), and those living in 
areas of deprivation (Gidlow and Ellis, 2014) into the NHSHC (Dachsel and Lee, 
2011). This community approach is perceived to be effective at allowing a 
spontaneous opportunity to engage with the NHSHC that would not have been 
prioritised had the individual needed to make a formal appointment to attend a GP 
practice (Perry et al., 2014).  However, the main mode of NHSHC delivery is 
currently through GP practices and it is the experience of people accessing the 
NHSHC in this setting that is the focus of the thesis. 
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Graley et al. (2011) found that within one area (North West London) which was 
made up of eight PCTs, there was huge variation in the amount of budget allocated to 
implement and deliver the NHSHC programme. These findings suggest the 
likelihood of a ‘postcode lottery’ effect on the identification and therefore reduction 
of CVD. Whilst it is important to allow commissioners to have autonomy on service 
design and delivery, there are valid reasons for the setting of national minimum 
standards which emphasise equity of access. 
 
 
2.4 The contentious nature of the NHS Health Check programme  
It should be noted, at this point, that the NHSHC programme is not one of the UK 
National Screening Committee’s (UK NSC) approved screening programmes. In the 
UK, the UK NSC has the responsibility to advise the NHS and government about 
different aspects of screening  such as; how a screening programme is defined, 
ethical implications  and social impacts of screening as well as supporting the 
implementation of approved screening programmes in the UK (UK National 
Screening Committee, 2013). The UK NSC uses a standardised, 22 point, set of 
criteria to assess how viable, effective and appropriate a screening programme could 
be, set around four domains of assessment: the condition, the test, the treatment, and 
the screening programme (Appendix 2). In 2012, there were 12 approved screening 
programmes in the UK offered over the life course. Their availability varies between 
UK countries (UK National Screening Committee, 2012, UK National Screening 
Committee, 2013). In England, the screening programmes offered are shown below 
in Table 4. 
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Table 4: UK Approved screening programmes 
 Life stage 
 Antenatal and newborn Young People and Adults 
Conditions Downs syndrome 
 
Fetal Anomaly Ultrasound Scan 
 
Infectious Diseases in 
Pregnancy 
 
Antenatal Sickle Cell and 
Thalassaemia 
 
Newborn and Infant Physical 
Examination 
 
Newborn blood spot 
 
Newborn hearing screening 
 
Abdominal Aortic Aneurysm 
 
Diabetic Retinopathy 
 
Breast Cancer 
 
Cervical Cancer 
 
Bowel Cancer 
 
Alongside the approved set of screening programmes there are also three screening-
related programmes of work that do not meet, for various reasons, the strict criteria 
to be adopted and approved by the UK NSC. These are; Prostate Cancer Screening, 
Chlamydia Screening and the NHS Health Check (UK National Screening 
Committee, 2013). The UK NSC did recommend the development of a vascular risk 
management programme in 2006 that would provide vascular risk assessment, risk 
reduction and risk management, but not a screening programme as it does not meet 
the UKNSC criteria (Davies et al., 2012). Capewell et al. (2015) argue that the 
NHSHC fails to meet several criterion in relation to the tests used to identify CVR 
and treatment offered (explored in more depth in section 2.10). 
 
The NHSHC programme has raised a number of contentious issues that link into 
wider academic debates. For the purposes of the following section, the NHSHC 
programme and the issues that have been raised about it are explored under the UK 
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NSCs criteria for a screening programme; the condition, the test, the treatment, and 
the programme. Each section will explore the key issues raised by opponents and 
supporters of the programme and also the wider academic literature that links into the 
theme. 
 
2.4.1 The condition 
It is widely accepted that CVD is a clinical condition that is an important public 
health problem as it accounts for approximately 34% of UK deaths annually 
(Townsend et al., 2012). However, how a condition becomes classified and 
categorised as a condition is important to explore, especially as what the NHSHC 
programme actually identifies is not CVD but rather CVR. Cardiovascular risk is 
essentially a prediction of possible future illness based upon the synthesis of 
surrogate markers. The act of illness classification and categorisation requires a 
process of identifying or creating a problem that can be afforded a name and 
subsequently a treatment pathway. What constitutes a problem that is important 
enough to classify is culturally bounded and specific (Goldstein-Jutel, 2011).  As 
Illich (1976) wrote: 
Each civilisation defines its own diseases. What is sickness in one 
might be chromosomal abnormality, crime, holiness or sin in 
another (p112). 
 
The construction and management of health problems can be illustrated by the case 
of dyslexia, which in Western society is problematised and treated as a disorder. This 
disorder would, however, not be deemed as important in a society that did not place 
so much weight on the ability to understand the written word (Goldstein-Jutel, 2011). 
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It is only by developing a concept of what is normal, within a specific society or 
cultural group, that we can begin to classify and understand what is then deemed 
abnormal. Defining normality, through epidemiological inquiry, allows the 
imposition of thresholds and cut points, beyond which outliers and extreme cases can 
be described and explored and subsequently categories developed for these 
infrequent cases (Armstrong, 2011).  
 
This is pertinent to the PhD study, especially in the context of the problematisation of 
one of CVRs surrogate markers – cholesterol. Cholesterol levels, ascertained from 
clinical testing of blood samples, are used to define an individual’s risk for 
cardiovascular disease and the associated complications that are attributed to 
elevated cholesterol levels. However, the cut off point for ‘normal’ cholesterol is 
contested between expert groups (Will, 2005). During the time of this study, the cut 
off point for the upper level of normal cholesterol has been lowered from a total 
cholesterol level of seven down to five. This demonstrates how the categorisation of 
a medical problem is subject to change and how such a small change in the 
categorisation of a problem can create huge numbers of ‘patients’ from a previously 
‘healthy’ population (Smith, 2002a).  
Therefore, how a society classifies and defines disease has a massive impact on how 
we view the population within it. Once a condition has been identified as problematic 
and adopted into a formal classification or categorisation system, the diagnostic label 
has the power to silence certain voices whilst giving credibility to others (Jutel and 
Nettleton, 2011). The classification of illness has the power to change the individual 
from a healthy member of society to one who is now a ‘patient’ with far reaching 
potential repercussions such as loss of insurance or employment, for example (Smith, 
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2002b). The power of the medical professions is kept through their elite medical 
knowledge, their power to diagnose, treat and provide access to services (Conrad, 
1979).  
 
To understand what constitutes a condition, illness, or disease it must first be 
acknowledged what it is to have health. Health is more than just the absence of 
illness. Illich (2003) writes that a healthy individual is one who shows the ability to 
cope with pain, sickness and death, all of which are an integral part of the ‘human 
condition’. Societally, we value health. As such we strive to make sense out of what 
it is to be healthy and more importantly we strive to understand what creates ill 
health and when it might strike (Rosenberg, 2002, Rosenberg, 2007, Conrad, 2011). 
Modern medicine has endeavoured to map and make sense of signs and symptoms of 
illness and their expected trajectories in order to treat them through medical 
intervention. Historically, through the practice of medicine, we have sought to find 
coherent, explanatory relationships between external threats to health or behaviours 
and their related consequences and outcomes (Rosenberg, 2007).  
 
The process by which aspects of the human condition or symptoms of human 
existence become allocated to medicine so that they can be defined, categorised and 
ultimately managed by the medical profession has been termed ‘medicalisation’ 
(Goldstein-Jutel, 2011). The breadth of what is classified as a medical condition is 
constantly evolving (Armstrong, 2011, Eborall and Will, 2011). Medicine’s power to 
diagnose and claim conditions is a gradual process, encompassing and releasing 
conditions and syndromes within its elastic boundaries (Conrad, 1979, Smith, 
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2002b).  The creeping boundaries of ‘medicalisation’ are constantly shifting, 
enveloping an expanding set of ‘conditions’ that have never previously been included 
within the medical domain. For example, ‘conditions’ such as; childbirth (Johanson 
et al., 2002), mental illness (Conrad, 2005), learning difficulties (Goldstein-Jutel, 
2011), and even death (Clark, 2002) have become medicalised.  
 
Whereas other conditions have become demedicalised by shifts in culture. Which 
conditions are deemed as lying within the purview of the medical professions is 
symptomatic of the views and priorities of each specific society and relative to points 
in history. However, whilst these boundaries have the capacity to grow and expand 
they simultaneously have the capacity to contract and withdraw through the process 
of demedicalisation (Conrad, 1992). One famously cited example is the removal of 
homosexuality as a disorder in the seventh printing of the Diagnostic and Statistical 
Manual II, in 1974 (American Psychiatric Association, 1968), which demonstrates 
how societal shifts in morals and ideals can shape the boundaries of what is defined, 
categorised, diagnosed and treated as a medical ‘problem’.  
 
The expanding remit of medicalisation has arguably led to better care and outcomes 
for many (Ebrahim, 2002). The drive of the medical profession to develop tools to 
identify and treat illness has led to the eradication of many illnesses and the control 
of others, at least in the Western world (Rosenberg, 2007). However, the concept of 
medicalisation, has been associated with negative connotations through its link with 
overtreatment and making patients out of healthy populations (Conrad et al., 2010).  
There is thus a tension between the benefits to society and to patient outcomes that is 
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experienced by ‘conditions’ being adopted and treated by medical professions and 
the overburden and treatment of conditions (Moynihan and Smith, 2002). 
 
Medicalisation has been associated with the control of what society deems as deviant 
behaviours. Thus, behaviours which once may have been described as immoral, 
sinful and unacceptable have instead been branded with a medical meaning so that 
they can be controlled, monitored and treated (Gabe, 2013, Rosenberg, 2007). Some 
have argued that the expansion of medicine’s jurisdiction is primarily a consequence 
of the medical profession exercising its power to define and control what constitutes 
health and illness in order to extend its professional dominance (Turner, 1995). 
Others have considered medicalisation to be the result of broader social and 
pharmaceutical processes to which doctors are simply responding (Gabe, 2013). The 
ever growing remit of medicine has also been responsible for huge increase in health 
spending of governments and insurance companies (Conrad et al., 2010).  
 
Inevitably, the rise of medical intervention has not reduced total mortality rates; we 
still experience a 100% death rate. What it has achieved is to shift the age at which 
we meet our end and the predominant causes of death. Arguably, it has also created 
social divisions and inequalities in how we die. Modern medicine has facilitated the 
decline of many illnesses and diseases and in some cases eradicated the threat of 
many infections which historically would have exterminated huge chunks of the 
population (Illich, 2003). This, alongside the technological advances in clinical 
procedures that allow the identification and diagnosis of a new breed of ‘illnesses’ – 
the risk factor.  
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Future risk of disease can be defined as a probability of a future event occurring, 
often expressed as a numerical value, or percentage chance of suffering an adverse 
event within a given time period (Spiegelhalter and Riesch, 2011). Recent decades 
have seen a sharp rise in interest in risks and risk factors, as demonstrated in a 
proliferation of academic literature, this obsession, it has been noted, itself reaching 
epidemic proportions (Skolbekken, 1995). Probabilities and percentages are helpful 
tools for policy makers when considering population level planning and allocation of 
resources (e.g. what proportion of a population might eventually require care for 
diabetes or cancer). However, these concepts may be less helpful in communicating 
possible health outcomes to individuals because population based probabilities are 
incapable of incorporating the specific circumstances of the individual (Heyman et 
al., 1998). Rather, we need to develop ways of looking beyond the expression of risk 
as a probability of a future event and acknowledge the effects of wider determinants 
of health on the individual (Aven, 2013). 
 
It is clear that the process of medicalisation has the power to determine what is 
deemed to be a bona fide medical condition in need of intervention and treatment at 
any given time. This process of medicalisation leads to the categorisation of 
illnesses, giving them validity. In terms of CVR identification, which is the 
prediction of a possible future event rather than the identification of a physiological 
condition, it is clear that the medical profession has identified it as a ‘condition’ that 
is necessary to tackle. However, it is unclear if the general population accept this 
classification of CVR in the same way (explored in Chapter 3). The identification of 
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future risk is pertinent to this thesis because it links to uncertainty rather than 
certainty of an event occurring or having already occurred which could influence the 
level of engagement with all aspects of the NHSHC programme. The following 
section focusses on the tests undertaken to identify CVR in the NHSHC programme. 
 
2.4.2 The test 
It has been argued that the testing offered as part of the NHSHC programme is not 
demonstrated to be either adequate or acceptable as the tools used to calculate CVR 
are imprecise at an individual level (Capewell et al., 2015) and low uptake of 
assessment suggests a lack of interest in the population (Cochrane et al., 2013). The 
NHSHC assessment involves a risk calculation based upon measurement of BMI, 
blood pressure, smoking status and lipid levels, alongside socio-demographic 
variables and anthropometric measurements (Department of Health, 2008c). These 
measurements are entered into a risk equation for calculation.  
 
There are several available CVR calculators on the market that generate an 
individual’s ten year risk score, for example Framingham, JBS, QRISK2 (Davies et 
al., 2012). Each risk calculation is based upon a different equation, using varying 
surrogate risk factor markers within it. Initially it was recommended that the 
Framingham 1991 calculation be used in the NHSHCs. However, the Framingham 
equation has a tendency to overestimate risk in low risk populations and 
underestimate risk in high risk populations (Brindle et al., 2006). The 
underestimation of risk in high risk populations is especially pertinent when 
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considering the reduction of health inequalities. For populations such as South 
Asians, other BME groups and all those living within deprived areas of the UK the 
underestimation of risk, when they could be at highest risk, is problematic  (Davies et 
al., 2012). The QRISK2 calculation, which incorporates ethnicity, family history and 
deprivation into its calculation (Davies et al., 2012), is now recommended for use in 
the UK. The calculation is thought to be superior to the Framingham at accurately 
predicting ten year cardiovascular risk in a UK population (Collins and Altman, 
2010, Collins and Altman, 2012, Scott, 2010, Jackson et al., 2009, Gholap et al., 
2011, Wald et al., 2011).  In March 2014 a new calculator, JBS3, was launched, 
which not only provides a ten year risk score but also provides a lifetime risk score 
alongside generating an individual’s ‘heart age’ in years (Joint British Societies for 
the prevention of cardiovascular diseases, 2014).  
 
The process of using surrogate markers to predict the risk of a future adverse event 
also locks into wider academic debates about the rise of surveillance medicine. 
Armstrong (1995) describes this rise of surveillance medicine, a medicine that is 
concerned with identification with precursory signs of illness – so called risk factors. 
Technological advancements have allowed this shift in focus from the outcomes of 
illness to a new space, as Armstrong describes it, a fourth dimension outside of the 
body – time. This is a space before any disease has taken form but where risk factors 
may point to the potential for disease. Technological advancement and the 
development of pharmaceutical intervention have been identified as facilitators of 
this increase in the jurisdiction of medicine and become drivers for medicalisation 
(Conrad, 2005), suggesting that technology and drugs were once responsive to need 
but that now they have been identified as drivers in the creation of conditions. 
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Moreover, in addition to these ‘supplier’ issues, there has been a rise in what is 
termed the ‘health consumer’ and there is more consumer demand for medical 
products and services than ever before (Conrad, 2005).  Now, more than ever before, 
technology has the power to identify illness and precursors of disease. Skolbekken 
(1995) argues that technological developments have facilitated a shift in our beliefs 
about health and illness. The advancements in science and technology have shifted 
attention away from risks that are outside of our control that are situated outside of 
the body to factors that are inside of our bodies and within our control. By their 
nature, the use of surrogate markers is not fool proof, and identification of risk is not 
a guarantee that disease will develop. Rather, it shows evidence of a process that is 
assumed to be a predictor of disease (Temple, 1999). Indeed, risk of disease, as 
identified through surrogate markers, or genetic testing may be problematic. 
Traditionally, diagnostic boundaries, which trigger the validation of treatment 
through medical intervention, have expanded to include milder instances of disease 
or new categories have been defined to encompass pre or proto disease (Armstrong, 
2011, Melzer and Zimmern, 2002, Rosenberg, 2007).  Grimes and Schulz (2005) and 
Freemantle and Calvert (2007) both indicate that the use of surrogate markers is 
more useful to market interventions than it is in improving patient outcomes. This 
treatment of risk is explored in the following section. 
 
The previous section highlighted how CVR has been identified as appropriate for 
medical intervention; however, the tools currently available to identify CVR in the 
population are imprecise and widely contested. Technological advancements have 
been shown to have the power to identify disease and illness before it physically 
manifests in the body. However, the CVR risk calculators used in the NHSHC 
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programme rely on the computation of surrogate markers for CVD to offer a 
prediction of future risk expressed as a percentage which may or may not be reliable. 
This raises questions as to the appropriateness of rolling out a country-wide risk 
identification and management programme that relies on calculator tools that work 
better at a population level rather than at an individual level. 
 
2.4.3 The treatment 
The ‘risk factor’, essentially a surrogate marker, has been adopted within the medical 
sphere as synonymous with disease itself and managed and treated as such 
(Aronowitz, 2009). However, the treatment options offered within an NHSHC have 
been argued to be unacceptable. Studies have shown that behavioural interventions 
(diet and physical activity) often lead to short term behaviour changes; however, 
these changes are rarely sustained over the long term (Booth et al., 2014, Heath et al., 
2012). Similarly, reduction of alcohol consumption through Brief Intervention has 
been shown to make only a small difference in the amount of alcohol consumed 
(Platt et al., 2016). Evidence also suggests that patients actively and successfully 
conceal their drinking behaviours from their healthcare providers (Haighton et al., 
2016). There is evidence that smoking cessation offered within a healthcare setting 
that is mindful of people’s preferences and needs is effective in helping people to 
quit smoking for good (National Institute for Health and Care Excellence, 2018). 
Adherence to statins for primary prevention is also low (Benner et al., 2002). Added 
to this, general health checks as a mechanism to reduce morbidity and mortality in 
the population have been demonstrated to be ineffective (Krogsbøll et al., 2012). For 
a programme such as the NHSHC which relies on the impact of sustained behaviour 
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change this means that the full intended positive outcomes of behaviour change on 
CVR may never be fully realised. 
 
Oliver (2009) argues that annual health checks are contributing to the creation of 
patients out of an elderly population that is actually feeling fit and well. He states 
“they [patients] may feel reasonably well, but the NHS does not permit such 
euphoria” (p603). He argues that, once identified as an ‘at-risk’ person, individuals 
who entered the doctor’s office as happily aging people leave as a patient, with a 
treatment pathway which could, in turn, lead to feelings of being scared or uneasy, 
instead of comfortably aging. Individuals are, it is argued, being actively recruited 
into risk states (Aronowitz, 2009). This warning about turning healthy elderly people 
into patients and the dangers of over-prescription of medicines has also been echoed 
in the national press (Dawson, 2013, Smith, 2009). 
 
Not all changes that occur to an aging body necessitate treatment, and certainly, 
some natural processes are actually beneficial. Oliver (2009) discusses how, as the 
body ages, the cardiovascular system becomes more rigid. If through medical 
intervention mild hypertension is reduced this could actually lead to vertigo in 
elderly people. Vertigo is dangerous in an aging population where falls can lead to 
disability.  
 
As previously discussed, the main treatment offers through the NHSHC programme 
are behavioural advice and prescription of lipid lowering medications. Within the 
UK setting, the link between cholesterol and the effects of raised cholesterol on the 
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body are familiar and well-rehearsed through health promotion campaigns and 
advertising through the media. Our supermarket shelves are crammed with products 
from bread and cereals to yoghurt and butter substitutes all claiming to reduce 
cholesterol, and improve heart health (Sainsbury's, 2017). For example, whilst 
cholesterol and the need for cholesterol reduction may sit firmly in the public 
consciousness, in recent times focus has shifted from reducing overall cholesterol 
levels to lowering low density lipoprotein cholesterol (LDL) (bad cholesterol) and 
increasing high density lipoprotein cholesterol (HDL) (good cholesterol) 
(Kritharides, 2014). It is also widely accepted that statins are both a safe and 
effective treatment for hyperlipidaemia (high cholesterol) and primary prevention of 
CVD (Taylor et al., 2011b). 
 
As discussed, the links between saturated fat, cholesterol, and diseases of the 
cardiovascular system are well rehearsed in Western society. However, just because 
these ‘causal’ links have been drawn and accepted into the wider public and 
professional consciousness, it does not mean this ‘taken for granted’ knowledge is 
not contested. Health historian Greene (2007) maps a long and tempestuous history 
of cholesterol’s demonisation, from its identification as an marker that has been 
associated with CVD and the development of pharmaceutical interventions to ‘treat’ 
it. He writes; 
The average consumer is not conversant with the chemical structure 
of this five ringed sterol [cholesterol] or its role in the biosynthesis 
of bile acids, sex hormones, and gallstones, chances are that he or 
she knows cholesterol to be an agent of progressive disease of the 
heart and blood vessels, to be avoided in one’s diet and minimised 
in ones bloodstream to prevent illness and promote longevity 
(p151).   
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Cholesterol was first identified in the Framingham (1957) studies and identified as 
one of the top two “pre-pathological” categories, along with hypertension, that was 
predictive of CVD (Greene, 2007). Unlike other risk factors such as hypertension, 
diabetes, smoking, gout, and obesity which were branded as risk factors for CVD in 
the Framingham studies and had enjoyed a huge increase in promotion as 
preventable risk factors with prophylactic intervention available, cholesterol did not 
have an appropriate treatment available. Treatments that were available were 
intolerable, dangerous, or simply did not work. Cholesterol as a marker for CVD was 
subsequently shelved (Greene, 2007). Many treatments have been developed over the 
years and had limited success in managing cholesterol, and even those treatments 
that did show clinical effectiveness were often unpalatable: 
 
The dose [of cholestyramine] is very large, and patient compliance 
is very low, because they don’t want to take all of this stuff. The side 
effects: it has an odor of rotten fish, which we had some trouble 
getting rid of it. It was a granular material, which sandpapered a 
part of your anatomy on the way out, it also caused fecal impaction 
in old people…but still, nevertheless, it’s still a drug that actually 
works. It’s safe, it’s not absorbed, it’s safe. (Alfred Roberts, Merck, 
Sharpe, & Dohme Cholesterol Project Manager (1987) Cited in; 
Greene, 2007, p169).  
 
It was not until 1987, when Merck launched lovastatin, that cholesterol had a more 
palatable treatment available. From that point, under heavy marketing and 
promotion, cholesterol enjoyed a process of categorisation and adoption into the 
medical domain as a modifiable risk factor for CVD. 
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The causal link between consumption of fat, the body’s production of cholesterol, 
and subsequent development of CVD has not been proven. There are correlations 
between the three variables (Greene, 2007), and these associations are documented at 
a population level. However, they are not “sufficiently causal at the individual level” 
(Rockhill, 2001, p336). Historically, several trials were conducted to assess the 
impact of lifestyle intervention; diet, smoking, reduction of blood pressure but 
showed negligible results in reduction in morbidity and mortality (Greene, 2007). 
Nevertheless, diet, physical activity, and lipid lowering medications have become 
synonymous with CVR and CVR reduction and prevention. 
 
Advice on the threshold for prophylactic statins treatment, within the NHSHC, has 
changed during the period of this PhD study from 20% to 10% (National Institute for 
Health and Care Excellence, 2016), now including those previously deemed at low 
CVR. This decision has been controversial, Abramson et al. (2013) suggest that the 
benefits derived from treating a low CVR risk population with statins are minimal, 
whereas the potential to cause harm is increased in this population, raising an ethical 
question about harm/benefit ratios. Their analysis shows that to prevent one serious 
cardiovascular event, 140 low CVR patients would need to be treated for five years 
with statins. 
 
It seems logical that adherence to medication regimens is essential to the 
effectiveness of intervention. To reap the supposed benefits of prophylactic statin 
intervention, patients need to take their medication regularly and for sustained 
periods (Ho et al., 2009, Cramer et al., 2008). The monetary costs of non-adherence 
to medical intervention mean that this is not just an effectiveness issue but also 
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represents a huge cost to the healthcare system that provides the medication. 
Hovstadius and Petersson (2011), in their Swedish population study, conclude that 
secondary non-adherence (where prescriptions are picked up by the patient but never 
taken) should be the focus of non-adherence cost reduction activity. They suggest 
that this specific and costly type of non-adherence is associated with free provision 
of medications, in that those prescribed free medications are less likely to adhere to 
the regimen.  
 
Sustained adherence with statins treatment is generally low, with many patients 
discontinuing use within six months of initial prescription (Benner et al., 2002). In 
their study exploring adherence to simultaneous antihypertensive and lipid lowering 
medications, Chapman et al. (2005) found that patients with previous evidence of 
CVD were more likely to adhere consistently to their prescribed medication regimen 
than when statins were used for primary prevention. This finding has been replicated 
in other studies (Poluzzi et al., 2008), with one study reporting two year adherence 
rate for primary prevention at only 25.4% (Jackevicius et al., 2002). 
 
Many reasons are proposed for discontinuation of statin treatment. In their cohort 
study of statin use and discontinuation analysing 107,835 real world patient records, 
Zhang et al. (2013) found that more than half of their sample had, at least 
temporarily, discontinued their statin. 17.4% of their study sample had a ‘statin-
related event’ recorded within their record that may have contributed to the decision 
to discontinue statin therapy. Of those who discontinued, half reinstated a statin 
(reconfigured) and of those 90% of them continued with statin therapy at 12 months. 
Side effects such as gastric discomfort and muscular pain or heaviness of limbs have 
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been attributed to statin use and cited as a reason for seeking reconfiguration or 
discontinuation of statin (McNaughton and Shucksmith, 2015, Mann et al., 2007). 
 
Behaviour change interventions such as dietary advice, physical activity and brief 
intervention for alcohol consumption have been shown to instigate small but 
measurable changes in patients, however, these changes are often not sustained over 
the longer term. Conversely, the prescription of statins is thought to be both safe and 
effective for the primary prevention of CVD.  However, studies have shown that 
adherence to statins is variable at best and low at worst. Many people who embark on 
a regimen of statin use experience side effects which are deemed to be intolerable 
and therefore discontinue their use. This raises questions for programmes such as the 
NHS Health Check that rely on such behaviour change interventions and medications 
to reduce individual CVR – if patients do not sustain the changes or take these 
medications over the longer term they are unlikely to reap the proposed benefits of 
CVR reduction. 
 
2.4.4 The programme 
Despite the aim of positively influencing the health of the population, the NHSHC 
has been met with voices of caution since its very inception. In 2012 the NHSHC 
programme came under very public criticism, when Krogsbøll et al. (2012) published 
the results of their systematic review which questioned the effectiveness of the 
programme and criticised the NHSHC programme for being rolled out based upon 
theoretical modelling, rather than evidence from randomised controlled trials. 
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Krogsbøll et al. (2012) highlighted evidence that suggested universal health checks 
were neither effective at reducing morbidity or mortality in the general population. 
This was further backed up by the findings of the inter99 trial that showed an 
intervention similar to the NHSHC programme had shown no benefit on morbidity or 
mortality (Jørgensen et al., 2014). Krogsbøll et al. (2013) went on to call for the 
abandonment of the NHSHC programme until such time as the evidence base for 
effectiveness of the programme is stronger. Rebuttals have been played out through 
the BMJ, with some defending the universality of the programme (Soljak et al., 
2013) and suggesting that abandonment of the programme to wait for the evidence 
would be irresponsible (Waterall et al., 2015). 
 
It has also been suggested that instead of delivering intervention to individuals, 
which relies on their sustained participation and engagement, population level 
intervention would be most appropriate (Barton et al., 2011, Capewell and Ford, 
2011, Capewell and Graham, 2010, Jørgensen et al., 2013, O'Flaherty et al., 2013). In 
their view, changes to population-wide policies such as tobacco control and making 
healthy food choices affordable and accessible could promote cardiovascular health 
and would be more effective and cost effective than the NHSHC programme 
(Capewell et al., 2015). Tackling contributing factors to CVD and CVR in this way 
would, it is suggested, be effective in tackling health inequalities by acknowledging 
that environment and circumstance make many choices for us. Taking a true public 
health approach could positively influence the health of those most at need, who may 
not access the NHSHC (McCartney, 2014). Moreover, there has been a call from 
some quarters to develop a targeted approach, rather than a universal approach, to 
NHSHC delivery (Dalton, 2013). A targeted approach to inviting individuals for their 
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check has been identified as more cost effective than offering the check universally, 
and has been demonstrated to effectively identify those at greatest risk by targeting 
invitations to deprived communities and family members of those with CVD 
(Chamnan et al., 2010b, Hingorani and Hemingway, 2011, Lawson et al., 2010) 
 
To develop and implement a complex population-based intervention takes 
meticulous planning. Many warned that in order to be successful, the NHSHC 
programme needed to incorporate widespread advertising to raise awareness and 
normalise the new programme, an element of proactive case finding so as not to 
widen already disparate health inequalities, robust provision of appropriate lifestyle 
intervention and the development of robust IT systems (Patel et al., 2009, Khunti et 
al., 2011, Capewell, 2008). In our own evaluation of the NHSHCs in Tees, we 
identified the same factors as barriers to implementation in GP practices and 
community pharmacy (McNaughton and Shucksmith, 2014, McNaughton et al., 
2011, Oswald et al., 2010).  
 
Evidence has shown that intervention in the shape of universal health checks to 
identify CVR are relatively ineffective in reducing morbidity and mortality in the 
population. Rather, population level interventions that tackle the wider determinants 
of health (section 2.1.2) would likely lead to greater impact on the health of the 
population. 
 
Chapter two has set the contextual scene about the NHSHC programme and how it 
came into being in the UK, how the programme is shaped and has evolved, and also 
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highlighted some of the contentious issues around its development and 
implementation. It was noted earlier in this chapter that the majority of the evidence 
relating to the roll out of the NHSHC has focussed on the processes of 
implementation and neglected to focus on the experiences of those individuals who 
have accepted an NHSHC assessment and been identified as at increased risk. Any 
successes of the programme will essentially be brought to fruition only if those at-
risk individuals implement and sustain changes to their lifestyles and engage with 
medications. This thesis is concerned with the patient journey from risk identification 
through making and sustaining (or not) changes post assessment. The following 
chapter introduces the idea of what it means to be a ‘patient’ and explores literature 
from the social sciences to provide further context to the thesis before moving on in 
chapter 4 to critique the theoretical lens used to underpin the analysis of data. 
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3 Being a patient 
Chapter 3 explores some of the sociological literature that is pertinent to exploring 
what it means to be a ‘patient’ and some theoretical literature about how this is 
experienced. Modern western medicine is built around a biomedical model of health 
and illness (Portney and Watkins, 2009). This model assumes that there is specific 
and identifiable cause for illnesses that alter the anatomy and physiology of the body, 
in turn presenting symptoms which can be identified (Bury, 2013).  Adoption of this 
conceptual framework of health and illness assumes a linear relationship between the 
cause of ill-health (pathology) and its resultant impairment (Portney and Watkins, 
2009). ‘Health’ is often conceived as the absence of a biological abnormality, and it 
is assumed that illnesses have specific causes and subsequently end points. It is 
expected that through medical intervention illness can be treated, therefore stopping 
or reversing (curing) the biological process (Bury, 2013). In the UK, the medical 
profession has largely been built around the execution of this biomedical model. 
People expect and are expected to engage with a traditional pathway from identifying 
signs and symptoms of illness, undergoing medical testing, formal diagnosis, to 
treatment or intervention to halt or reverse illness.  
 
This is, of course, a rather siloed way to conceive of health and illness and gives 
precedence to an objectivist epistemological explanation of health, illness, and 
treatment. The focus on a biomedical model neglects the contribution of social and 
environmental influences on health and illness. The following chapter is grounded in 
a socio-medical explanation of health and illness and what it means to become and 
‘be’ a patient. Chapter 2 explored the medicalisation of conditions and briefly 
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touched upon the process by which these become categorised, classified, and 
labelled. However further exploration of this is needed to unpack the effects of 
diagnosis and the patient journey.  
For an illness to be recognised, diagnosed, and treated it must first be identified as 
problematic. Illness is socially defined and may range from physiological 
abnormalities, psychological disorders, to moral sickness. Each society deems what 
is and is not within the bounds of acceptability (Illich, 1976). 
  
In modern western society, the classification and categorisation of health and illness 
is the privilege of the medical professions (Armstrong, 2011). Claiming power over 
people's bodies, medicine imposes labels on individuals or groups through the 
process of diagnosis, to identify physical or social conditions that are deemed to be in 
violation of what is acceptable for the time (Davis, 2011). A standard classification 
system for modern illnesses was first constructed in the 18th century. Over time this 
has been revised, updated and amended with the identification of new conditions. 
The International Classification of Disease (ICD) was developed as a standardised 
tool to catalogue these conditions (Armstrong, 2011). New disorders and illnesses are 
identified periodically. Thanks to technological advancement the scope of illness 
identification is ever expanding. Medical professionals now have access to a myriad 
of tools to facilitate their role i.e. blood tests and x-rays and routinely rely on 
technologies to accurately diagnose conditions (Goldstein-Jutel, 2011). 
  
The pharmaceutical industry plays a major role in the creation, as well as treatment, 
of illness. Ebeling (2011) illustrates how pharmaceutical companies can create 
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conditions, and thus demand for their product, by marketing signs and symptoms of 
ill health. If these symptoms are generic enough, a mass market can be created for 
their drug. Ebeling (2011) uses the recent case of the rebranding of the drug, Prozac, 
to fresh branding of Sarafem. The Prozac patent was coming to an end and so the 
manufacturer had to find novel ways to sell the drug, to avoid losses from Prozac 
generics being used. As such, Sarafem, a chemically identical drug to Prozac, had 
been approved, endorsed and marketed to treat a little known condition called 
premenstrual dysmorphic disorder (PMDD), illustrating how pharmaceutical 
companies promote disorders in order to create a market for their drug. Likewise, 
Greene (2007) recounts how statin was marketed for the control of cholesterol, a 
disorder that was not in the public consciousness until there was a drug that was 
available to treat it. In the UK, the role of cholesterol in the development of CVD has 
been heavily emphasised. Products to reduce cholesterol are marketed direct to 
consumers, e.g. Flora proactive, and lipid lowering medications are routinely offered 
to reduce cholesterol levels. Moynihan et al. (2002) warn of the dangers of ‘disease 
mongering’ alliances between pharmaceutical companies, doctors and consumer 
groups that take the newest ‘risk factor’ and market it as a disease in its own right. 
Goldstein-Jutel (2011) also highlights the effect of these alliances, below. 
Helping people to consider themselves ill or at-risk of illness 
provides a platform for piggybacking commercial interests onto 
medical authority. And creating a disease category out of a self-
identifiable statistical deviation such as weight enables the 
commercial exploitation of those afflicted (p48-49). 
 
Once a condition has been identified, categorised, and a suitable treatment 
developed, the first step to becoming an individual with a condition – or patient – is 
the act of diagnosis. 
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3.1 Diagnosis 
The act of diagnosis, is central to modern medical practice, providing clarity, 
organisation, categorisation, and proposed course of action to an otherwise random 
set of signs and symptoms (Armstrong, 2011, Jutel and Nettleton, 2011, Rosenberg, 
2007). Goldstein-Jutel (2011) describes this process as: 
 
Like being handed a road map in the middle of the forest. It shows 
the way - but not necessarily the way out. It indicates what the path 
ahead is going to look like, where it will lead, the difficulty of the 
climb, and various potential turn offs along the way. Perhaps it 
identifies the destination, but not necessarily (p1). 
 
In this way, diagnosis can be understood to be an event that opens up doors of 
opportunity and access to treatments and services to manage the identified condition 
(Conrad, 2011, Rosenberg, 2007). Therefore, diagnosis not only provides a 
conceptual framework to organise symptoms into an illness or disorder, it also offers 
a proposed course of action – practical steps that can be taken to halt or navigate the 
illness trajectory. The ‘space’ created by the act of diagnosis is a place where 
differing knowledges, and practices converge with multiple vested interests, social 
values, and anxieties of different parties from which an ever expanding set of social 
consequences emerge (Jutel and Nettleton, 2011).  
 
Diagnosis is thus a social act, constructed between a set of social actors i.e. 
government bodies, medical professionals, patients and wider social networks. Each 
has a role in deciding what deserves diagnosis, what can be diagnosed and 
subsequently what follows from diagnosis (Brown et al., 2011). Not only does 
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medicine hold the power to legitimise illness through affording it a name and 
diagnosis, it also has the power to allocate resources, and treatment (Turner, 1995). 
This highlights how the process of diagnosis is an exercise that sets the professional 
apart from the layperson. Having the power to diagnose provides medical 
professionals authority in their superior medical knowledge and training, increasing 
the medical professional's status and introducing a power differential in the 
interaction with the layperson.  However, whilst the act of diagnosis affords the 
medical professional power over illness and ultimately the individual’s body, it 
affords certain privileges to the patient too (Parsons, 1975). Diagnosis gives the 
individual access to resources, services and treatments permission to take sick leave 
from work, access to the sick role (described later in the chapter) and a label to 
identify with, or contest (Goldstein-Jutel, 2011).   
 
Not all diagnoses are straightforward. Brown et al. (2011) describe how the act of 
diagnosis provides a place for contestation and compromise between actors (health 
professionals and laypersons). In cases where the opinion of the layperson and that of 
the medical professional are at odds, there is the opportunity to contest a diagnosis or 
treatment, especially when the individual receives a diagnosis that they were not 
expecting. This, however, is framed in the context of individuals that have sought a 
diagnosis of symptoms.  
 
For the patient, the diagnostic event can be a powerful experience; an experience that 
can divide one’s life into ‘before’ and ‘after’ receiving the news.  
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"The verbal act of presenting a patient with a diagnosis is never a 
simple act of conveying value-neutral biomedical information. It is 
an act fraught with symbolism. If a person is told 'you have cancer' 
(or any life threatening disease) these words irrevocably alter that 
person's consciousness, view of the future, relationships with family 
and friends and so on. Moreover, the utterance marks a boundary. 
It serves to divide life into 'before ' and 'after', and this division is 
henceforth superimposed onto every rewrite of the individual's life 
story" (Fleischmann cited in; Goldstein-Jutel, 2011; p10).  
 
Diagnosis can mark a boundary and spur many chain-reactions in a person’s life. The 
effects of diagnosis reach far beyond the doctor’s surgery. As noted previously, 
diagnosis can provide access to resources, but also to the sick role and a host of other 
privileges but it can also have a huge effect on how the individual perceives 
themselves and their identity (biographical disruption is discussed later in this 
chapter).  
 
The doctor-patient relationship is changing. Where once Parsons (1951) wrote that 
the patient was a helpless actor who was technically incompetent, with the rise of 
technology and the availability of information ever expanding laypeople can now be 
expert in their symptoms or condition well before approaching a medical expert for 
help and advice. Internet-based tools can be used to diagnose possible illness, 
research treatment options and have information to support or refute a clinician's 
opinion and course of action and ultimately question the doctor’s dominant status 
(May, 2007).  
 
3.2 Sick role 
Medical professionals, doctors and increasingly other professions allied to medicine, 
have the power to define a disease or condition, which ultimately gives them the 
60 
 
power to treat it and provide access to resources and services (Smith, 2002b). These 
professionals are therefore gatekeepers to the ‘sick role’ and have the power to afford 
or remove exemptions from societal obligations, thus having a direct role in social 
control (Conrad, 1979). Beginning with the work of Talcott Parsons in the 1950s 
there has been a focus on the way in which individuals conceptualise illness, carry 
out the work of being a patient and conform to the expectations of what it means to 
be ‘ill’. Through the notion of the ‘sick role’, illness can be viewed, not just as a 
clinical condition with an expected trajectory, but also as a social role which brings 
along with it a set of expectations and obligations in return for certain rights and 
privileges for the duration of the illness (Parsons, 1951). The focus of this seminal 
work centred on the ‘labour’ that those who are ill are expected to undertake in order 
to become well again. For example, an individual is afforded the right to be relieved 
of their social obligations for the duration of a sickness ‘episode’, as long as they are 
seen to be doing the work of attempting to become well again by enlisting the 
expertise of health professionals and following their advice. Seeking out the sick role 
can be used as a tool to provide legitimation for signs and symptoms of illness and 
provide rational reasons for opting out of social responsibilities (Glenton, 2003). This 
release from social duty is afforded by peers (family, friends, work colleagues) in a 
reciprocal social agreement until such time as the sick person is able to resume their 
responsibilities (Miczo, 2004). However, for some conditions that are difficult to 
biologically determine, such as chronic back pain or Myalgic Encephalopathy (ME), 
individuals may strive to be accepted within the sick role. The lack of ‘clinical 
evidence’ that can be ‘objectively measured’ can leave these individuals lacking the 
professional endorsement of medical care and treatment and also provoking 
accusations of malingering or hypochondria (Glenton, 2003).  
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Given that healthcare professionals are the only group of people who can 
legitimately give access to the sick role and other benefits and treatments for the sick 
(Turner, 1995), the clinical encounter can be a fraught dynamic, with negotiations of 
power and dominance whereby the actors (professional and lay person) enact specific 
roles. These encounters may raise frustrations if the actors do not conform to their 
subject position (Fahy and Smith, 1999). However, in recent times – as a 
consequence of the change in the availability of medical information, but also 
because of the increasing number of long term or chronic conditions - there has been 
a shift in the dynamic of the medical encounter, away from the original Parsonian 
model of a patient seeking legitimation of illness and access to the sick role, to an 
encounter that also allows for co-construction of health, illness, and treatment 
pathways in a context where multiple complex agendas are at play (May, 2007, 
Parsons, 1975). This shift allows for a move towards a clinical encounter whereby 
the professional and patients come to a communal specification of an illness and its 
treatment pathway and make shared decisions about how the patient would like to 
proceed along their journey and especially when the patient is required to engage in 
self-management of their condition (Montori et al., 2006). 
 
3.3 Illness careers 
Building on Parsonian conceptions of the sick role, sociologists such as Bury (1984) 
turned to explore the experiences of those diagnosed with chronic conditions, a 
population unlikely to move back out of the sick role, to understand the meaning of 
illness and how it is experienced. Bury’s work surfaced the highly influential concept 
of biological disruption. He suggests that those identified with chronic illness 
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journey through stages of biographical disruption from acknowledgement and 
identification of signs and symptoms of illness, leading to a decision to seek 
professional help, to constructing a narrative to explain why this has happened at the 
current time, to mobilising resources to deal with the disruption experienced. The 
process of internalising and identifying as a sick person has been highlighted as 
potentially producing feelings of engulfment with hopelessness and despair, and of 
having severe negative impacts on the lives of patients (Beanlands et al., 2003). 
Patients often develop narratives as a mechanism to explain their illness and 
contextualise it within their own lives (Bury, 2001). Prioritisation is often given to 
striving to continue to live a ‘normal life’ by continuing to engage in social roles 
such as being a parent or being in employment, so that ‘patienthood’ does not 
consume one’s entire identity  (Townsend et al., 2006).  
 
Other influential works have tried to unpack the processes of formation and 
management of patient identity. Karp (1994) likens the journey towards 
‘patienthood’ to career progression – a process that moves through distinct stages to 
an ‘endpoint’. Like Bury, Karp identifies five stages of the process of becoming a 
patient and reshaping the concept of self and identity. Again, this is presented as a 
linear model moving through distinct stages, namely; noticing a symptom or set of 
symptoms, recognising the symptom as ‘wrong’, suffering a period of crisis 
(realising you are sick), restructuring narratives of the self to develop an illness 
identity, and arriving at a state of acceptance and ‘getting on with it’. It is 
acknowledged that the process of constructing illness narratives and new concepts of 
self are not achieved in a vacuum. Rather, these concepts are co-constructed in 
partnership with other people; spouses, family, friends, and health professionals to 
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arrive at a narrative that not only explains the self of the past and present but also the 
self of the future (Radcliffe et al., 2013).  
 
 
3.4 The work of being a patient 
Sociologists of health and illness have characterised the effort required by 
individuals with health conditions to navigate the sick role and understand and 
manage their health as a form of ‘work’. These individuals are increasingly required 
to deal with and navigate highly complex healthcare systems, medication regimens, 
and carry out and sustain changes to their lifestyles and health related behaviours 
(May et al., 2009b). This often requires individuals to make substantial investments 
of time, effort and resources. In many respects, once an individual is identified as 
having a medical condition, they are required to behave differently in order to 
manage their condition.  
 
One aspect of the work undertaken by patients is adhering to lifestyle advice and 
medications recommended as treatments by health providers. Within the literature 
there is a wealth of information on adherence to health interventions – a term often 
used, incorrectly, interchangeably with compliance. For the purposes of this study we 
use the following definitions as proposed by Horne et al. (2005): 
 
  
64 
 
Compliance:  “the extent to which the patient’s behaviour matches the prescriber’s 
recommendations” (p12). 
Adherence: “the extent to which the patient’s behaviour matches agreed 
recommendations from the prescriber” (p12). 
Concordance: “process in which doctor and patient agree therapeutic decisions that 
incorporate their respective views” (p12). 
 
The nuanced differences between the terms demonstrates that in the case of 
adherence that the patient has an element of freedom to decide if they will adhere to 
the health professional’s recommendations whereas compliance indicates a lack of 
involvement in decision making by the patient. A move towards concordance 
suggests a process of coproduction in the consultation processes to meet a mutually 
agreed treatment pathway (Horne et al., 2005). 
 
Many factors have been identified as influencing patient’s adherence to medications 
and lifestyle interventions in both positive and negative ways. Patient’s knowledge 
about risk factors for CVD showed to have a positive impact on physical activity and 
diet interventions and increased adherence, however, knowledge had no impact on 
adherence to smoking cessation or statin use (Alm-Roijer et al., 2004). Higher 
education attainment and being in employment are associated with increased 
adherence, suggesting a social gradient (Mathes et al., 2014). Adherence is 
demonstrated to increase with age (Gadkari and McHorney, 2012, Walker et al., 
2006) as well as increase in perceived necessity for medical intervention (Gadkari 
and McHorney, 2012, Horne et al., 2013). The value of support, trust, and effective 
communication in the relationship with healthcare providers is deemed to increase 
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adherence (Martin et al., 2005). Moreover, increased social support through peer-led 
interventions have shown some capacity to increase adherence to medications 
(Enriquez and Conn, 2016). Many factors have also been demonstrated to have a 
negative impact on adherence. Patients from some ethnic minority groups have been 
shown to be less adherent with interventions (Mathes et al., 2014). Medication costs 
decrease people’s adherence (Gadkari and McHorney, 2012, Mathes et al., 2014) as 
does having unresolved concerns about the medications themselves (Horne et al., 
2013). It has also been demonstrated that the more complex treatment regimens are, 
increasing treatment burden, the less adherent people are to them (Benner et al., 
2009, Mathes et al., 2014, May et al., 2009b, Gallacher et al., 2018). 
 
Social networks are often relied upon in order to carry out the tasks of self-
management and the work of being a patient (Vassilev et al., 2011). Health 
professionals are often acutely aware of the excessive burden of work passed on to 
the patient in order for them to conform to the monitoring and management of 
disease and as such can find discussions around self-management activity difficult to 
navigate (Blakeman et al., 2010). As an example, newly diagnosed diabetics may 
need to make changes to their diet in order to manage blood sugar levels, which may 
necessitate learning new skills around food. They may be required to lose weight and 
may choose to do this by increasing physical activity, meaning they now need to fit 
this into their daily lives and dedicate financial resources to new equipment. They 
may be required to inject insulin, requiring the acquisition of skills to do so safely 
and effectively. They will enter into a ‘contract of surveillance’ whereby they attend 
hospital appointments, undergo medical monitoring and have to dedicate resources to 
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getting to the appointments. This new burden of work may have a huge impact on the 
individual’s life in both practical and emotional terms. 
 
The acknowledgement and exploration of conceptualisations and understandings of 
health and health behaviours of the ‘lay populace’ is important, if our goal is to 
inform health promotion activity that is effective (Emslie and Hunt, 2008). 
Presenting ‘hard’, ‘rigorous’, ‘statistically sound’ evidence to the general population 
and expecting them to take this on board at face value is problematic and is probably 
ineffective. In their influential paper, Davison et al. (1991) propose a complex and 
highly evolved ‘lay epidemiology’ that exists within the collective consciousness to 
explain and predict ‘misfortune’.it is argued that lay epidemiology draws on many 
knowledges (professional, scientific, personal), explanations and direct observations 
of illness and disease. The results of this synthesis of information manifest in a 
complex conceptualisation and socially constructed explanation about an individual’s 
candidacy for disease. 
 
 
3.5 Is there a difference between having a ‘condition’ and being ‘at-
risk’?  
Whilst these models of biographical disruption, illness careers, and identity have 
repeatedly been shown to have value when considering the journey to patienthood  
for those who are displaying signs and symptoms of ill health, it is unclear whether 
these same models would have the same utility for those newly adopting an ‘at-risk’ 
identity. 
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Since the rise of the identifiable risk factor there has been an assumption that 
knowledge is power for the individual patient and that this knowledge should equate 
automatically to uptake of preventative behaviours and interventions to reduce risk. 
Kenen (1996) coins this ‘the gift of knowing’ he suggests that once at-risk health 
statuses have been agreed, accepted and negotiated, at-risk status can be seen as 
"social positions accompanied by expected role performances and norms" (p1545).  
 
This suggests that the process of screening and identification of risk factors has a 
similar power to transform an individual’s life as diagnosis of illness. Both types of 
diagnosis (of illness or risk) give reason to provide intervention, such as drug 
treatment or lifestyle advice, in people that consider themselves to be fit and well 
(Goldstein-Jutel, 2011). In his study of men identified as having elevated cholesterol 
or prostate specific antigen, Gillespie (2012) found that the identification of risk had 
the power to symbolically alter the concept of self and identity, as did Hindhede 
(2014) and Hindhede and Aagaard-Hansen (2014) in their study of patients with an 
increased risk of diabetes (prediabetes). The communication of a probability statistic 
that was intended to provide clarity in the face of uncertainty served to promote 
uncertainty and produce anxiety (Gillespie, 2012). In individuals who have sought 
out risk identification through, for example, genetic testing, the acceptance of an at-
risk identity has been shown to act as a catalyst for change in behaviour and a sense 
of empowerment at being able to take control of one’s destiny (Harvey, 2010). 
However, it is unclear if this proposition would hold true for those individuals, like 
those in this study, who did not seek out a risk diagnosis, but who, rather, were 
invited for mass screening. There is limited evidence that identification of CVD risk 
leads to the enactment of healthier lifestyles. Farrimond et al. (2010) reported that at-
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risk individual’s intention to change was high at two weeks post intervention. 
However, intention to change is not the same as enacting change. Without 
longitudinal follow-up of individuals it is impossible to truly surface whether the gift 
of knowing their at-risk status did lead to any lasting engagement with preventative 
intervention. 
 
In recent years there has been a focus on the concept and effects of what is termed 
‘overdiagnosis’. There are several main drivers towards overdiagnosis: a culture that 
believes medical intervention is always the best avenue of action; healthcare systems 
incentivised to identify more disease and provide care; industrial and technological 
advancements that can identify ‘disease’; a fear of litigation should conditions not be 
identified in time; and public and patient expectations of the medical professions. All 
have been identified as contributing to the phenomenon (Pathirana et al., 2017). 
Linking to concepts of medicalisation (section 2.4.1), the awareness of a tendency in 
medicine to make patients out of healthy populations is widely explored in the 
literature (Smith, 2009, Smith, 2002b, Moynihan et al., 2002, Moynihan and Smith, 
2002) and links directly to the concept of receiving a diagnosis of risk. The 
utilisation of risk factor identification in an otherwise asymptomatic population 
serves to increase the likelihood of unnecessary treatments that will benefit only a 
fraction of the individuals prescribed them (Brodersen et al., 2018). In many cases, 
where risk factor thresholds (or cut-off points) are commonly reduced (thereby 
increasing the potential population to treat), the prevalence of proto-diseases (pre-
disease or risk states) increases to epidemic proportions, as is the case with 
prediabetes (Yudkin and Montori, 2014). Carter (2017), raises important questions 
about the ethical implications of such diagnoses and treatment in an age in which we 
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have a rising trend for overdiagnosis of conditions and/or risk factors deemed to 
warrant medical intervention. Often, the decision to provide medical intervention for 
the reduction of risk leads to the prescription of treatments that can have unintended 
negative effects (side effects) without affording any direct benefit to the individual 
(Carter, 2017), as discussed in section 2.4.3. Overdiagnosis can have several effects, 
such as increasing unnecessary treatment in the patient, but increasing demand for 
(and cost to NHS of) pharmaceuticals (van Dijk et al., 2016). 
 
 
Chapter 3 has outlined some of the pertinent literature about how illness is 
constructed and experienced in terms of beginning to identify as a patient and how 
this may relate to those individuals who are identified as at-risk of an illness or 
condition. The evidence reviewed indicates several issues that could impact on the 
proposed study and how I might approach it. As a society we are used to searching 
for disease and treating its causes or symptoms, we tend to classify conditions, 
thereby giving validity to their treatment with medical intervention. The very act of 
diagnosis has been demonstrated to act as a catalyst for taking action and engaging 
with the work of being a patient for those with physiologically diagnosable 
conditions. Much previous research has focussed on and unpacked the factors that 
may influence people’s adherence with these medical interventions i.e. lifestyle 
intervention and pharmaceutical intervention but again this work is mainly conducted 
with groups of people who have received a clinical diagnosis. Moreover, research 
has identified discrete stages that people with chronic conditions move through to 
accept and internalise the news that they are no longer a healthy individual, rather 
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they are coming to terms with becoming a ‘patient’. The work of being a ‘patient’ is 
far reaching and necessitates engagement in ‘work’ which brings its own burdens. 
 
The population included in this study are qualitatively different from those whom the 
majority of this evidence is based upon. People who have been identified as at 
increased CVR through the NHSHC are asymptomatic; i.e. they did not seek a 
diagnosis because of feeling unwell. Nevertheless, upon attending their CVR 
assessment they were given a diagnosis, one based upon the probability of a future 
event. The diagnosis of risk transforms the individual from healthy to someone with 
illness potential and that potential is treated with medical intervention. It is unclear 
from the evidence if this transformation into an at-risk patient, one who must make 
changes to their lifestyle and take medications will be accepted readily or resisted 
because it is at odds with their own perception of their health and wellbeing. The 
overdiagnosis evidence encourages an analysis of the ethical implications of 
programmes such as the NHSHC and unintended negative consequences of being 
identified as at high risk of CVD. These issues will be discussed again later in the 
thesis. In chapter 4 the focus of the thesis turns to Normalisation Process Theory, 
why it was chosen, and how it was used to underpin this study.  
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4 The theoretical lens – Normalisation Process Theory 
Chapters 2 and 3 have provided contextual information about the NHSHC 
programme and what is understood about how becoming a patient can affect people’s 
interaction with their social world and take on (or not) the role and work of being a 
patient. In this chapter the theoretical lens that was used to develop the study and 
provide insight into analysis, Normalisation Process Theory (NPT), is mapped out 
and discussed. Firstly, a brief background about the theory and how it has been used, 
to date, in previous studies is provided. Thereafter the main components of the theory 
are mapped out and an interpretation of the theory in relation to this study is provided 
to illustrate how NPT was used as a practical tool at each stage of the research 
process.  
 
4.1 Normalisation Process Theory 
This PhD study seeks to understand the ways in which individuals who have been 
identified as at increased risk of cardiovascular disease (CVR) understand, engage 
and adhere with the NHS Health Check (NHSHC) assessment and intervention 
process. As identified in the previous chapter, accepting at-risk status may require 
the individual to adopt an illness identity (even though they are not ill), accept 
medication, referral to treatment, and deal with the consequent biographical 
disruption. For the participants in this study they must do this, even though they were 
not ill to begin with and they do not become ill as a consequence. 
 
To provide a theoretical lens to the study, NPT was identified as an appropriate tool 
to engage with and sensitise the me to issues around implementation (the way in 
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which practices are actioned through social organisation), embedding (the process of 
practices becoming routinised), and integration (the process of sustaining) of 
practices (May and Finch, 2009). This process of implementation, embedding and 
integration of practices, it is argued, results in what is described as normalisation of a 
practice (May, 2010).  Normalisation Process Theory is termed a theory of action 
(May and Finch, 2009). It is primarily concerned with understanding the processes 
involved in what people ‘do’ and the way they construct what they ‘do’ both as 
individuals and collectively as part of a socially organised group (May and Finch, 
2009, May et al., 2009a). 
 
Developed between 2000 and 2009, by Carl May and colleagues, NPT has been 
defined as a ‘middle range theory’ (Boudon, 1991). Middle range theories are 
described by Davidoff et al. (2015) as frameworks for understanding problems and 
for guiding the development of interventions in a practical sense, and the authors 
highlight the fact that middle range theories can be restricted in their practical use to 
their specific area of application. It is an extension of previous work in which a 
Normalisation Process Model was developed (May et al., 2007). The Normalisation 
Process Model now forms the third construct of the wider NPT; collective action 
(discussed in section 4.5). Branded as a sociological tool, NPT can be used to 
understand the fluid, dynamic, and interactive processes that are at play between 
contexts, people, and objects (McEvoy et al., 2014). It offers a method to 
conceptualise and provide a rational, systematic description and explanation of the 
work of both individuals and groups. Rather than acting as a conceptual straight 
jacket, NPT can be utilised as a heuristic (problem solving) device (McEvoy et al., 
2014).  
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Unlike other middle range theories that attempt to provide a theoretical 
understanding of how innovations spread through social networks and organisations, 
such as Diffusion of Innovation (Greenhalgh et al., 2004) or theories that are 
concerned with an individual’s attitudes and intention to act in a specific way (Azjen, 
1991), NPT focusses on the work that actors undertake to engage with social 
contexts and objects to implement, embed, integrate, and therefore normalise a new 
practice or way of working (May and Finch, 2009, May et al., 2009a, May et al., 
2003).  
 
As a relatively new theory, under development by a team of researchers since 2000, 
it is still being refined. Much work has been undertaken to develop an interactive 
‘toolkit’ that is freely available online (May et al., 2015). The toolkit provides a 
resource for academics and practitioners to explore the utility of the theory to apply 
to their own contexts.  
 
 
4.2 The core components of Normalisation Process Theory 
Normalisation Process Theory seeks to surface factors that can promote, or inhibit, 
the normalisation of a set of practices and does so by identifying four core 
components (termed constructs) needed for normalisation; coherence, cognitive 
participation, collective action, and reflexive monitoring (May and Finch, 2009, May 
et al., 2015). A definition of each core construct can be found in Table 5. Each 
construct is explored individually in the following sections. In order to make NPT 
usable in this study, a great deal of interpretation work had to be undertaken to make 
the constructs relevant to the context of this study (May et al., 2015). In each of the 
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following sections the constructs of NPT are explained as they appear in the 
academic literature initially. The interpretation of those terms and how each 
construct is conceptualised for this study is then laid out clearly in a section under the 
‘interpretation’ heading. Subsequently the constructs and their underlying processes 
(mechanisms) were relabelled to provide clarity of meaning for the author and 
reader. Each table on the following pages presents the construct labels initially with 
the interpretations derived for this study in bold. Underneath these interpretations, in 
brackets, are the original labels for reference for the reader. 
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Table 5: Definition of Normalisation Process Theory constructs  
Making sense of it 
(Coherence - planning phase) 
Working out participation 
(Cognitive Participation - planning phase) 
The process of sense making and 
understanding that individuals have to go 
through in order to promote or inhibit the 
routine embedding of a practice to its users. 
These processes are energised by 
investments of meaning made by 
participants (Finch et al., 2012). 
 
How people understand and make sense of 
a practice with an emphasis on 
understanding and conceptualisation of 
interventions and their work (McEvoy et 
al., 2014). 
The process that individuals and 
organisations go through in order to enrol 
individuals to engage with a new practice. 
These processes are energised by 
investments of commitment made by 
participants (Finch et al., 2012). 
 
How people engage and participate with a 
practice with an emphasis on notions of 
legitimation and buy in, both in terms of the 
individuals involved and involving others 
(McEvoy et al., 2014). 
Doing it 
(Collective Action - doing phase) 
Reflecting on it 
(Reflexive Monitoring - appraisal phase) 
The work that individuals and organisations 
have to do to enact the new practice. These 
processes are energised by investments of 
effort made by participants (Finch et al., 
2012). 
 
The distribution of work required among 
stakeholders and the resources to support 
that with an emphasis on; organisational 
resources, training, divisions of labour, 
confidence and expertise as well as the 
workability of the intervention (McEvoy et 
al., 2014). 
The informal and informal appraisal of a 
new practice once it is in use, in order to 
assess its advantages or disadvantages and 
which develops user’s comprehension of 
the effects of a practice. These processes 
are energised by investments in appraisal 
made by participants (Finch et al., 2012). 
 
How people reflect and appraise its 
(practice) effects. With an emphasis on 
appraising and monitoring implementation 
work (McEvoy et al., 2014). 
 
I have broadly divided the four constructs into two categories; the first category 
being a planning phase of work that individuals, working as actors within a socially 
organised group, undertake to make sense of and organise themselves around the 
ideas and requirements of a new practice. This involves processes of understanding, 
organising, and planning (coherence and cognitive participation). The second 
category is a doing phase, where individuals and collectives carry out the practices, 
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then appraise and evaluate the appropriateness and effectiveness of what they are 
doing and take action to change practices once they have been appraised (collective 
action and reflexive monitoring). 
For the purposes of interpretation of the theory, and so that it could be applied in a 
practical way, I relabelled each of the constructs for ease of understanding. I 
interpreted the construct coherence as “making sense of it”, I interpreted cognitive 
participation as “working out participation”, I interpreted collective action as “doing 
it”, and finally I interpreted reflexive monitoring as “reflecting on it”. From here on 
in, the four constructs will be labelled with their interpretations, for consistency.   
 
Each of the four core constructs; making sense of it (coherence), Working out 
participation (cognitive participation), doing it (collective action), and reflecting on 
it (reflexive monitoring) are composites of four (each) underlying working 
mechanisms (or processes) (May et al., 2009a). Each core construct, its processes, 
and how I have interpreted it for the purpose of this study are described, in turn, over 
the following pages. 
 
4.3 Making sense of it (coherence) 
The making sense of it (coherence) construct is a planning phase of work that is 
concerned with identifying and unpacking what people actually do when trying to 
understand a new practice. Making sense of this new practice is achieved at both the 
individual level and in partnership with other people. This construct is made up of 
four discrete working processes; differentiation, communal specification, individual 
specification, and internalisation (May and Finch, 2009, May et al., 2009a). Each 
working mechanism is described, in turn, in Table 6. 
77 
 
Table 6: Making sense of it (Coherence) - working mechanisms 
Understanding the uniqueness of it 
(Differentiation) 
Collectively interpreting it 
(Communal Specification) 
An important element of sense-making work 
is to understand how a set of practices and 
their objects are different from each other. 
Sense making relies on people working 
together to build a shared understanding of 
the aims, objectives and expected benefits 
of a set of practices. 
Individually interpreting it 
(Individual Specification) 
Coming to a conclusion 
(Internalisation) 
Sense making has an individual component 
too. Here participants in coherence work 
need to do things that will help them 
understand their specific tasks and 
responsibilities around a set of practices. 
Finally, sense-making involves people in 
work that is about understanding the value, 
benefits and importance of a set of 
practices. 
Definition of working mechanisms is taken from May et al. (2015). 
 
My interpretation of the working mechanisms: Table 6 shows how each working 
process has been defined. Essentially, the process that people go through to make 
sense of a practice – or a thing – can be broken down into four interrelated processes. 
The first mechanism – differentiation – can be interpreted as how people understand 
the new practice to be unique or different from other ways of working 
(understanding the uniqueness of it). The second mechanism – communal 
specification – can be understood as the work people do, together, to interpret the 
new practice in order to come to a collective understanding of it (collectively 
interpreting it). The third mechanism – individual specification – can be understood 
as the work people do, individually, to interpret the new practice in order to come to 
an individual understanding of it (individually interpreting it). The fourth mechanism 
– internalisation – can be interpreted as the work people do to come to a conclusion 
about a practice and deciding to either engage with it, or not (coming to a 
conclusion).  
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The current study is interested in unpacking how individuals make sense of the 
NHSHC offer and how they begin to interpret its relevance in the context of their 
daily lives and what, if any, added value it offers. To do this the study explores the 
ways that individuals work individually and with others (health professionals, family, 
friends, and other social networks) to achieve an individual and shared understanding 
of the work involved to participate in the NHSHC process and in any recommended 
intervention. Table 7 shows the key questions raised by the construct of coherence, in 
relation to this study. 
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Table 7: Making sense of it (Coherence) - application 
Making sense of it 
(Coherence) 
Mechanism Key areas to explore 
Understanding the 
uniqueness of it 
(Differentiation) 
 
1. How does this differ from other routine checks I 
have been offered? 
2. How does this differ from other interventions that 
have been aimed at me 
a. That I have sought out 
b. That have been offered to me 
c. General health promotion activity 
3. Do I recognise the NHSHC brand? 
4. What is unique about the invitation/ offer? 
5. What were my expectations/ why did I attend? 
Collectively interpreting 
it 
(Communal Specification) 
 
1. Am I clear about everyone’s role in the NHSHC 
process? 
2. Am I able to work with others (health professionals/ 
family/ friends) to access information about the 
assessment and intervention? 
3. How is risk communicated to me? 
4. How is treatment/ intervention communicated to me? 
5. Do my friends and family have an opinion about the 
assessment and subsequent intervention? 
Individually interpreting 
it 
(Individual Specification) 
1. Do I understand the purpose of having a CVD risk 
assessment? 
2. What is my own role in the assessment and 
subsequent intervention? 
Coming to a conclusion 
(Internalisation) 
1. How do my previous experiences help me to make 
sense of 
a. The NHSHC 
b. CVD risk 
c. Intervention and treatment pathways 
2. Do I think there is added value from the 
assessment/intervention? 
3. What are the specific benefits to me from the 
assessment/ intervention? 
 
4.4 Working out participation (cognitive participation) 
The working out participation (cognitive participation) construct is a planning phase 
of work concerned with identifying and unpacking the work that people do when 
trying to think through and organise themselves and other people to undertake a new 
practice. It is about the relational work that is undertaken by people to build a group 
with shared agreement and engagement around the new practice. The four working 
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mechanisms of cognitive participation are; initiation, enrolment, legitimation, and 
activation (May and Finch, 2009, May et al., 2009a). Each working mechanism is 
described, in turn, in Table 8.  
 
Table 8: Working out participation (Cognitive Participation) - working mechanisms 
Having the skills to engage 
(Initiation) 
Organising people 
(Enrolment) 
When a set of practices is new or modified, 
a core problem is whether or not key 
participants are working to drive them 
forward. 
Participants may need to organise or 
reorganise themselves and others to 
collectively contribute to the work that may 
involve rethinking group relationships 
between people and things. 
Believing practice is valid 
(Legitimation) 
Defining actions 
(Activation) 
An important component of relational work 
around participation is the work of ensuring 
that other participants believe it is right for 
them to be involved, and they can make a 
valid contribution to it. 
Once it is underway, participants need to 
collectively define the actions and 
procedures needed to sustain a practice and 
stay involved. 
Definition of working mechanisms is taken from May et al. (2015). 
 
My interpretation of the working mechanisms: Table 8 shows how each working 
mechanism has been defined. Essentially, the process that people go through to think 
through and organise themselves and others around a practice – or a thing – can be 
broken down into four interrelated mechanisms. The first mechanism – initiation – 
can be interpreted as how people identify that they have the right skills set to drive 
forward the new practice (having the skills to engage (initiation)). The second 
mechanism – enrolment – can be understood as the work people do to organise 
themselves and other people so that they can carry out the new practice (organising 
people (enrolment)). This organisation work is the process of making sure that the 
right people, with the right skills are ready to carry out the work. The third 
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mechanism – legitimation – can be understood as the work people do to come to an 
understanding that a new practice is a valid thing for them to do, a legitimate part of 
their role (believing practice is valid (legitimation)). The fourth mechanism – 
activation – can be interpreted as identifying what actions need to be undertaken to 
carry out the new practice (defining actions (activation)). 
 
The current study is interested in exploring how high CVR risk individuals work to 
organise themselves and others to ‘buy into’ (or not) the NHSHC programme and 
define, explicitly, tasks need to be undertaken to engage with the NHSHC 
assessment and any recommended interventions. Table 9 shows the key questions 
raised by the core construct cognitive participation, in relation to this study. 
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Table 9: Working out participation (Cognitive Participation) - application 
Working out participation 
(Cognitive Participation) 
Mechanism Key areas to explore 
Having the skills to 
engage 
(Initiation) 
1. Do I have the right skills to 
a. Engage with the NHSHC 
b. Engage with the intervention(s) 
2. Do I know how to  
a. Eat better 
b. Take more (appropriate) physical activity 
c. Take lipid lowering medications correctly 
Organising people 
(Enrolment) 
1. How do I engage with and organise other people in 
the NHSHC process? 
a. Health professionals 
b. Family 
c. Friends  
Believing practice is 
valid 
(Legitimation) 
1. Have I sought reassurance from others about  
a. Having the assessment? 
b. Treatment options? 
2. Is risk reduction and prevention a legitimate part of 
my role? 
Defining actions 
(Activation) 
1. How can I arrange to carry out the requirements of 
the NHSHC 
a. Logistical issues (getting to appointments, 
shopping, physical activity) 
b. Administrative (ordering prescriptions etc…) 
c. Accessing services  
2. Are ‘doors opened’ for me? (have I been given 
access to services?) 
3. What are the actions I need to do to comply with the 
NHSHC?  
4. What actions do I need to sustain to stay involved in 
the NHSHC? 
 
4.5 Doing it (collective action) 
The doing it (collective action) is a doing phase of work that is concerned with 
identifying and unpacking what people actually do when enacting a practice. This 
action work can, of course, relate to the work undertaken to comply, or resist and 
subvert the therapeutic intervention (in the case of this study, statin and lifestyle 
changes) and the self-monitoring work undertaken by the individuals (May and 
Finch, 2009). This construct is made up of four working mechanisms; interactional 
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workability, relational integration, skill set workability, contextual integration (May 
and Finch, 2009, May et al., 2009a). Each working mechanism is described, in turn, 
in Table 10. 
Table 10: Doing it (Collective Action) - working mechanisms 
Performing the actions 
(Interactional Workability) 
Working with and trusting the work of 
others 
(Relational Integration) 
The interactional work that people do with 
each other, with artefacts, and with other 
elements of a set of practices, when they 
seek to operationalize them in everyday 
settings. 
The knowledge work that people do to 
build accountability and maintain 
confidence in a set of practices and in each 
other as they use them. 
Appropriate division of tasks 
(Skill Set Workability) 
Allocating resources 
(Contextual Integration) 
The allocation work that underpins the 
division of labour that is built up around a 
set of practices as they are operationalized 
in the real world. 
The resource work - managing a set of 
practices through the allocation of different 
kinds of resources and the execution of 
protocols, policies and procedures. 
Definition of working mechanisms is taken from May et al. (2015). 
 
My interpretation of the working mechanisms: Table 10 shows how each working 
mechanism has been defined. The actions that people perform to carry out the work 
of a practice – or a thing – can be broken down into four interrelated mechanisms. 
The first mechanism – interactional workability – can be understood as the physical 
action taken to perform the task (performing the actions (interactional workability)). 
The second mechanism – relational integration – can be interpreted as the work that 
is done to work with others and trust their work (working with and trusting the work 
of others (relational integration)). The third mechanism – skill set workability - can 
be understood as the work that is undertaken to make sure that the tasks are divided 
appropriately according to people’s skill, knowledge and expertise (appropriate 
division of tasks (skill set workability)). The fourth mechanism – contextual 
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integration – can be understood as the assigning of resources to undertake the task 
(allocating resources (contextual integration)). 
 
The current study, is interested in how and if high-risk individuals enact the tasks 
that are required to comply (or not) with the NHSHC principles by accepting CVR, 
taking prescribed medications (or not) and making sustained changes to their lifestyle 
(or not). Table 11 shows the key questions raised by the construct of collective 
action, in relation to this study. 
 
Table 11: Doing it (Collective Action) - application 
Doing it 
(Collective Action) 
Mechanism Key areas to explore 
Performing the actions 
(Interactional Workability) 
1. Do I perform the task of taking the tablets prescribed 
to me? 
a. Do I actively refuse to take tablets? 
b. How do I deal with side effects, practically? 
2. Do I make changes to my lifestyle? 
a. If so, to what extent? 
3. Do I attend appointments? 
4. Do I actively refuse to ‘comply’ or resist an illness 
identity? 
Working with others 
and trusting the work of 
others 
(Relational Integration) 
1. Have I developed relationships with others involved 
in the NHSHC process? 
2. Am I confident in the work that’s being carried out 
by the health professionals? 
3. Do I have confidence in the actions of the people 
involved in the NHSHC? 
4. Do I trust the actions of the people involved in the 
NHSHC? 
Appropriate division of 
tasks 
(Skill Set Workability) 
1. How are the tasks divided between actors? 
2. Have I set up routines to carry out the tasks required? 
3. Is the required ‘work’ appropriate for the skills that I 
have? 
Allocating resources 
(Contextual Integration) 
1. Do I integrate the notion of risk into my social life? 
2. Do I integrate medications and lifestyle changes into 
my social life? 
3. Do I have the financial resources to take medications 
and engage in lifestyle advice?  
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4.6 Reflecting on it (reflexive monitoring) 
The reflecting on it (reflexive monitoring) construct is an appraisal phase of work 
concerned with the formal and informal processes that are involved in monitoring 
and evaluating the work that has been carried out during the collective action phase. 
This reflexive stage of the normalising process is carried out, again, both individually 
and with others involved in the process. Reflexive monitoring is made up of four 
working mechanisms; systematisation, communal appraisal, individual appraisal, 
reconfiguration (May and Finch, 2009, May et al., 2009a). Each working mechanism 
is described, in turn, in Table 12.  
 
Table 12: Reflecting on it (Reflexive Monitoring) - working mechanisms 
Collecting feedback information 
(Systematisation) 
Collectively evaluating it 
(Communal Appraisal) 
Participants in any set of practices may seek 
to determine how effective and useful it is 
for them and for others, and this involves 
the work of collecting information in a 
variety of ways. 
Participants work together - sometimes in 
formal collaboratives, sometimes in 
informal groups to evaluate the worth of a 
set of practices. They may use many 
different means to do this drawing on a 
variety of experiential and systematized 
information. 
Individually evaluating it 
(Individual Appraisal) 
Changing the way things are done 
(Reconfiguration) 
Participants in a new set of practices also 
work experientially as individuals to 
appraise its effects on them and the contexts 
in which they are set. From this work stem 
actions through which individuals express 
their personal relationships to new 
technologies or complex interventions. 
Appraisal work by individuals or groups 
may lead to attempts to redefine procedures 
or modify practices - and even to change 
the shape of a new technology itself. 
Definition of working mechanisms is taken from May et al. (2015). 
 
My interpretation of the working mechanisms: Table 12 shows how each working 
mechanism has been defined. The process of gathering feedback on the actions 
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performed in the doing it (collective action) phase of work and evaluating them can 
be broken down into four interrelated mechanisms. The first mechanism – 
systematisation – can be understood as collecting information and feedback about 
how performing the task worked, in practice (collecting feedback information 
(systematisation)). The second mechanism – communal appraisal – can be 
interpreted as the work that is done to with others to evaluate the practice 
(collectively evaluating it (communal appraisal)). The third mechanism – individual 
appraisal - can be understood as the work that is undertaken individually to evaluate 
the practice (individually evaluating it (individual appraisal)). The fourth mechanism 
– Reconfiguration – can be understood as the process that people go through to take 
the information and feedback gained through the other three working mechanisms, 
synthesise this information and make changes to the way they enact the practice in 
the future (changing the way things are done (reconfiguration)). 
 
The current study is interested in how individuals appraise the NHSHC process, their 
engagement with the programme and how they evaluate the effectiveness and 
usefulness of the interventions both individually and in collaboration with others 
involved in the process (health professionals, family, and friends). It is also of 
interest how individuals may reconfigure their treatments again, individually or by 
engaging with others. Table 13 shows how the four working mechanisms of the 
reflexive monitoring construct have been interpreted in relation to the current study.  
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Table 13: Reflecting on it (Reflexive Monitoring) - application 
Reflecting on it 
(Reflexive monitoring) 
Mechanism Key areas to explore 
Collecting feedback 
information 
(Systemisation) 
1. How do I collect/ gather information about: 
a. Progress? 
b. Side effects? 
c. Usefulness of interventions? 
d. Effectiveness of interventions? 
Collectively evaluating it 
(Communal Appraisal) 
1. How do I work with other people (health 
professionals, family, and friends) to evaluate: 
a. If being involved in the programme is 
worthwhile? 
b. Medications are appropriate and effective? 
c. Lifestyle changes are appropriate and 
effective? 
d. Make a decision to continue or modify 
engagement? 
Individually evaluating 
it 
(Individual Appraisal) 
1. How do I use feedback from my experiences of the 
NHSHC process to: 
a. Evaluate appropriateness of interventions? 
b. Evaluate effectiveness of interventions? 
c. Make a decision to continue or modify 
engagement? 
Changing the way things 
are done 
(Reconfiguration) 
1. How do I use the information (from the first 3 
mechanisms) to: 
a. Alter/ subvert/ modify my actions, moving 
forward 
 
4.7 How has Normalisation Process Theory been applied, previously? 
Normalisation Process Theory is said to have emerged, in a grounded way, from the 
work Carl May and colleagues were engaged with in trying to unpick the 
mechanisms that resulted in the normalising, or not, of new practices introduced as 
part of complex interventions (May, 2006, May, 2013b, May, 2013a, May et al., 
2011a, May et al., 2011b). The theory has been refined over several iterations and 
continues to evolve as more practitioners and academics interact with it and utilise its 
concepts in their own work (May, 2013b, May and Finch, 2009, May et al., 2009a, 
May et al., 2015). Normalisation Process Theory was developed specifically to look 
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at the processes at play within organisational settings, mainly the NHS. Since NPT’s 
focus is to describe the processes at play when people work together to engage with 
and routinise practices, it has been described as having the potential to have an 
important role to successfully implement interventions that require interaction and 
engagement with improvement activities (Davidoff et al., 2015).  
 
Normalisation Process Theory is promoted as a tool that can be utilised and helpful 
at any stage of a research project’s lifecycle; from informing study design through to 
analysis and interpretation (May et al., 2015). McEvoy et al. (2014) found, in their 
systematic review, that researchers had used, and found useful, the constructs of NPT 
across the life course of the projects and that it had been used to inform study design, 
data analysis, and interpretation. The same systematic review concluded that NPT 
constructs had been operationalised and interpreted consistently across studies, with 
two notable exceptions (Gunn et al., 2010, Sanders et al., 2011). Regardless of these 
slight variations in interpretation, it was concluded that NPT constructs were helpful 
to researchers by providing a framework to highlight important issues relating to 
routinisation. 
 
The majority of papers reviewed for this thesis and those included within McEvoy et 
al. (2014) systematic review of studies that have utilised NPT at various stages of the 
research process have identified NPT as a beneficial framework. NPT’s utility seems 
to lie in its capacity to provide a systematic way of interrogating the processes of 
implementation, integrating and embedding (Macfarlane and O'Reilly-de Brun, 2012, 
McEvoy et al., 2014, Blakeman et al., 2012, Elwyn et al., 2008, Gunn et al., 2010).  
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There is little critique of NPT and any limitations encountered in its use in the 
literature. Finch et al. (2012) highlight that whilst NPT provides a framework to 
explore the processes of implementation, it cannot provide a definition of what 
‘normalisation’ looks like in a given context. This is a judgement call to be made by 
those exploring any given intervention or practice. Other critiques relate to the 
interpretation of the constructs and mechanisms of NPT. Gunn et al. (2010), Atkins 
et al. (2011), Franx et al. (2012), and Macfarlane and O'Reilly-de Brun (2012) all 
describe difficulties in ensuring that interpretations of constructs are congruent with 
those in the original theory. Finch et al. (2012) also discusses the intensity of the 
translation work that has to be undertaken to ensure NPT constructs are interpreted in 
relation to the context in question. 
 
I feel the core constructs of NPT could be seen to encapsulate the underpinning 
stages of biographical disruption (Bury, 1984) and developing an illness identity 
(Karp, 1994) (discussed in chapter 3). Table 14 shows the similarities between 
theories and how each stage could be mapped onto a core construct of NPT. This 
demonstrates one of the reasons I selected NPT as a tool for use in this study. It 
draws together concepts from divergent theoretical standpoints and processes into a 
single tool that can be applied across the research process. 
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Table 14:  Biographical disruption, illness identities, and NPT 
Bury’s biographical disruption stages Normalisation Process Theory constructs 
Acknowledge signs and symptoms of 
illness 
Coherence  
Identification of illness Coherence  
Decision to seek help Cognitive participation  
Constructing a narrative Collective action 
Mobilising resources Collective action 
Karp’s illness identities stages  
Noticing signs and symptoms Coherence  
Recognising the symptom is wrong Coherence 
Suffering period of crisis  Cognitive participation and collective 
action 
Restructuring narrative to include illness 
identity 
Coherence and reflexive monitoring 
State of acceptance Illness identity has been ‘normalised’ 
 
 
The processes offered by the concept of biographical disruption and illness career 
progression mirror many of the stages of NPT and the normalising of behaviours or 
work by making sense of the issue, internalising and enrolling oneself and then 
practically dedicating resources to action. 
 
Normalisation Process Theory has, in recent years grown in popularity – as seen by 
the increased number of publications that utilise it as their theoretical framework. It 
is widely used to illuminate issues around implementation of health interventions 
such as care for chronic conditions (Harris et al., 2017), digital health interventions 
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(Band et al., 2017). However, to my knowledge, only one previous body of work has 
used NPT to explore processes of routinising practices outside of a formal 
organisational setting. The work of Gallacher et al. (2011) explores the issue of 
treatment burden in a population that has chronic heart failure. This work and that 
around minimally disruptive medicine (May et al., 2009b, Montori et al., 2006) have 
resulted in the development of Burden of Treatment Theory (May et al., 2014a). 
However, this thesis focusses on how individuals, outside of a formal organisational 
structure, interact with a health intervention and work through the processes of 
understanding what the intervention is offering them, working out their participation, 
doing (or not) what is asked of them, and participating in ongoing monitoring and 
surveillance. To my knowledge, this is the first time that NPT has been utilised in 
this way. 
 
Chapter 4 has introduced NPT as the theoretical lens used to underpin this study and 
discussed how it has been used previously in other research. I have unpacked the 
interpretation work I engaged with to make sense of the constructs and subordinate 
working mechanisms and then applied each one in practical terms to generate the 
questions used to build the interview questions for the semi-structured interview 
guide (discussed further in Chapter 5, section 5.2.3). The following chapter, chapter 
5, moves on to discuss the methodology that was employed to collect and analyse the 
data. 
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5 Methodology and process 
The following chapter is comprised of two parts. Part one (5.1) describes the 
methodological approach taken in the research and discusses the epistemological 
position, theoretical perspective, methodology, and methods used to collect data and 
analyse it. Part two (5.2) describes the procedural methods of the study, how the 
study was conducted, how data was analysed, and a description of the achieved 
sample. 
 
As discussed in Chapter 1 this PhD project was developed alongside a collection of 
projects that were undertaken to explore the local roll out of the NHSHC programme. 
The PhD project was identified at the very beginning of the development phase of a 
commissioned piece of work that focused on patient adherence to the NHSHC. As 
such, the commissioned piece of work was constructed to serve both purposes – to 
meet the needs of the commissioning body (for which descriptive data, thematically 
analysed was required) but also to allow the collection and further theoretical 
analysis of data for the PhD study. The processes described over the following pages 
define the work undertaken by me to design and carry out the research. Essentially, 
because the analysis for the PhD study was carried out after the commissioned work 
was completed, what is described is a secondary analysis; however, this was planned 
from project initiation. 
 
5.1 Methodology 
This section (5.1) provides a rationale for the selection of a qualitative approach and 
a justification of its appropriateness for exploring how individuals experienced their 
involvement in the NHSHC programme and being identified as at increased risk of 
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an adverse cardiovascular event. Drawing heavily on what Crotty (1998) describes as 
the ‘four pillars’ of research, the following section outlines the links between 
epistemological position that underpins this work, the theoretical perspective, the 
methodological design, and chosen methods of data generation and analysis. Below 
these ‘four pillars’ are displayed pictorially for the reader (Figure 2). These will be 
referred to throughout this chapter. 
 
FIGURE 2: CROTTY’S FOUR PILLARS OF RESEARCH 
 
The selection of method of data generation and analysis must be firmly rooted in its 
capacity to explore and illuminate the question(s) of interest. This forms the basis for 
study design, situating the question firmly within the centre of any decision making 
processes (Ritchie et al., 2014). Method selection and methodology are intrinsically 
linked to their parent theoretical perspective and overall epistemological position 
meaning that there must be congruence throughout the whole approach taken (Crotty, 
1998). Each of the ‘four pillars’, in relation to this study, are discussed below. 
 
Epistemology
Constructionism
Theoretical Perspective
Interpretivism
Methodology
Phenomenology
Method(s)
Semi-structured interviews 
& Thematic Analysis
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5.1.1 Constructionism (Epistemology) 
 
FIGURE 3: CROTTY’S FOUR PILLARS OF RESEARCH - EPISTEMOLOGY 
 
What, then, is constructionism? It is the view that all knowledge, 
and therefore all meaningful reality as such, is contingent upon 
human practices, being constructed in and out of interaction 
between human beings and their world, and developed and 
transmitted within an essentially social context (Crotty, 1998).  
 
This study is borne from a constructionist (Silverman, 2005) standpoint; an 
epistemological position that at its core acknowledges that there is no singular 
objective truth about reality, experience, objects, or phenomena to be unearthed 
(Crotty, 1998). Rather, constructionism acknowledges that meaning is attributed to 
objects and experiences through a process of communal and individual interaction 
with the world (Silverman, 2005, Giacomini, 2010). Constructionism recognises the 
collective work of social groups, alongside the individual, to ‘construct’ 
understanding and generate meaning (Silverman, 2005, Crotty, 1998). A nuanced yet 
clear difference should be highlighted between constructionism and constructivism, 
the latter being concerned with generation of meaning by the individual (Crotty, 
1998).  
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The theoretical lens (NPT) chosen to explore the data generated for this thesis is 
primarily concerned with the work that people do, interacting with each other, to 
make sense of processes in order to normalise actions and behaviours. Therefore, 
grounding the thesis in constructionism is congruent with both the methodology and 
data generation and analysis techniques (discussed below), but also the theoretical 
lens underpinning interpretation of the data.   
 
A worked example from the thesis can be used to understand how this 
epistemological position is consistent with the topic under exploration. For example, 
how cardiovascular risk (CVR) is interpreted and internalised as meaningful (or not) 
will differ from individual to individual. No doubt there will be similarities in 
experience due to the shared social context from which the sample is drawn. This 
CVR meaning will be synthesised by the individual and will draw upon personal 
experiences of CVD and its component ‘risk factors’, knowledge passed on through 
interactions with other people, media coverage, health promotion activity, 
physiological symptoms, and so on. Each individual will take parts of these 
collective ideas to formulate their own understanding of CVR, and what it means 
within the context of their own lives. There will be similarities between individual 
interpretations of CVR but also nuanced differences. Evidence of similarities of 
interpretation of CVR experience will indicate a socially constructed reality present 
within this group of people (Ritchie et al) and help build an understanding of the 
ways in which this group of people engage, or not, in the work of being at increased 
CVR. Adopting a constructionist standpoint, epistemologically speaking, 
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acknowledges and gives space for that voice and construction of reality to emerge 
(Quinn Patton, 2015). 
 
5.1.2 Interpretivism (Theoretical Perspective) 
 
FIGURE 4: CROTTY’S FOUR PILLARS OF RESEARCH – INTERPRETIVISM 
 
People are constantly involved in interpreting and reinterpreting 
their world – social situations, other people’s actions, their own 
actions, and natural and humanly created objects. They develop 
meanings for their activities together, and they have ideas about 
what is relevant for making sense of these activities. In short, social 
worlds are already interpreted before social scientists arrive 
(Blaikie, 2007). 
 
If, through the adoption of a constructionist epistemological position, we believe that 
meaning is afforded to an object or phenomenon through a process of collective 
construction (Quinn Patton, 2015, Crotty, 1998, Silverman, 2005, Denzin and 
Lincoln, 2000, Giacomini, 2010), we must assume that those creating meaning are 
actively interpreting, integrating, and synthesising different forms of knowledge to 
make sense of the object or phenomenon (Smith et al., 2009, Weber cited in Blaikie, 
2007). These perspectives and meanings are unique to the individuals involved in the 
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process of interpretation and are directly related to their situation and their 
relationship to the world around them.  
 
The process of interpretation is a common thread, weaving through the entire 
research process from initiation, through data collection, and analysis. Whist an aim 
is to capture and understand how individuals at-risk of CVD make sense of being an 
‘at-risk individual’ and what that means for the integration, embedding and 
normalisation of associated practices, interpretation is happening at many other 
levels throughout the process. The researcher is bound within the research process 
(Creswell, 2013). She is an active participant in the process of data generation and 
interpretation process  (Giacomini, 2010). Essentially, the participant and researcher 
are bound in what is termed the ‘double hermeneutic’  (Blaikie, 2007, Smith et al., 
2009), whereby the participant constructs,  explains, and makes sense of a 
phenomenon and the researcher, in turn engages in sense making of the participant’s 
interpretation (this is further discussed in section 5.2.4).  
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5.1.3 Phenomenology (Methodology) 
 
FIGURE 5: CROTTY’S FOUR PILLARS OF RESEARCH - PHENOMENOLOGY 
 
[phenomenology calls us to] set aside all previous habits of 
thought, see through and break down the mental barriers which 
these habits have set along the horizons of our thinking…to learn to 
see what stands before our eyes (Husserl, cited in; Crotty, 1996; 
p58).  
 
Methodology refers to the research design selected to undertake the study; a 
phenomenological approach has been utilised for this study. Phenomenological 
approaches focus on and try to surface how individuals ‘make sense’ of their 
experiences of, for example, an organisation, a service or in the case of the current 
study a CVR reduction programme, as individuals and as members of a social group 
(Quinn Patton, 2015), making it congruent with both a constructionist 
epistemological perspective and an interpretivist theoretical perspective.  
 
Developed by Husserl, phenomenology can be understood as both a philosophy and a 
methodology (Smith et al., 2009). A Husserlian phenomenological approach is 
concerned with understanding and surfacing how people come to know what they 
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know and how they construct meaning of their experience of being participants in the 
world (Smith et al., 2009). However, Heidegger, originally a student of Husserl, 
expanded his own arm of phenomenological investigation to interpretative 
phenomenology (Crotty, 1996). For Heiddeger, a phenomenological approach not 
only describes the phenomenon, but is a process of interpretation, by participant and 
also researcher (van Manen, 1990, Creswell, 2013). This focus makes the selection 
of a phenomenological approach sit well within a constructionist epistemological 
standpoint and also an interpretative theoretical perspective. Moreover, it provides 
justification for the selection of NPT as a theoretical lens for the study, as NPT has, 
at its core, an interest in unpacking the individual and collective roles that people 
play in making sense of a practice when engaging in the process of ‘normalising’ and 
the interactions between ‘actors’ to that end (see chapter 2.1).  
 
Taking a phenomenological approach is intrinsically linked to the selected methods 
to collect data (discussed in chapter 3.1.4). To elicit individuals’ interpretation of an 
experience necessitates paying attention to how they perceive the experience, how 
they describe it and make sense of it (Quinn Patton, 2015), ideally lending itself to 
the selection of in-depth interviews as a data generation method (described in section 
5.1.4). 
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5.1.4 Semi-structured interviews and Thematic Analysis (Methods) 
 
FIGURE 6: CROTTY’S FOUR PILLARS OF RESEARCH - SEMI-STRUCTURED 
INTERVIEWS & THEMATIC ANALYSIS 
It takes no great self-awareness or self-confidence to report a 
statistically significant t test with confidence intervals based on a 
formula and calculations easily replicated and confirmed. It can 
take considerable self-awareness and confidence to report: I coded 
these 40 interviews, these are the themes I found, here is what I 
think they mean, and here is the process I undertook to arrive at 
those meanings. The latter statement calls for, even demands, a 
sense of voice and perspective (Quinn Patton, 2002). 
 
A semi-structured interview technique was utilised as the tool to generate data. 
Interviews, essentially a conversation with a purpose (Berg, 2007), are tools 
congruent with the methodological approach described on the previous pages. Semi-
structured interviews allow the researcher to cover a standardised set of topics whilst 
giving the freedom to explore these topics in any order as the conversations flow and 
evolve, and also to explore new lines of enquiry as they arise, spontaneously (Quinn 
Patton, 2002, Berg, 2007, Rapley, 2007). The process of interview schedule 
generation and interviews is described in the following section (Chapter 5.2). 
Interviews were selected as a data generation technique because it is impossible to 
Epistemology:
Constructionism
Theoretical Perspective
Interpretivism
Methodology
Phenomenology
Method(s)
Semi-structured interviews 
& Thematic Analysis
Question
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directly observe other people’s feelings and experiences of a phenomena – in this 
case engaging with the NHSHC programme. 
 
The timing of the research is also crucial. Phenomenological studies require that the 
individual has had sufficient time to reflect upon the experience of interest. People 
are unable to reflect upon an experience whilst they are in the process of going 
through it, therefore, phenomenological studies are generally carried out ‘after the 
event’ (Van Maanen, 1979). In the current study, it was important to understand 
participant’s experience of not only the NHSHC assessment process, but also more 
longitudinally, their experience of living with a ‘risk diagnosis’ for a period of time, 
to understand their engagement with lifestyle advice and adherence to lipid lowering 
medication. Individuals were therefore approached who had undergone at least one 
annual review, so there had been ample opportunity to engage with the NHSHC 
programme and opportunity to reflect both individually (over the course of the year) 
and collectively (at the annual review appointment). The timing of interviews was 
also developed so all aspects of NPT, including reflexive monitoring, could be 
explored. Interview at an earlier time point would not have captured this important 
information. Of course, I should note that I am relying on rather historic accounts of 
their experience of the assessment, however, this trade off was deemed necessary to 
capture a more holistic interpretation of the NHSHC process. 
 
In keeping with all other aspects of the methodology outlined, an inductive approach 
to data analysis was undertaken. This allowed analysis to be rooted in the 
descriptions of experience presented by the participants. A description of this process 
can be found in section 5.2.4.  
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Part of a phenomenological approach, as outlined by Husserl, is the process of 
epoche or bracketing. This process is achieved through the researcher attempting to 
set aside their own experiences of the phenomenon, in order to view it through a 
fresh lens (Creswell, 2013). One way in which bracketing is achieved is through the 
utilisation of a semi-structured interview approach, allowing the experiences and 
interpretations of the participant to be central. However, by acknowledging the 
constructionist, interpretative approach employed within this study we must also 
acknowledge the central role the researcher plays in eliciting the data and 
subsequently synthesising and interpreting it (Crotty, 1998). The data and the 
researcher, as an active participant in the research and ultimately the social context 
within which the research is situated, are inextricably bounded. The notion of 
objectivity is not in keeping with the epistemological and theoretical stance taken in 
this research. However, whilst not seeking objectivity I have tried to remain faithful 
to the interpretations provided by participants (Ahern, 1999) and provide an 
acknowledgement about my own position within the research in Chapter 1 and 
Chapter 3.4 
 
5.1.5 Assessing methodological quality 
Yardley (2000) offers a framework to explore and assess the characteristics of good 
quality qualitative research. Yardley describes four key areas of qualitative research 
where quality is demonstrated and can be assessed; sensitivity to context, 
commitment and rigour, transparency and coherence, and finally, impact and 
importance. Yardley’s framework has been chosen to explore issues of 
methodological quality as the broad concepts are more applicable to assessing a 
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study that is grounded in phenomenology rather than the more commonly cited 
concepts of trustworthiness (Lincoln and Guba, 1985).  
 
Sensitivity to context  
Demonstrating sensitivity to context includes awareness of, and engagement with 
previous theoretical and empirical work that has been undertaken in the same, or 
similar, area of study interest (Yardley, 2000). Chapters 2, 3, and 4 demonstrate how 
the policy and practice context, previous academic work, and underpinning theory 
have been acknowledged and explored. Furthermore, Yardley highlights the fact that 
the importance of sensitivity to participants’ experiences and ethical issues is 
paramount. Participants’ experiences are central to this study and care has been taken 
through data gathering stages, analysis, and reporting to ensure that findings and 
implications drawn from the study are rooted in participants’ experiences.  
 
Commitment and rigour 
Yardley describes how commitment and rigour relate to depth of engagement with 
the topic and methodological competence demonstrated through data collection, 
analysis, and reporting. Methodological rigour was a concern over the lifespan of the 
study. Care was taken at the design stages by engaging with more experienced 
researchers (supervisory team) and utilising NPT to construct a study that was 
methodologically sound and robust. Supervisory meetings were held to discuss the 
unfolding project and issues that arose. Data analysis was guided by standardised 
processes and a proportion of transcripts were coded and agreed by both members of 
the supervisory team and myself. Care was taken in the reporting stages to ensure 
they were a true reflection of participants’ experiences and NPT was used as a 
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confirmatory tool to abstract the descriptive themes from the analysis to implications 
that were relevant and grounded in the findings. 
 
Transparency and coherence 
Yardley discusses the importance of clarity and power of description and argument, 
transparency of methods and how data are presented. In the study, this has been 
achieved through the presentation of verbatim quotations from the participants 
alongside a description of the theme to which they relate. Procedural methods are 
described later in chapter 5.2. The fit between method and theory is also imperative, 
states Yardley. Chapter 5.1 has described how Crotty’s four pillars of social research 
were taken into account to ensure a congruent fit between epistemological position, 
theoretical perspective, methodology, and method. Section 5.1.6 demonstrates how 
NPT was utilised within the study also. 
 
Impact and importance 
Yardley’s final measure of methodological quality relates to the impact and 
importance of the research and its ability to enrich understanding and its practical 
utility for those who may utilise the findings for example policy and practice. This 
study seeks to explicitly demonstrate the utility of the findings in Chapter 9. 
Implications derived from the findings are presented for future users of NPT 
(theory), for policy and practice, for training, for support and education and finally 
for future research. 
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5.1.6 Normalisation Process Theory’s role within the methodology 
Normalisation Process Theory was used as a tool across the lifecycle of the PhD 
project. In the initial planning stages, it provided a framework to sensitise me to 
issues around the implementation, embedding, and integration of knowledge and 
practices. At the planning stage, NPT helped to think through what, in a best-case 
scenario, would need to be in place within the NHSHC process to facilitate an 
individual’s journey if adhering to the principles of the programme. With this in 
mind, the interview schedules were constructed in such a way that they would elicit 
information about the process of normalisation through ‘making sense’ of the 
NHSHC and CVR (coherence), ‘working out participation’ the NHSHC and 
suggested intervention (cognitive participation), ‘doing the work’ of being at high 
CVR (collective action), and ‘reflecting on it’ (reflexive monitoring). 
 
At the analysis stage, NPT was utilised to make sense of the themes emerging 
through the inductive coding stage. Initially, the constructs and working mechanisms 
were used as the basis to undertake a Framework Analysis (Ritchie and Spencer, 
1994). However, this process proved unhelpful and raised concerns about imposing a 
deductive approach to data analysis that did not sit within the ethos of the 
methodology previously outlined. Thus, Framework Analysis was abandoned in 
favour of an inductive analysis process, a blended approach taking principles from 
both Interpretative Phenomenological Analysis (Smith et al., 2009) and Braun and 
Clark’s six-stage thematic analysis (Braun and Clarke, 2006, Braun and Clarke, 
2013). Once the inductive coding was complete, the domains of NPT were 
considered in relation to the findings to see if the NPT domains could help to shed 
light on the issues that had arisen and help make sense of the findings. In essence, 
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NPT was used as a theoretical lens with which to interrogate the findings. Three 
constructs; making sense of it (coherence), doing it (collective action), and reflecting 
on it (reflexive monitoring) were especially helpful when making sense of the data; 
the construct working out participation (cognitive participation) less so. However, 
this could be a reflection on how the constructs were interpreted initially and 
therefore the way in which the interview schedule was constructed, rather than the 
usefulness of the construct per se.   The theory was helpful, however, in illuminating 
the strengths and weaknesses of the NHSHC programme, at the time of the study, 
and allowed the emergence of implications for policy, practice, and further research 
(discussed in Chapter 9). 
 
5.2 Process and design 
The following procedural methods section is described utilising the COREQ 
framework (Tong et al., 2007) for reporting qualitative studies. 
5.2.1 Participant selection 
A purposive sampling technique (Quinn Patton, 2015) was employed to include 
individuals who fitted the following inclusion criteria: 
1. Had undergone a full NHSHC assessment at their GP practice 
2. Had been identified as at high risk (>20%) of having a cardiovascular event 
in the next ten years 
3. Had been given lifestyle advice and/or been prescribed prophylactic lipid 
lowering medication 
4. Had attended at least one annual review 
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This approach was selected to fit the needs of the commissioned evaluation, to 
ensure that participants had experienced the entire NHSHC process from invitation 
through to annual review. 
 
Participants were approached to take part through their GP practice. Four GP 
practices that had taken part in the first evaluation (Oswald et al., 2010) were 
approached to help with participant recruitment; one in each of the Hartlepool, 
Stockton on Tees, Middlesbrough and Redcar and Cleveland Primary Care Trust 
(PCT) localities. The practice manager or lead CVD nurse, who had overall 
responsibility for the delivery of the NHSHC programme, was contacted by email. 
The email explained the research project, and what would be involved in terms of 
fieldwork if their patients did decide to take part. Of the four practices that were 
initially contacted all agreed, in principle, to help recruit participants into the study.  
 
Once a practice indicated they were happy to contact patients on behalf of the 
research team, each GP practice was visited to discuss what would be required of 
them and to answer any questions that they might have had. During this initial visit 
practices were provided with copies of key information for staff (Appendix 11.4), a 
participant information sheet (Appendix 11.6) and a patient contact details form 
(Appendix 11.7). Practices were asked to discuss the project with patients at the point 
of annual review using the key information sheet as a reminder. Patients who 
expressed an interest in taking part were then given a hard copy of the participant 
information sheet. Their contact details were recorded, using the contact details form, 
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and kept in a safe place, according to each practice’s protocol for storing patient 
information, until they were ready to be collected. 
 
The practices kept in contact through regular email and telephone contact. Once 
several patients had expressed an interest in taking part in the study, I visited each 
practice to collect the information. All this contact information was kept securely in a 
locked filing cabinet at Teesside University until the interview with that patient was 
complete. Once all data had been collected and all tapes transcribed. All of the 
participant contact details were shredded using Teesside University’s secure 
shredding system. 
 
This method of patient recruitment posed a challenge, as the number of patients 
called into practices for their annual review was variable. Some practices had 
engaged with the programme much more than others (Oswald et al., 2010) and 
therefore had many more patients attending for the review. Some practices were 
experiencing difficulty getting patients to attend for their annual review 
appointments and speculated that this was because patients had not been taking their 
medications or keeping up with the lifestyle changes proposed at their assessment. 
 
Recruitment of GP practices in the Middlesbrough locality was challenging and took 
some time. In Stockton one practice agreed to take part but, after recruiting two 
participants, withdrew from the study. Therefore, another practice was identified in 
that area in order to achieve the required number of participants. Table 15 shows the 
number of practices contacted in each area, how many agreed to take part and finally 
how many practices went on to identify and approach participants. 
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Table 15: GP practice recruitment  
 Locality 
Number Hartlepool Middlesbrough Stockton-on-
Tees 
Redcar 
Contacted 1 14 2 1 
Agreed 1 3 2 1 
Took part 1 1 2 1 
 
 
Each participant who expressed interest in the study was contacted, via telephone, to 
establish that they were happy to be interviewed. Participants were given the 
opportunity to ask any questions they had about the study and what would happen if 
they agreed to be interviewed. Each participant was asked if they had had the 
opportunity to read through the printed information sheet to ensure they had read and 
understood it. Once interest in the study was established an appointment was made 
for them to take part in an interview at a time and location that was convenient to 
them. 
 
Thirty-one participants expressed an interest in the study and all went on to be 
interviewed. However, at the point of interview I had concerns about three of the 
patients’ ability to give informed consent. Upon arriving at one interview the 
participant was found to be accompanied by a carer, who explained that the 
participant had suffered a hypoxic brain injury and might not be able to recollect the 
assessment. After a short conversation with the participant it became clear that they 
could not recollect their assessment or review, so the participant was thanked for 
their time and the interview was terminated. Another interview was terminated 
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because it quickly became apparent that the participant was drunk. The final 
interview that was terminated was with a lady who was in a semi-secure forensic unit 
and who did not remember her NHSHC or review. In these three instances I made a 
decision to abandon the interview process. One other interview had to be removed 
from this analysis as the interview failed to record. One further interview was 
excluded from analysis as the interview was cut unexpectedly short when I left early 
because of safety concerns. Twenty-six interviews were therefore taken forward for 
analysis. No participants asked to be removed from the study once they had taken 
part in interview. 
 
Participants were given the opportunity to choose the location where the interview 
would take place, for example, their home, at the university, a coffee shop or a local 
community centre. Many of the GP practices offered rooms in their buildings to host 
interviews. However it was felt preferable to conduct the interviews in a place that 
was neutral for the participant, to facilitate frank and open discussions about their 
experiences of being involved in the NHSHC programme. It was also important that 
participants did not assume that I was linked to their GP practice. 
 
Interviews therefore took place either in participants’ homes or at Teesside 
University. As interviews took place at participants’ homes, the Teesside University 
lone worker policy was implemented. This necessitated the use of a ‘buddying’ 
system, whereby a colleague was aware of where interviews were to take place, to 
ensure my safety at all times.  
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For the majority of the interviews there was only the participant and I present. 
However, on five occasions the participant’s partner/ spouse was also present. This 
was because the interview was being conducted in their own home. Consent was also 
gathered from the spouses that were present so that their commentary could be 
included within the analysis, if it was relevant. 
 
5.2.2 Ethics and ethical scrutiny 
As discussed in the opening sections of chapter 5, this study is a secondary analysis 
of data that I collected as part of a commissioned piece of work. As such, approval to 
undertake the secondary analysis was sought from Teesside University’s School of 
Health and Social Care Research Ethics and Governance Committee. A copy of the 
approval letter is included in Appendix 11.5. The original commissioned study that 
this data was collected for received approval from the same committee in February 
2011. Approval was sought from the National Research Ethics Service (NRES) 
(latterly replaced by the HRA) to undertake the study. However, it was classified, as 
per the guidance at that time, as a service evaluation. Therefore, full NHS ethics was 
not required for the original study. Local R&D permission was given by the relevant 
Trusts. 
 
The acquisition of informed consent was an iterative process. Participants were given 
written and verbal information about the project and given the opportunity at several 
points, before the interviews took place, to ask questions. Immediately before the 
interview took place they were asked if they were happy to go ahead. Each 
participant was informed that they could stop the interview at any time to ask further 
questions or to stop participating. If they wanted to stop the interview and leave, they 
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did not have to give a reason. No participants decided to stop the interview. 
However, on three occasions participants became distressed whilst recounting 
personal experiences. On these occasions the interviews were paused, the 
participants given time to collect themselves and I offered to terminate the interview. 
On each occasion the participant was happy to continue. 
 
All participants were ensured that the information they gave would be kept 
confidential, in that only I and my supervisory team would read the transcripts in 
their entirety. However, each participant was made aware that direct quotations from 
what they said would be used when reporting the study. For this reason, they were 
assured that they, as participants, would be granted anonymity through the use of 
pseudonym. All transcripts were anonymised – all participants were given 
pseudonyms and I was selective about the demographic information that was 
attributed to direct quotations so as to maintain this. 
 
 
5.2.3 Data collection 
Data were collected through semi-structured interviews to (as much as possible) 
facilitate frank and open discussions and were guided by the interview schedule 
presented in Appendix 11.8.  Chapter 4 described how I used NPT constructs to 
identify key areas to explore with participants to understand their engagement with 
elements of the NHSHC programme.  I developed the interview schedule to cover 
the aims of the aforementioned evaluation but furthermore to probe into deeper 
questions which served to explore the aims of the PhD study. 
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To design the tool that would be used in each of the interviews (Appendix 11.8) I 
followed a six stage process as outlined by Braun and Clarke (2006): Brainstorming 
initial questions, considering the sequencing of questions, constructing and wording 
the questions, developing prompts and probes, piloting the interview guide, and 
finally refining the interview guide. 
 
Brainstorming initial questions: I began by taking the four constructs of NPT and 
brainstorming how each construct and working mechanism might be helpful in 
understanding the journey that potential participants might travel through the 
NHSHC programme. Tables 7, 9, 11, and 13 demonstrate the types of questions that 
I generated through this process. Initial question generation was also informed by my 
previous work evaluating aspects of the NHSHC programme from an organisational 
perspective and the requirements of the commissioned piece of work already 
discussed. This was an important process to undertake as it identified a wide variety 
of issues and aspects of potential engagement with the NHSHC programme to 
explore (Quinn Patton, 2015).  
 
Sequencing of questions: I then began a process of grouping questions by ‘topic’ or 
‘theme’ in order to sequence the questions. I decided that the most logical way to 
sequence them was by stages of the NHSHC journey: receiving the invitation, 
attending the initial risk assessment, being informed of CVR status, making changes 
to lifestyle, attending annual review. This allowed the interview to progress logically 
and thereby shift from one topic to the next (Braun and Clarke, 2013). 
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Constructing and wording the questions: the next stage was to consider how the 
questions might be worded. In order to allow the interview to progress in a 
conversational manner, strict questions that had to be adhered to were not developed, 
rather example phrasings were developed whilst being mindful that the wording of 
the questions may change depending on participants’ previous responses in the 
interview. I wanted to allow the interview conversations to emerge in a natural but 
purposeful way (Burgess, 2002), whilst being mindful of the specific topic areas I 
wanted to address.  
 
Developing prompts and probes: the next stage of the process was to develop a set 
of prompts and probes for my questions. Prompts and probes can encourage 
participants to open up a little more and expand on their answers in more detail 
(Braun and Clarke, 2013). Prompts and probes were not developed for every 
question – only those where I felt it would be most helpful to delve a little deeper 
should the interview require it. 
 
Piloting and refining the interview guide: the final stages in the development of 
the interview guide included the piloting of the tool and refining it prior to use. The 
tool was appraised and agreed with the supervisory team. Before I began piloting it 
members of the commissioning organisation also appraised the tool to ensure that it 
met their needs and to offer expert insight from those tasked with commissioning and 
implementing the NHSHC locally. I undertook a ‘mock interview’ with a colleague 
to ensure I was happy with the flow and wording of the questions prior to embarking 
on ‘live’ interviews.  
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Each participant was asked to sign a consent form (Appendix 11.9) prior to the 
commencement of the interview. Once interviews had been completed each 
participant was thanked for their time and given a £20 High Street voucher as a 
gesture of good will. Each participant was also sent a thank you card. Interviews 
lasted between 20 and 90 minutes. The interviews were, with the permission of the 
participants, digitally recorded and later fully transcribed ready for analysis. Field 
notes were made after each interview and were used to inform the analysis stage.  
 
5.2.4 Analysis and findings 
All interviews were conducted by RM and all transcripts were coded by her. JS and 
AS coded a subset of six transcripts. All coders met to discuss and agree the patterns 
and themes that were evident in the transcripts to ensure consistency of coding and to 
ensure that themes were not being overstated. 
 
An inductive approach to data analysis was undertaken to ensure that all themes were 
derived from the data corpus. Data analysis drew on (Braun and Clarke (2006), 
Braun and Clarke (2013)) six stage thematic analysis framework and Interpretative 
Phenomenological Analysis (IPA) (Smith et al., 2009). Table 16 shows the stages of 
each type of analysis. 
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Table 16 Key stages of analysis 
 Thematic Analysis 
(Braun and Clarke) 
Interpretative 
Phenomenological Analysis 
(Smith et al) 
Relevant stages of 
analysis 
Stage 1: Familiarisation with 
the data 
Stage 1: Initial familiarisation 
with the text 
 
Stage 2: Generating initial 
codes 
Stage 2: Identification of initial, 
preliminary themes 
 
Stage 3: Searching for themes Stage 3: Grouping of 
preliminary themes into clusters 
 
Stage 4: Reviewing themes Stage 4: Tabulation of clusters 
and themes into a summary 
table (Smith et al., 2009, 
Biggerstaff and Thompson, 
2008) 
 
Stage 5: Defining and naming 
themes 
 
 
Stage 6: Producing the report 
 
 
 
Each participant’s account was dealt with, initially, on an individual basis.  
 
Each transcript was read whilst listening to the tape simultaneously. This allowed me 
to make notes on tone and language used by the participant and to immerse herself in 
the account that the participant was describing. During this process of familiarisation 
descriptive notes were made, about language used, repeated phrases, inconsistencies 
in the participant’s account, questions about the data and my own emotions and 
preconceptions that may affect analysis. The latter notes were made in a separate 
research diary in an attempt to acknowledge, suspend and lay aside the my own 
opinions and judgements as a form of bracketing (Smith et al., 2009, Creswell, 
2013). 
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Each transcript and the accompanying notes made in stage one were then re-read. 
NVIVO 10 was used to manage the large corpus of data and to facilitate the 
organisation of data into themes. At this second stage the descriptive ‘free notes’ 
were condensed and transformed into phrases which captured and summarised the 
meaning contained in the ‘free notes’. These phrases, or initial themes, became 
abstracted from the data and began to convey deeper meanings that had been derived 
from the text. This second stage of analysis saw me move away from working with 
the text of the transcript to working more analytically with the initial notes, but with 
regular cross checking back to the data to confirm interpretations. At this stage I was 
not only abstracting themes but looking for connections between the themes, in each 
transcript. 
 
The third stage of analysis consisted of taking these newly derived initial themes and 
clustering them into a logical structure of concepts, clustering was tried in several 
ways, cross checking back to data. This stage of analysis aimed to arrange and group 
themes into super-ordinate categories and to identify relationships between the 
clusters (Biggerstaff and Thompson, 2008). During this phase of analysis I began to 
move into a stage of interpretation from the story the participant had told. Whilst the 
interpretation began to become more and more abstracted from the data it should be 
noted that the words and description from the participant were always the 
springboard for interpretation and all interpretation was rooted in the data from the 
participant, representing how the hermeneutic circle is manifest in the analysis 
(Smith et al., 2009). 
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Clusters and their related themes were then mapped to make sure they were distinct 
from one another and to show how the themes fit together. At this point in the 
analysis the constructs of NPT were cross referenced against the emergent themes to 
see if NPT could illuminate the themes derived from the data. This phase of 
deductive analysis was performed at this stage to ensure that any themes were 
directly derived from the data and data was not forced to fit the constructs of NPT. 
The themes were then named ready for reporting. 
 
The themes reported in Chapters 6 and 7 are presented descriptively alongside direct 
quotations from the interview transcripts to show how the theme was derived from 
the data. The analytical interpretation is presented in the discussion chapter (Chapter 
8) where it is linked back to relevant literature. 
 
5.2.5 Research team and reflexivity 
All interviews were conducted by me, a female full time Research Associate working 
in the School of Health and Social Care at Teesside University. I hold a BSc 
Psychology and MSc Social Research Methods and have a decade of practical 
qualitative research experience. I am not a medical practitioner. At the beginning of 
each interview this was stressed to participants so that they were aware she could not 
offer any medical advice or enter into conversations about the appropriateness of 
their treatment or care. On many occasions participants seemed conflicted by this 
information, as they did try to engage in these kinds of conversations. The 
participants were made aware that I was not affiliated with their GP practice and that 
anything they told me would not be passed back to their practice. This enabled 
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participants to be frank and honest about their experiences of the NHSHC 
assessment, the staff delivering it, and their experience of the annual review process. 
 
This process of identifying myself as separate to the intervention and the staff 
delivering it had both advantages and disadvantages. Participants could speak openly 
about the care and treatment they had received without fear of repercussions from 
practice staff. In many cases participants took the opportunity to tell me things they 
suggested they would not normally tell staff responsible for their care. This process 
of separating myself from the intervention also allowed me to ask naïve questions 
that perhaps a health professional would have taken for granted and to explore 
avenues that would otherwise have been left. However, this separation did have 
another side. I was not known to them and also not a ‘trusted professional’; I was not 
affiliated to any organisations that were responsible for care. On some occasions this 
caused participants to think I was an undergraduate student from the University 
carrying out a project for my course, very similar to the case outlined by Richards 
and Emslie (2000). In the case reported by Richards and Emslie, participants 
changed the way they interacted with the researchers based upon their perceptions of 
who the researchers were, professionally. One of the researchers was a trained 
medical doctor. When participants were aware of this information they tended to ask 
for reassurance about medical conditions and adopt a more subordinate role within 
the interview process. The other researcher was an academic. When participants were 
aware of this information they questioned if the researcher was a student, 
undertaking fieldwork for study. This study demonstrates that participants change 
how they interact with researchers based upon their perceptions of positions of 
power.  This impacted on the project, as the reality that participants described me 
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may well have been different to what had actually happened in the assessments or in 
the subsequent year leading to the annual review. 
 
It must be acknowledged that I was integral to the analysis and that this analysis was 
formed and shaped by me. Phenomenology acknowledges the pivotal role of the 
researcher in generating the data and of course its subsequent analysis.  
 
5.2.6 Limitations to study design 
There are, of course, limitations to the chosen methods of data collection. 
Recruitment of patients was reliant on the cooperation of General Practice staff, 
mainly Practice Managers and Practice Nurses. Some practices that were approached 
to take part in the study agreed quite quickly. Others agreed but never actually 
produced any patient details or they refused completely. Recruitment of participants 
in one locality proved difficult, this was overcome by continual recruitment of 
practices until one finally agreed to help. However, this created a long delay in the 
project. 
 
Once I had approached the relevant person within the GP practices, responsibility for 
recruitment was handed over. I had no way of knowing if the personnel were sticking 
to the protocol for giving out the appropriate information. Moreover, GP practice 
participation was subject to other professional priorities such as staff sickness and 
holidays which caused, in some cases, much delay in participant recruitment.  
 
The sampling strategy was chosen to suit the priorities of the commissioner, the 
evaluation, and for pragmatic purposes. It must be noted that patients who agreed to 
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take part were, to all intents and purposes, a self-selecting sample. To fully 
understand patient adherence with the NHSHC programme it would have been 
beneficial to include patients within the sample who had refused to have a NHSHC 
in the first place. Identifying and contacting that cohort of patients however, carries 
many practical and ethical implications. It should also be noted that participants were 
not recruited from all age groups eligible for the NHSHC. Through the sampling 
strategy employed, participants who agreed to be interviewed were from older age 
groups. No one between the ages of 40-56 years old is included within this sample. 
As stated earlier this could be a reflection on the approach taken by the Tees PCTs to 
target those who were most likely to be at increased risk of CVD in the early stages 
of roll out. 
 
Chapter 5 has outlined the philosophical underpinnings of the research, the 
procedural methods employed in data generation, analysis and the limitations to this 
approach. The following chapters move on to discuss the findings of the study. 
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6 Findings – making sense of it and working out 
participation 
The following chapters present the findings from the study and discussion about how 
findings can be understood through the theoretical lens adopted for this study. The 
two findings chapters (6 and 7) are presented descriptively. Each theme is presented 
alongside example verbatim quotations that demonstrate how the theme was derived 
from the data. Analytical interpretations of the data and how they relate to the NPT 
constructs are presented in chapter 8. 
 
Chapter 6 presents findings that mainly relate to the patient ‘work’ involved in 
making a decision to attend assessment and understanding the initial diagnosis of 
increased cardiovascular risk. This can be illustrated through exploring the constructs 
of making sense of it (coherence) and, to some extent, working out participation 
(cognitive participation). Chapter 7 relates to phases of patient ‘work’ that relate 
mainly to the constructs doing it (collective action) and reflecting on it (reflexive 
monitoring). The themes presented in these two findings chapters thus follow the 
progression of the patient journey from invitation to attend assessment through to 
annual review. This was done purposively to allow the voice of the participant to 
shine through and to demonstrate how NPT constructs relate to each stage of the 
journey through the NHSHC. Deeper, conceptual discussion about the implications 
of the findings is presented in chapter 8. 
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This first findings chapter explores the phases of work that participants undertook to 
engage with the NHSHC programme, make sense of their diagnosis of risk, and 
engage with questions around preventative medicine. Therefore, the findings in this 
chapter relate primarily to the first two constructs of NPT; making sense of it 
(coherence) and working out participation (cognitive participation).  
 
Section 6.1 presents demographic information about participants. Section 6.2 is 
concerned with the reasoning that took place to make a decision to attend and engage 
with the initial stages of the NHSHC assessment. 6.3 describes how people reacted to 
being told they were at increased CVR. 6.4 discusses the identity work undertaken 
after identification of increased CVR. Finally 6.4 assesses participant’s views on 
preventative action in terms of CVR. 
    
6.1.1 Participant demographic information 
Of the 26 participants, the majority (65.4%, n= 17) were male and nine were female 
(34.6%) (Table 17). Participants were aged between 57 years old and 76 years old at 
the time of interview. Whilst the NHSHC assessment is available to the entire 
English and Welsh population who are aged between 40 and 74 years old, no one 
from the younger age groups (40-56 years old) took part in the study. This could be a 
reflection on the way in which the Tees PCTs implemented the check by utilising a 
targeted approach alongside the recommended universal approach. It can be seen in 
Table 17 that the majority of participants in the sample (60%) were in the older age 
categories and aged between 65 and 74 years old. The majority, 84.6% (n=22), were 
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currently married with 7.7% (n=2) divorced, 3.8% (n=1) widowed and a further 3.8% 
(n=2) being single.  
 
Despite efforts to recruit evenly from each of the four PCT areas; Hartlepool, 
Middlesbrough, Redcar, and Stockton on Tees, the distribution of participants 
included within the sample was far from equal (Table 18). However, as participants 
were, essentially, a self-selecting sample, the distribution of participants across the 
localities was dictated by the responses to the study invitation. 
 
The majority of participants included within the study were retired (78.6%, n=22), 
two were still in employment and two were unemployed due to disability (Table 18). 
All participants had attended at least one annual review. Twenty participants (76.9%) 
had attended just one annual review at the point of interview and six had attended 
two annual reviews (23.1%). It should be noted that the people included within this 
study are already compliant to some extent as they have received an assessment, 
been identified as at high risk and have attended at least one annual review. A 
majority of participants (69.2%, n=18) had a history of CVD in their family, eight 
(30.8%) stated that there was no history of CVD in their family but two (7.7%) of 
those eight did describe a history of cancer.  
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Table 17: Sex, age, and marital status of participants  
 Sex Age group Marital status 
 Male Female 55-59 60-64 65-69 70-74 75+ Married Divorced Widowed Single 
Number 
(%) 
17 
(65%) 
9 
(34.6) 
3 
(11.5) 
5 
(19.2) 
3 
(4.6) 
7 
(26.9) 
2 
(7.7) 
22 
(84.6) 
2 
(7.7) 
1 
(3.8) 
1 
(3.8) 
 
 
Table 18: Recruitment locality and employment status of participants  
 Locality Employment status 
 Hartlepool Middlesbrough Redcar Stockton-on-
Tees 
Retired (semi-
skilled) 
Retired 
(professional) 
Employed 
(professional) 
Disabled 
Number 
(%) 
2 
(7.7) 
9 
(34.6) 
6 
(23.1) 
9 
(34.6) 
13 
(50) 
9 
(34.6) 
2 
(7.7) 
2 
(7.7) 
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Table 19: Statin status and dietary advice given to participants  
 Statin status 
 
Dietary advice 
 Taking Discontinued refused Not prescribed Made changes Made no changes No advice offered 
Number 
(%) 
17 
(65.4) 
4 
(15.4) 
4 
(15.4) 
1 
(3.8) 
14 
(53.8) 
8 
(30.8) 
4 
(15.4) 
 
 
 
Table 20: Physical activity advice, alcohol consumption advice, and smoking status  
 Physical activity Alcohol consumption Smoking status 
 Made 
changes 
Made no 
changes 
No advice 
offered 
Made 
changes 
Made no 
changes 
No advice 
offered 
Non smoker Ex smoker Made no 
changes 
Quit 
Number 
(%) 
2 
(7.7) 
7 
(26.9) 
17 
(65.4) 
1 
(3.8) 
3 
(11.5) 
22 
(84.6) 
10 
(38.5) 
13 
(50) 
1 
(3.8) 
1 
(3.8) 
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Table 21: Participant Demographic information 
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 =discussed and no changes made 
- =no recollection of discussion 
 
Alex 
 
Male 67 Married  2 Refused   - Ex-smoker 3 
Barbara 
 
Female 66 Married  2 Discontinued   - Ex-smoker 3 
Bernie 
 
Female 61 Married  1 Refused   - Non-smoker 3 
Brian 
 
Male 66 Divorced  1 Taking  - - Non-smoker 3 
Carol 
 
Female 75 Divorced  1 Taking - - - Ex-smoker 1 
Colin 
 
Male 57 Married  1 Taking  - - Ex-smoker 3 
David 
 
Male 62 Married  1 Taking - - - Non-smoker 2 
Dennis 
 
Male 65 Married  1 Taking  - - Ex-smoker 4 
Doug 
 
Male 71 Married  1 Not prescribed   - Non-smoker 1 
Fran 
 
Female 70 Married  1 Taking  -  Ex-smoker 3 
Gary 
 
Male 67 Married  1 Taking - -   4 
Harry 
 
Male 75 Married  1 Taking   - Ex-smoker 1 
Jeff Male 71 Widow  2 Discontinued  - - Ex-smoker 1 
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Jim 
 
Male 61 Married  1 Taking  - - Ex-smoker 1 
John 
 
Male 71 Married  1 Taking  - - Ex-smoker 3 
Kate 
 
Female 68 Married  1 Refused  - - Ex-smoker 4 
Keith 
 
Male 60 Married  2 Taking    Non-smoker 2 
Ken 
 
Male 74 Married  1 Discontinued  - - Ex-smoker 4 
Linda 
 
Female 66 Married  1 Refused - -  Ex-smoker 4 
Maureen 
 
Female 58 Married  2 Taking   -  3 
Nigel 
 
Male 72 Single  1 Taking   - Non-smoker 3 
Paul 
 
Male 63 Married  1 Discontinued  - -  1 
Paula 
 
Female 57 Married  1 Taking   - Non-smoker 2 
Phillip 
 
Male 65 Married  1 Taking  - - Non-smoker 1 
Shirley 
 
Female 72 Married  2 Taking  - - Ex-smoker 3 
Tom 
 
Male 66 Married  1 Taking  - - Non-smoker 3 
129 
 
6.2 Making a decision to attend an NHS Health Check 
The success of the NHSHC programme relies on several distinct processes taking 
place, these processes are congruent with the processes proposed by the constructs of 
NPT. Firstly, individuals must accept the invitation of assessment and attend their 
assessment appointment (making sense of it (coherence)). Individuals must then 
receive and accept their diagnosis of CVR (making sense of it (coherence) and 
working out participation (cognitive participation)) and go on to internalise the 
necessity to implement lifestyle changes and also accept, comply, and sustain 
engagement with prophylactic medications (doing it (collective action)). Individuals 
must also agree to long term monitoring of CVR through the annual review process 
(reflecting on it (reflexive monitoring)). Therefore, the way in which people are 
approached to undergo a CVD risk assessment may be pivotal to their initial ‘buy in’ 
to the NHSHC programme. In order to encourage people to attend assessment, the 
invitation needs to be presented in a way that makes sense and offers something that 
is attractive, coherent, and worthwhile for them to attend.  
 
For the individuals in this study, the invitation offered to them to undergo risk 
assessment, was not initially interpreted as unique, or different from many other 
invitations to attend their GP practice (understanding the uniqueness of it 
(differentiation)). In fact, their invitation for assessment seemed to be part of a 
routine offering by their GP practice. As Jim summed up in his interview: 
It was just a routine check (Jim, 61).  
General curiosity and interest in maintaining overall health led this group of patients 
to attend their NHSHC assessment. As Nigel described:  
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It was a letter from the surgery, and that was it, inviting me to take 
part. So I thought “I’ve got nothing to lose” so I went (Nigel, 72). 
The importance, or value of the health check was not particularly scrutinised at an 
individual level. It was suggested that if routine health checks are offered by health 
professionals, it must have some clinical importance, and therefore it is good practice 
to attend:   
If they invite you to go and do these things then I think you should 
go and do them. They obviously regard it as something important, 
so why not? It doesn’t cost you anything, just 20 minutes (Kate, 
68). 
People often did not distinguish the NHSHC as different from their current ways of 
routinely engaging with their GPs (understanding the uniqueness of it 
(differentiation)). For example, Alex and Barbara described how Barbara had been 
having the NHSHCs for a number of years, even before the NHSHC programme was 
in existence. This lack of differentiation between the NHSHC and other checks that 
were routinely accessed led some participants to not even realise they were engaging 
with a ‘new’ programme: 
Alex:  Well, my wife has been going on a Healthy Heart 
Check (NHSHC) for what must be three or four years 
now, haven’t you? 
Barbara: I think so, yeah? 
Alex:  I don’t know why the women got theirs, but the men’s 
came after, if you like? (Alex, 67. Barbara, 66). 
 
 
In addition to the perceived routine nature of the offer of a health check, many 
participants interpreted the offer of assessment as a result of their advancing age 
(individually interpreting it (individual specification)). Again, reiterating the 
interpretation of risk assessment invitation as a routine offering from the health 
services:  
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I thought it was everybody of a certain age who got invited. I never 
actually wondered why I had been invited. I thought it was 
something people have to go through at a certain age, and that 
people at that age had all been invited (Brian, 66). 
People are used to being offered routine checks for many different possible health 
complaints right across the life course, and this was not distinguished as different 
from any of those other health screenings: 
You get to a certain age and you need to come in and get a Healthy 
Heart Check-up for different things when you get to 60 you get that 
thing through the post for the check [of] your stools for the bowel 
cancer (Paul, 63). 
Another participant noted: 
 
I was just called up. As far as I was aware, it was for an MOT3…I 
mean a lot of GPs do this thing now, every year or two, if you’re 
over 60 you get invited for an MOT (Gary, 67). 
These findings highlighted how individuals were passively compliant in the 
initial stages of the NHSHC journey. 
 
6.2.1 Feeling fit and well 
Whilst the invitation to attend a health check did not, initially, seem out of the 
ordinary to participants, the need to have a health check to assess CVR was not 
something many of them had ever considered they needed, as, prior to the 
assessment, they all felt fit and well. All participants in the sample had been 
asymptomatic prior to invitation, and none of them had sought out or requested a 
CVD risk assessment. For example, as Brian describes: 
 
  
                                                          
3 MOT is an abbreviation of Ministry of Transport. MOT is a common name given to a vehicle safety 
test in the UK. https://www.gov.uk/getting-an-mot/when-to-get-an-mot  
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I mean I really wouldn’t know? If you were having problems with 
your heart what it would be like? But I mean I have never felt as 
though I am having a problem with it…I mean, I walk miles! 
(Brian, 66).  
 
And Phillip describes: 
I mean I only go to the doctors if I don’t feel very well, but I felt 
healthy [prior to assessment]. So there were no signs of anything, I 
wasn’t suffering with anything due to high cholesterol (Phillip, 65). 
 
The offer of CVR assessment did, for some, act as a catalyst to begin a process of 
analysis leading to the consideration that even though they felt fit and well now, the 
assessment could highlight underlying conditions or point to future ill health:  
 
In one way you can think about it and think am I being healthy, am 
I doing the right things, is it worth it because I am feeling alright?  
I don’t have any problems that I think would cause me any 
problems. So, do I really need to go?  So, I suppose it can sow the 
seed of doubt (Tom, 66). 
 
It was clear from discussions about being invited for an NHSHC that whilst people 
feel fit and well, and in this respect may feel that attending the assessment may not 
make immediate sense, the routine nature of the request seemed to override this. For 
many, the offer of a CVD risk assessment is interpreted as something that is just par 
for the course – just one of those things you expect to do as you get older. People are 
used to being offered health checks for illness that may lie symptomless for many 
years, for example many forms of cancer, so in this respect the CVD assessment is 
not differentiated as unique in comparison to any other invitation that is accepted as 
‘normal’ or ‘routine’. Rather, the perceived routine nature of the assessment led many 
to attend the check. As people age, the number of routine health assessments they are 
invited to attend increases and the CVD risk assessment seems to fit neatly into just 
another one of those things that is offered. 
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6.2.2 Reasoning about the likelihood of being a candidate for cardiovascular 
disease 
When making a decision about attending the NHSHC, and subsequently throughout 
the NHSHC journey, individuals considered their likelihood of being a candidate for 
CVD. Candidacy, as demonstrated in Davison et al. (1991), is a construction by 
individuals, drawing in many different types of knowledge about themselves, their 
lifestyles, experiences of CVD, understanding of clinical information, and the way in 
which numerical risk scores are calculated and presented. In one case, a participant 
described a very high level understanding of CVR and the way in which CVR scores 
were relevant to different sections of the population:  
Well, that’s another issue I have with numbers. It’s calculated on 
a total population, which is nonsense, because I am not a total 
population. The white indigenous population is quite different to 
the Asian population; it’s quite different to the black 
population… (David, 62). 
 
This high level analysis was not the norm; however, it demonstrates participants’ 
methods of constructing a perceived likelihood of a cardiovascular event through 
processes of individual interpretation (individual specification) and coming to a 
conclusion (internalisation). 
 
The impact of behavioural choices such as poor diet, carrying excess weight, 
physical inactivity, and smoking were highlighted as reasons that people would be 
expected to be at increased risk of cardiovascular disease. Participants often 
discussed who they felt should be at increased risk of CVD: 
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To me, I suppose, somebody who is overweight and has a bad 
lifestyle, you know [would be at high risk of CVD]. [Who has] 
bad eating habits and eats chocolate and stuff like that. Which I 
don’t! (Linda, 66).  
 
Barbara: Alex’s mother died of a heart attack. A 
massive heart attack, and that was at 80. 
Alex: But she had smoked, from when she was 12 
year old, right through her life. So, she had 
created a problem for herself, I think! 
(Alex, 67. Barbara, 66). 
 
These interpretations at both the individual and collective (individual and collective 
interpretation) demonstrated a synthesis of myriad sources of information about 
candidacy gleaned from health promotion information and from interacting with 
friends, family and the social world to come to a conclusion (internalisation) about 
what factors affect CVR. 
 
Interestingly, in the majority of interviews, when discussing what it was that would 
make an individual a candidate for a CVD related event, people were able to recall 
an instance of an exception to ‘the rule’. People, who were physically fit, lived a 
virtuous lifestyle, yet in spite of this were still either disabled or killed by CVD. 
These stories seem to run counter to any coherent argument for risk reduction and 
management as they point to a more random and fatalistic understanding of CVD. 
Fran described: 
I have a friend who’s six years older than me. Five years ago we 
were all out [for a celebration]…and within two weeks of that 
she was paralysed with a stroke. She was about five foot, 
weighed about seven stone wringing wet, you know? Went 
swimming, I mean she’d been swimming that afternoon! (Fran, 
70). 
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Gary also noted: 
I worked with a lad, and he was 38 [when he died of a heart 
attack]. He was built like a robber’s dog; I mean he was fit and 
skinny…he rode his bicycle every day to work, and back… [He 
had] a heart attack at 38. Didn’t drink, didn’t smoke! (Gary, 67). 
 
These examples of exceptions to the rule were not limited only to cases of disability 
and death. Examples of the unfair nature of precursors to disease were also noted:  
I don’t eat butter; if I have anything it’s margarine. I always 
have skimmed milk. So, yeah, that was a shock – because I have 
a friend; she has full cream, she has butter, and she hasn’t got 
high cholesterol! (Carol, 75). 
 
6.2.3 Clinical testing for cardiovascular risk 
In discussions, participants rarely focussed on the testing that they were offered as 
part of the NHSHC. When testing was discussed it was described as something that 
was routine. Again, this suggests that the NHSHC was not seen as offering anything 
particularly unique, by way of offer or testing:  
[Testing was] the usual things; you know, blood pressure and all 
the rest of it. [The nurse] advised me to go on statins (laughs) 
and that sort of thing (Jim, 61). 
 
The lack of distinction of the NHSHC testing process from other routine tests that 
participants are offered locks in to the construct of making sense of it (coherence), 
particularly the working mechanism of understanding the uniqueness of it 
(differentiation). This could suggest that the type of tests offered to participants 
(height, weight, blood pressure, lipid testing) are already routinised, therefore leading 
participants to think there is no need to question or consider them in any great depth. 
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It has been previously noted (in chapters 2 and 3) that cholesterol and cholesterol 
testing are both very common notions in the UK population’s collective 
consciousness. It is understandable, therefore, that this became the focus when 
recalling testing during the NHSHC process. There was an awareness, in general, 
about the thresholds of what is considered to be ‘normal’ cholesterol and what is 
considered to be ‘high’. However, in some cases where an individual’s total 
cholesterol lay within the recommended limits, the concepts of high density 
lipoprotein (HDL) – also termed ‘good cholesterol’ –  and low density lipoprotein 
(LDL) –  also termed ‘bad cholesterol’ –  were introduced, by the nurses in the 
consultation, as a way of justifying the provision of statins. As Gary describes, 
below, how good and bad cholesterol were introduced as concepts during the 
assessment encounter as a way of encouraging him to take statins for the purposes of 
prevention, regardless of his seemingly low total cholesterol level: 
She put me on statins. My cholesterol is 3.5, but I have got more 
bad statins than good statins. Err, more bad cholesterol than 
good cholesterol. So, she put me on these statins, which I don’t 
like (Gary, 67). 
 
This demonstrates a tension between individual interpretation (individual 
specification) of what constitutes high cholesterol and therefore the need for medical 
intervention and collective interpretation with the health professional  about the 
justification for pharmaceutical intervention and how the process of collective 
interpretation (communal specification) can be used as a tool to influence the 
outcome of the encounter. 
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6.3 Receiving and interpreting a diagnosis of cardiovascular risk 
There were differing reactions displayed by participants regarding the news that they 
had been identified as at-risk of suffering a cardiovascular event in the next ten years. 
How people reacted to this news had the power to influence their subsequent journey 
and engagement with lifestyle advice and prophylactic medication. As mentioned 
previously, individuals who had been identified as at high risk, had, essentially been 
offered a ‘diagnosis of risk’. This diagnosis of risk was based on the assessment of 
surrogate markers (anthropometric measurements; family history; cholesterol 
screening; and lifestyle factors). These surrogate markers, when assessed singly do 
not constitute illness or disease but when assessed in conjunction with one another by 
means of an algorithm which calculates odds, it is posited that they indicate 
increased CVR. This lack of defined clinical diagnosis of a physiological condition 
meant that individuals did not always perceive that there was a problem that 
warranted attention through the implementation of behavioural changes or embarking 
on prophylactic medications.  
 
Upon hearing the news that they were at increased risk of a cardiovascular event, 
individuals began to engage with another layer of sense making work in order to 
unpack this news and integrate (or not) the concept of risk into their identity and 
lives. The following pages will explore; the differential reactions to the ‘at-risk’ 
diagnosis, how individuals begin to interpret and understand CVR, the working out 
participation (cognitive participation) work that individuals do to resist or accept a 
risk identity and finally how individuals engaged with concepts of prevention and 
fatalism.  
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6.3.1 Reactions to being identified as at high risk of a cardiovascular event 
Individuals reacted in three ways to the news that they were at CVR; some were 
shocked at the news; some felt they had had a diagnosis of ‘nothing’ and others felt 
that being identified as at-risk was actually reassuring. The following section will 
unpack these findings more fully. 
 
For many, learning that they were now considered to be at increased CVR, came as 
quite a shock. Confirmation of CVR was something unexpected. For some, like Fran, 
the communication of CVR expressed as a percentage drove home the message of 
risk and allowed the recipients to begin to internalise risk as something real and 
tangible that could be changed. Coming to a conclusion (internalisation) that CVR 
was indeed a threat became a catalyst to engage with preventative behaviours and 
accept prophylactic medications:   
But it was a bit of a shock because it was 25 point something 
chance of having a heart attack or stroke within ten years. I mean, 
I thought it would be high. I mean, I didn’t think it would be that 
high (Fran, 70). 
 
The emotion of shock allowed health professionals to work with individuals to co-
construct the problem of CVR through the process of collective interpretation 
(communal specification) and provide reassurance to the individual about the extent 
of the risks posed to them. Brian demonstrates this co-construction of the problem 
and how the health professional provided legitimation of the problem by providing 
reassurance that he was ‘just’ over the limit, so there was preventative action that 
could be taken: 
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As I said it is something that came as a great shock, when they said 
that I had a problem, I've got to say. Because, I always felt I was 
pretty healthy, for a 66 year old. But it comes with a bit of shock. I 
couldn’t quite believe it to be honest. The one consolation was she 
[the nurse] said "you are just over the limit" (Brian, 66). 
 
Again, Barbara describes how the health professional worked with her to co-construct 
the problem of CVR whilst allowing her as the individual to interpret, specify and 
internalise the news in relation to her current lifestyle practices and family history: 
Yes, it came as a shock to me. And the cholesterol thing came as 
a shock as well because we do eat well…and it seemed the way 
the nurse put it over, it seemed to be the fact, that I was 
overweight, well, obese. That was the reason that I was at high 
risk of a heart attack. That was the only reason. Well, my 
cholesterol and my weight because everything else, we don’t 
smoke, we don’t drink, there’s no family history of it. So it was 
only the fact that I was obese that was making me at-risk 
(Barbara, 66).  
 
As mentioned earlier, a diagnosis of CVR is based on mathematical calculations and 
projections of risk derived from surrogate markers. None of these markers constitute 
illness on their own – something that many individuals were well aware of. The lack 
of identification of a physiological condition that could be clinically diagnosed and 
treated led to many dismissing the concept of CVR. For these individuals, the 
NHSHC had failed to identify, classify or provide a name for a condition that 
warranted medical intervention: 
If someone came along and said "I'm sorry to have to tell you this, 
but you have angina or your blood pressure is either too high or 
too low", then you could be like "oh right! What can you do for 
me?” and, they could give you something, whether that just be an 
aspirin or something to get your blood pressure up or down. You 
have got something then, where you can say that there is something 
wrong with me. They can put it right and I have to take whatever, 
and do whatever they tell me (Alex, 67). 
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For those who recognised that the identification of CVR did not constitute a tangible 
illness to be treated with prophylactic medications and lifestyle intervention, attempts 
were made to open up a dialogue with the health professional who had undertaken 
the assessment to explore the reasons for the increased CVR and to acquire robust 
reasons for their at-risk status, providing an opportunity for collective interpretation 
(communal specification) about the reality of CVR. Health professionals often did 
not give a satisfactory explanation:  
She didn’t seem to know, really. You see, she went through did I 
smoke? Well, she knew I didn’t smoke. Do I do this? Do I do that? 
She really didn’t know what caused it to be honest with you…I 
mean if there was something that you could say "right that’s what 
caused it" you could do something about it. If nobody can say that 
"that caused it" there is nothing, in my mind, there is absolutely 
nothing you can do about it. You just have to live with it, type of 
thing (Brian, 66). 
 
Brian had decided to accept his risk status (come to a conclusion/internalisation) and 
to take medication to reduce his risk, since there was nothing he could do to change 
it, demonstrating a perceived lack of control. However, this response was not the 
only way people reacted. Like Alex, Linda interpreted her risk as something that did 
not warrant medical intervention. Linda had also probed the nurse performing her 
assessment about what had caused her risk to be increased, and again, she did not get 
an answer that satisfied her. Linda resented being directed straight down the route of 
medication, a route that she felt very strongly was an unnecessary course of action: 
But, if she'd [practice nurse] gone through and said "your 
cholesterol's high, we'll go through your diet and see what's what 
and see if we changed something in your diet and see if we can 
bring it down" but no. It was straight away, you know - take these 
[statin]. But there's nothing wrong with me, why do I want to? I 
believe people only take tablets if there's something wrong with 
them (Linda, 66). 
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This demonstrates how the process of making sense of CVR through understanding 
CVR’s relevance, individual interpretation that CVR does not warrant intervention, 
and the process of communal specification between health professional and 
individual failing to convince that CVR is indeed a risk, leads to a breakdown in 
internalisation of risk. 
 
In some cases, paradoxically, people found knowledge of their at-risk status 
comforting. Having a risk confirmed was preferable to having a physiological 
condition that could be life threatening. Risk in this case was something to aspire to, 
meaning that there was a lack of condition that needed treatment and could affect 
quality of life. Paula explained how she felt after her assessment:  
I know I'm ok really. You know? It’s not… I've not got nothing 
life-threatening! (Paula, 57). 
People were sometimes concerned that visiting the doctors for a check-up inevitably 
meant that you went in feeling fit and well but came out 15 minutes later with a 
diagnosis of illness, and probably medications. However, the delivery of a risk 
diagnosis did not hold the same weight. It instead led to internalising a sense of 
relief, rather than fear of potential CVD: 
You go in thinking you are pretty fit and healthy, and you come out 
[after initial assessment, before calculation of risk score] thinking 
you might have something that is going to floor you. But, 
fortunately, they haven't come back with anything (Tom, 66). 
 
The NHSHC assessment provided the opportunity to assess current health status and 
led some people to leave feeling that they had excelled - it was almost like passing an 
exam. This was further reinforced by messages given by the health professionals 
conducting the assessment. In Harry's case the nurse had complimented him on his 
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overall fitness, for his age. These positive messages left Harry feeling that he was 
doing well and that CVR was probably not all that bad, demonstrating that the 
process of collective interpretation during the assessment may lead to unintended 
(mis)understandings about health status:  
Harry:  [talking proudly] She [nurse] wishes she was 
as healthy as me! 
Interviewer:  Did she? 
Harry: That was her words, not mine. Everything was 
above normal (Harry, 75).  
 
The number and frequency of tests relating to the NHSHC assessment also sent 
messages of comfort to individuals.  The perceived concern of the health profession 
was related to the level of fear the individual experienced. Here, Colin describes how 
he relies on the health professions to alert him to health concerns and, if they are not 
overly concerned, neither is he: 
Colin: Well, I mean, they aren't over concerned, otherwise 
they would have done more checks on my cholesterol 
levels, if they were worried about it 
Interviewer: So, if they are happy, are you happy? 
Colin: Yes. I put my faith in their hands (Colin, 57). 
 
The opinion of health professionals, who were perceived as being experts and of high 
standing, held weight for individuals. Positive messages seemed to reinforce the lack 
of an actual physical condition and provided a source of comfort for the individuals, 
and their families. As Ken’s wife explains:  
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Dr [name], who is the head of the doctors' association, he did 
say "you have got the body of a young man, slim" (Ken’s wife).  
 
Receiving a diagnosis of risk provided peace of mind by signalling that there was no 
biological disease present in the body at the current time. Doug, the only participant 
who had not been offered statins for the purposes of prevention, described how he 
had left his assessment with the sense that he did not need to worry, that the 
assessment had not identified elevated cholesterol that justified intervention and 
therefore he had been afforded peace of mind, regardless of being at increased CVR 
and therefore a candidate for intervention, according to NHSHC protocol and 
guidance: 
They said my cholesterol was slightly up, but nothing to worry 
about at all. There was no need for any medication to bring the 
cholesterol down…it definitely is a good thing [the NHSHC], I 
think. It gives me peace of mind (Doug, 71). 
 
These positive messages, arrived at through the processes of collective interpretation 
(communal specification), were not limited to discussions about cholesterol and 
medication, Alex explained how, after refusing to initiate treatment with statins, he 
felt that the health professional who carried out his assessment must not have been 
overly concerned that anything was fundamentally wrong with him. Participants 
were relieved when a health professional confirmed that aspects of their health, such 
as weight or cholesterol, were within satisfactory limits. For example: 
He said it was up to me but I said I don’t want to take them, full 
stop. I take enough tablets as it is! My weight was OK, so I wasn't 
really overweight...so as far as they were concerned I was OK 
(Alex, 67). 
 
These positive messages were reiterated, for some, at the annual review, giving 
people a clean bill of health, at least for the coming year. As Harry explained:   
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So when you go for these check-ups and they say you're fine, 
well you think to yourself "that's me for a year now, I'm good for 
a year” (Harry, 75). 
 
Doug also described how the annual review process reinforced positive messages 
about good health through the process of collective interpretation with the health 
professional:  
But, going to the Healthy Heart Check once a year, I do find it 
reassuring - especially to come away with a fairly good, clean 
bill of health (Doug, 71). 
 
6.3.2 Understandings of CVD risk 
Risk of future illness can be a difficult concept for health professionals to 
communicate clearly and accurately. In order for the recipient of this risk 
communication to make sense of what danger, if any, it poses, they must attribute 
meaning to risk to make sense of it in the context of their own life. Understanding of 
risk is not solely based on facts and figures and decisions that are based on risk 
perceptions are not always made in a clear cut rational manner. Rather, it is a 
synthesis through processes of individual interpretation of risk, where information 
gathered from interacting with friends, family, media is processed to conclusion.  
 
Risk was often described by participants as a ticking time-bomb, over which the 
individual did not have ultimate control. The hereditary nature of certain illnesses 
and conditions were often acknowledged, as was the role of the genetic make-up of 
the individual, in relation to the likelihood of experiencing illness. In the extract 
below, Fran described how she had no control over the genetic nature of disease and 
subsequently cardiovascular risk. She acknowledged that measures could be put in 
145 
 
place to reduce risk but ultimately felt that disease and illness progression is not 
controlled by the individual, but rather that fate played a role:  
Fran: I think it is something in your genes, it’s 
gonna be, I mean you can prevent it, I 
suppose you can? You know, help prevent it, 
but I think it’s inevitable if it is in your 
genes that you’re gonna, you know? 
Interviewer: So you’ve got a limited control? 
Fran: Yeah 
Interviewer:  But you do have some control? 
Fran: You have some control over it but I think the 
older you get, the more (laughs) 
philosophical you get about it. I mean, when 
you’re young you’re invincible! (laughs) 
(Fran, 70).  
 
The influence of genetic and biological factors in the development of ill health was 
pertinent. These were factors that participants often felt were outside of their control. 
Whilst lifestyle choices and behaviours were within the remit of an individual’s 
regulation, should they prioritise behaviour change, many changes within the body 
were hidden from sight and may present no symptoms.  
 
In the extract below, Keith explains his realist view of illness and behaviour change. 
He describes how one must strike a balance between taking control of behaviours, 
acknowledging the limits of one’s ability to control the biological nature of illness 
and live in a way that is sustainable, without going to extremes: 
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Keith: I will do what I have to do to get by, but 
you’re not in control of the (clicking 
fingers) 
Interviewer: Outcome? 
Keith: You are not in control. I don’t know what’s 
inside of me, what’s going on. I have no 
control of it really. In one sense, what goes 
in – lifestyle. I can control that. But you 
can’t control, you know, whether you are 
going to get Alzheimer’s or whatever. Who 
knows? 
Interviewer: So there are biological factors outwith your 
control? 
Keith: What was I reading the other day? Four out 
of five men over 50 catch some sort of 
cancer and you think “well what can I do 
about that?” You can’t do anything, can 
you? I know that some are related to 
lifestyles but some are not, are they? Others 
are just part of life, if you abuse your body, 
you know. But you can’t go the other way 
and be like a monk and eat porridge every 
morning! (Keith, 60) 
This ‘realism’ in attitude demonstrates how participants were aware that there is 
value in doing prevention work, but also acknowledge that preventative behaviour 
may not be enough to guarantee avoidance of an adverse event.  
 
There was an acknowledgement that illnesses can be symptomless, for extended 
periods of time, and there was a feeling that family history, along with age, played a 
role in its development. Colin described:  
You could have hardly any symptoms, you know. So, if it runs in 
your family, it will always be on your mind you know, and 
especially like when you come to a certain age (Colin, 57). 
 
Colin later went on to describe how his family history of asthma concerned him, 
rather than the possibility of cardiovascular disease: 
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It’s always on my mind about certain things. Like I brought up with 
the doctor, the other week [when] I was there, one of my older 
brothers, ‘cause I’m the youngest in our family, he died of 
emphysema and he was asthmatic, and with me being asthmatic it’s 
a bit of a, I call it a bit of a phobia. It’s in my head that one day I 
might get it. So, he died at 53 so, I’m past him now; I’m 57 (Colin, 
57). 
The onset of illness was described as unexpected in nature, something that could 
sneak up on you and expose itself, regardless of putting measures in place to lead a 
healthy lifestyle. Keith described this in the context of his own father who had been 
fit and healthy for the majority of his life, until he developed diabetes and suffered 
multiple heart attacks:  
It could happen tomorrow, but you’re not expecting it. Me dad 
cycled for 40 years. He didn’t drink. He didn’t smoke. He biked to 
work for 45 years. He had three heart attacks in one year and died 
at 68, and he was ten stone. But he caught diabetes. I looked at his 
death certificate and it said that one of the side effects was failure 
of the arteries, and that’s what he died with (Keith, 60). 
The link between lifestyle factors and cardiovascular events was explored by 
participants and facilitated their interpretations, individual and collective, of CVR. 
Brian described how he was surprised that he had been told he was at-risk of such an 
event at this point in his life. For him, he had always made a connection between 
heart problems and being in a stressed state, something that he experienced more 
when he was employed and working in a stressful environment: 
I was surprised, I’ll be honest with you. I mean I always think of 
heart [problems] equals stress. I mean if I had got this problem 
when I was taxiing I would have said “well fair enough, it’s all 
part of the job” but I really don’t understand what caused it? [The 
increased risk of CVD] (Brian, 66). 
Often, ideas about likelihood of suffering an adverse event were linked to 
understandings of weight management and being physically fit. Tom and Maureen 
describe, below, how they had thought of themselves as reasonably fit and healthy 
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for their age and had therefore not identified themselves as candidates for 
cardiovascular disease prior to their risk assessment: 
I suppose it was [a surprise] in a way. I mean I don’t think of 
myself as a fat person, and I’d have thought if I had been fat and 
that [I would have been at-risk]. But, because I wasn’t so fat I 
would have thought I was reasonably healthy? (Tom, 66). 
 
 
I was surprised because I had always thought of myself as 
reasonably fit (Maureen, 58). 
 
David also described the link between physical fitness and the likelihood of suffering 
heart problems and suggested that this had not been taken into consideration within 
the NHSHC assessment and subsequent provision of advice about lifestyle and 
medication. He describes a tension between knowing his body’s limits physically and 
being assessed as at high risk, based upon one consultation: 
[I’d go to] the gym and I’d be on high impact aerobic type activity 
and I’d be going flat out. Now does that indicate a bad heart? 
That’s what I would be doing… so that’s what I mean, you’ve got 
to look at people [and] see what they are doing and [their] 
lifestyle…rather than [taking] a single reading. Even if you read 
medical books it says single readings have no meaning (David, 62). 
 
Whilst the hereditary nature of cardiovascular disease was widely acknowledged by 
participants it was noted that the NHSHC programme failed to acknowledge the very 
different lifestyles participants had from those experienced by their parents. Both 
Kate and Linda describe, below, how they acknowledge the role that family history 
may play in increasing their risk of cardiovascular disease but also noted that their 
lifestyles are very different to their parents. They were mindful to acknowledge not 
only the biological factors that contribute to CVD risk but also environmental and 
lifestyle factors too: 
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I don’t have the same lifestyle as my father and brother did. They 
were both manual workers. I mean, my father, it was hard work 
that killed him, purely hard work. I have never had that sort of 
lifestyle. Apart from that, my mother died of breast cancer and I 
have a very high risk of dying of breast cancer. One thing or the 
other is going to get me, so why worry? (Kate, 68).  
 
 
There’s nothing wrong with me – nothing at all! I said [to the 
nurse] I have a different lifestyle to my parents. They worked very 
hard, you know? My dad had a very manual job, in fact he had 
three jobs. My mum had six children, you know, it doesn’t help, 
does it? Especially during the war they were poor. I said I have a 
completely different lifestyle to my parents and I’m very healthy, I 
think, for my age of 66. I still go out on the motorbike, still go and 
do all of my exercise classes, still go line dancing. In fact I said to 
her [the nurse] “I think I have a healthier lifestyle than you” and 
she said “I think you have” (laughs) (Linda, 66).  
The role that family history of CVD plays in the development of disease risk 
provided participants with some understanding of why they had been identified as at 
high risk and that this genetic role increased the likelihood of experiencing a CVD 
related event:  
My father and all his family have heart problems so it’s 
hereditary in that respect (Dennis, 65). 
 
Gary also described how illnesses such as heart disease and cancer have a tendency 
to ‘run in families’: 
That sort of stuff, heart problems, I believe is family [related] and 
quite a lot of cancer is family [related]. Because, how often do you 
hear about someone say “she died of cancer. Oh yeah it was only 
two year since her sister died of cancer”. You know, and to me it 
all seems family related – in your genes – and I think [that] heart 
problems, [and] cancer, I’m not saying it’s all in your genes but I 
think a lot of it is in your genes (Gary, 67).  
 
 
Keith describes below how he felt his family were responsible for his increased risk 
of CVD, rather than acknowledging that multiple factors could have played a part: 
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Interviewer: When you were told that you were at high 
risk, how did that make you feel? 
Keith: Err, it’s all their fault, not mine! (laughs) 
Interviewer: Who’s fault? 
Keith: Well me mam and dad had the heart attack, 
and me brother’s got diabetes, but I have 
always been pretty healthy. (Keith, 60) 
 
Although there was a link made between family history of disease and developing it 
oneself, there was an acknowledgement that other factors could also influence 
susceptibility to disease, such as lifestyle factors and, of course, chance or fate. Gary 
went on to describe how his mother had been a candidate, as he saw it, for a heart 
attack and that was indeed what had taken her life. However, his father who had also 
lived life in such a way as to make him a candidate for a heart attack had succumbed 
to pneumonia, highlighting how chance or fate plays a role making it difficult to 
predict what would finally end your life: 
My mother did die of a heart attack when she was 72, but she had 
angina and she was really overweight. She loved dairy products 
and she loved fried food…. My father who lived to 87, I think he 
was, lived out of the frying pan all his life and he smoked all his 
life…and he died of pneumonia (Gary, 67). 
 
There was an air of mystery surrounding how CVD risk was actually calculated and 
an acknowledgement that family history obviously played a significant part in 
determining an increased risk and that lifestyle choices, family history, and 
propensity for disease were entwined. Linda uses the case of her husband to try and 
unpack why she had been offered intervention after her assessment and her husband 
had not. She concluded that even though her husband ate and drank the same as her 
(if not more) he was not at the same risk as her because cancer, rather than CVD, ran 
in his family: 
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My husband, she checked him [he received an NHSHC] and all she 
said to him was, I mean he drinks as much as I do, if not more 
because he has a pint. He’s underweight, she said that, and then 
she didn’t offer him any [statins] because his parents died of 
cancer. His aunties and uncles and cousins all died of cancer. Well 
you can’t do anything about that. You can’t stop getting that, well 
unless its lung cancer (Linda, 66). 
 
Diseases of the cardiovascular system, whilst they posed a threat to the individual, 
were not described as the only illness that was threatening. Alzheimer’s disease was 
identified as much more of a risk. Barbara described taking measures to ward off 
Alzheimer’s disease by keeping an active mind, not just an active body:  
I do an awful lot of crosswords to keep the mind active – for 
Alzheimer’s! You don’t know what’s going to happen (Barbara, 
66).  
 
Alzheimer’s was described, by Maureen, as being much more of a threat than CVD. 
Maureen, a full time carer for her husband with heart failure, was fearful of 
developing an illness that would cause her to be a burden on her family: 
I think I’m more frightened of getting Alzheimer’s or something like 
that. And then I think who is going to look after me? I’ve got both 
sons over here [in the UK], but they are absolutely useless...or like 
the unexpected happens and then you think “oh God! I’m a burden 
on somebody”. I would hate to, I’m more scared of getting 
Alzheimer’s or something like that (Maureen, 58). 
Much of the population of Teesside has, historically, worked in heavy industry and 
that comes with its own set of consequences. Gary describes, below, how fear of 
CVD was low on his list of priorities. Gary had worked with asbestos for many 
years, and had watched several of his colleagues die from complications attributed to 
asbestos:  
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I worked in the chemical industry, petrochemical industry all my 
life. The stuff you breathe on those plants, and you work with 
asbestos, you know the killer asbestos, I’ve been covered in it. I’ve 
eaten sandwiches amongst it. I’ve drank tea amongst it. So I’ve got 
asbestos in me without any doubt. So, I’m not going to worry about 
a heart attack! (Gary, 67). 
Risk is all around us, in everyday life, and many participants acknowledged it, whilst 
refusing to let it take over their lives or stop them from engaging in daily activities. 
Kate discussed how with each returning visit for her annual review her risk of CVD 
had increased, regardless of any changes she had made to her lifestyle in the previous 
year. 
It has gone up again this year [risk score] of course, because I am 
a year older. Each year they add on a little bit more on. I say “yes 
but you are another year nearer the grim reaper anyway aren’t 
you?” (Laughs) I don’t take it terribly seriously as you can tell. 
You can’t or else you would wrap yourself in cotton wool (Kate, 
68). 
The acknowledgement that risk of future illness was something one has to live with, 
without it taking over your life, was reiterated by Keith:  
Well without going over the top or morbid or stupid – you just 
have to live well, try to eat properly, exercise without it actually 
absorbing your life! (Keith, 60). 
Being conscious of one’s health, keeping fit and active and being mindful of dietary 
habits were seen as a way of keeping risk of CVD ‘in check’: 
I don’t go mad. I do believe in healthy eating and looking after 
yourself. And as I say I don’t smoke. I don’t, I mean you couldn’t 
call me a drinker… (Carol, 75). 
 
Linda described how she felt she already did enough to combat CVD risk through 
diet and exercise:  
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I’ve been aquafiting this morning and line dancing. I got a salad 
and salmon croutons for my lunch – what more could you want? 
(Laughs) (Linda, 66). 
 
Kate reiterates this vein of thought, stating that she felt a healthy lifestyle was 
sufficient to reduce any risk posed to her by CVD without the need for prophylactic 
intervention: 
I think it is all just a bit of a lottery, but I think you can do as much 
you can by living a healthy lifestyle. I mean I have never been 
overweight and I am well within my band for my BMI. You now, I 
have always been pretty active and I eat as much fruit and veg as I 
can. I can’t manage five [portions of fruit and vegetables] everyday 
but I eat healthily and I mean, what else can you do? You do 
everything you can apart from popping pills! (Kate, 68). 
 
However, there was sometimes surprise that looking after yourself in this way was 
not sufficient to eradicate risk, as Fran described: 
I try and eat fairly healthy but you see, as I said to her [nurse], I do 
like my butter, I don’t like the spreads and I would rather have the 
butter. But it was a bit of a shock because it was 25 point 
something chance of having a heart attack or a stroke within ten 
years. I thought it would be high but, I mean, I didn’t think it would 
be that high! (Fran, 70). 
The mechanism used to deliver a person’s CVD risk score had the potential to impact 
on an individual’s embodiment, or internalisation, of the notion of ‘risk’ and 
subsequent action. Whilst Fran described, above, her horrified reaction to being told 
she was at 25% risk, this did not hold true for all individuals who recalled being told 
of their percentage chance of CVD. This interpretation of percentage risk had the 
potential to be reassuring. Jeff discusses how the interpreted his risk for CVD as low 
when her was told his risk score of 28%: 
When they said that I was 28 out of 100, well I thought that was 
quite low. If I was 50%, 60%, 70% then I would be quite worried. 
At 28% I wasn’t all that worried, if you know what I mean? (Jeff, 
71). 
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Paul also describes how the receipt of his risk score had not evoked a fear response 
that would be sufficient to instigate any significant changes to the way in which he 
lived his life:  
If I was at a stage where I really, like I was told that you must 
change your lifestyle otherwise you are not going to last the next 
five years type of thing then, yeah, I would definitely change what I 
could (Paul, 63). 
Participants clearly drew on many sources of information about their current 
lifestyle and family history to formulate a conclusion (internalisation) about their 
candidacy for cardiovascular disease through processes of individual and collective 
interpretation of knowledge (individual and communal specification). They used 
this knowledge to either internalise, or not, CVR. This suggests that the 
internalisation mechanism of NPT is a product of the other three working 
mechanisms; differentiation, communal specification, and individual specification.  
6.4 Identity and responsibility – am I really at-risk now? 
Prior to the NHSHC assessment participants were asymptomatic and afterwards, 
despite their ‘diagnosis’, to all intents and purposes they still were, due to lack of 
physiological symptoms. Participants had not sought out assessment; rather they 
were invited to attend. Every participant described themselves as feeling fit and well 
(for their age) despite being classified as at an increased risk of CVD in the next ten 
years. The incongruence of feeling well within themselves and being told they were 
at increased future risk posed problems for many when trying to engage in sense 
making work about CVR and what could be done, if anything, to reduce risk through 
lifestyle changes and medications. 
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Shirley acknowledges, below, how experiencing symptoms is important to 
identifying as being ill. However, she was generally well within herself and felt there 
was no cause for concern: 
Shirley: As long as I don’t feel bad, I’m OK 
Interviewer: And do you feel healthy? 
Shirley: Oh yes; a few aches and pains, but that’s 
old age! (Shirley, 72). 
Again, in the extract below, Paul describes feeling in good health. The absence of 
symptoms that could be explained by CVR led him to feel like nothing much has 
changed as a result of his check and subsequent diagnosis of risk, especially as he 
was not taking medication for the prevention and reduction of risk. Like Shirley, to 
Paul being an ill person was intrinsically linked to signs and symptoms of illness: 
I am just doing what I am doing. I am quite happy with what I am 
doing. I don’t feel unhealthy. I am not one of these people that is 
coughing and sneezing and dying all the time (Paul, 63). 
 
Tom expands on this below: 
I suppose in one way it is a good service and I suppose in another 
it could make you think well “Am I healthy or not?” otherwise you 
could just plod on and carry on and not bother and not even think 
about these things. I suppose it’s good and bad. In one way you can 
think about it and think “Am I being healthy?” “Am I doing the 
right things?” “Is it worth it?” Because I am feeling alright, I 
don’t have any problems that I think would cause me any problems, 
so do I really need to go? [For annual review] (Tom, 66). 
Participants, especially those who had made a conscious decision not to embark on a 
pharmaceutically aided journey, tended to describe how they actively resisted the 
temptation to think of themselves as ‘at-risk’ or to begin to identify as an ill person 
when they had been given no clinical reason to do so. People were aware of their 
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body’s limitations and used this information to inform their understanding of 
potential candidacy for CVD, rather than accepting the clinical information that had 
been presented as their predicted ten year risk score. This suggests that without 
coming to a conclusion (internalisation), CVR participants were unlikely to 
undertake the ‘work’ of complying with the NHSHC by making and sustaining 
lifestyle changes or taking prophylactic treatments. Kate describes how she resisted 
the temptation to identify as being at-risk and changing her behaviours accordingly: 
 You could get yourself very depressed and think of nothing but that 
[being ill]. You can’t! I mean if I thought like that then I wouldn’t 
have gone out climbing in the hills in the Lake District because I 
would have been thinking I would have a heart attack. You can’t 
live like that. I’m sure people do, but no way! (Laughs) (Kate, 68). 
Alongside the refusal to identify oneself as an ill or at-risk person, some participants 
described how they did not want the outside world to now perceive them as an ill 
person. Phillip describes, below, how he disliked taking medications whilst in public, 
for example with a meal, and would, in those circumstances, not take that particular 
dose of medication: 
[If] I’m in a restaurant, you don’t want to take a pill if you are in a 
restaurant (laughs), so you’ll probably skip it once if you were 
eating out that day (Phillip, 65). 
Receipt of an NHSHC did act as a means to take stock of behaviours and lifestyle 
choices, sometimes regardless of any subsequent behaviour modifications. The 
process of spending time with a health professional, to engage in collective 
interpretation and collective evaluation, and having a sustained opportunity to 
discuss health, behaviours and the future was a valued opportunity for many:  
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I wouldn’t say it was frightening in the very first meeting I had, but 
when they sort of lay it out, what’s happening to your body, 
basically through taking all of these fats in, it does make you think 
that maybe I need to do something different that I haven’t done in 
the last 30 or 40 years (Phillip, 65). 
 
6.5 The question of prevention  
The majority of participants felt that taking preventative action to avoid future ill 
health was a good idea – it made sense.  Phillip describes his reasoning about 
embarking on a preventative journey. He incorporates notions about candidacy for 
disease and the asymptomatic nature of ‘risk’ to make sense of and weigh the pros 
and cons of medicating for the purposes of prevention: 
Otherwise I felt healthy. I mean I only go to the doctors if I don’t 
feel very well, but I felt healthy. So, there were no signs of 
anything. I wasn’t suffering with anything due to high cholesterol 
but then she did explain that it can lead to heart attacks and 
strokes, which I suppose can happen to the healthiest person, even 
if you are feeling healthy – it can happen to you anytime. So, I 
thought, well its good preventative medicine. I would rather go for 
preventative medicine than try and get somebody to sort me out 
after the event (Phillip, 65). 
 
Likewise, Fran justifies taking medications for the purposes of prevention by 
drawing in previous knowledge of visiting her husband after his heart attack and 
other benign preventative behaviours: 
It's preventative. Well I mean a lot of people take aspirin – they 
think that that’s going to be preventative and that. I don’t mind 
taking it [statins] because I’ve been into heart wards and I have 
seen how some of them are. So I think if I can take this and it stops 
me being like that, along with other things, you know, I don’t mind 
taking it, it doesn’t bother me (Fran, 70). 
Taking preventative measures was seen as a way of planning for the future, in some 
respects. Keeping the body as fit and healthy as possible was a way of ensuring that 
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participants got to enjoy the rest of their years, in relative good health, as Phillip 
describes: 
I sometimes sit and think “do you realise you only live three score 
years and ten?”…if you look at all the programmes on the telly and 
that, that’s what they are saying and anything over that is 
borrowed time. So I want a lot of borrowed time. There’s a lot of 
places I want to go and see, a lot of things I want to do yet. So 
yeah, if I keep myself fit and healthy I’ll be able to do it. That’s the 
way I look at it (Phillip, 65). 
Dennis describes how engaging in preventative behaviours can act as an insurance 
policy for later life: 
I think you can certainly put safeguards in place, well not 
safeguards, but you can sort of change your lifestyle. If you are 
having a [healthy] lifestyle then you would hope that that would 
pay off in future years (Dennis, 65). 
Whilst prevention may act as an insurance policy for the individual to allow them to 
enjoy a full and happy life, it may also mean that people can live independently for 
longer, as Maureen discusses:  
The preventative things we are taking, I think that’s better. I would 
rather know of something than the unexpected happens and then 
you think “oh God I’m a burden on somebody” (Maureen, 58). 
Wider society stands to benefit from preventing illness at an individual level. It was 
appreciated that "the powers that be" were being seen to be caring for the individual, 
even if the motive was to save money, in the long run, by reducing hospital 
admissions, morbidity and mortality. Phillip explains below: 
 
So, as I say, I'm a big believer in preventative medicine and I think 
it's a good thing that they're going to see people and to help them.  
I suppose you're saving the medical system some money, aren't you, 
if you haven't got to be taken in with a heart attack (Phillip, 65). 
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Whilst the majority of people felt that prevention of future ill-health was a good idea, 
there was feeling in some quarters that screening and intervention had gone a step 
too far. For these people, the ever growing remit of the medical gaze felt obtrusive:  
Personally, I think we are going too far with a lot of these 
medical things. I think it’s a load of bollocks, to be honest (Gary, 
67). 
 Whilst CVD was acknowledged as potentially life threatening, the necessity to 
reduce CVR through medical intervention was afforded meaning not only through 
interaction with health professionals during the assessment but also by taking into 
account one’s own context or situation and future aspirations. Jeff described how he 
was reluctant to take prophylactic medications to reduce his risk when they had the 
potential to cause physical damage:  
I am 72, right? What have I got to look forward to? Nothing. Old 
age, what’s the point of going on a statin which probably 
destroys my kidneys or whatever it does? (Jeff, 71). 
Furthermore, Jeff acknowledged how he would prefer to suffer an acute event that 
caused his death, rather than lingering in a hospital bed. He felt that developing a fear 
of a CVD event may impinge on the small things he took pleasure in:  
To be quite honest it didn’t really bother me [being identified as at-
risk of CVD]. Like I said, I don’t want to end up in a hospital [or] 
in a care home or in a bed for two to three years. I don’t care if I, I 
love walking, I go on the hills, I go by myself with the dog. I do a 
lot of walks – seven miles, ten miles. If I drop down dead there I’d 
be quite happy or if I dropped down dead here sitting down, I 
would be quite happy. I don’t want to end up as a cabbage, you 
know what I mean? (Jeff, 71). 
 
The first two NPT constructs – making sense of it (coherence) and working out 
participation (cognitive participation) – help to illuminate the work patients 
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undertake to make sense of their personal need for CVR assessment and taking part 
in the programme.  These two constructs are helpful in unpacking people’s journeys, 
regardless of whether or not they go on to engage with making changes to their 
lifestyles.  
 
Understanding the uniqueness of it (differentiation) and individually interpreting it 
(individual specification) were the most useful constructs to understand the processes 
people underwent when considering their initial attendance to CVR assessment, this 
process was mostly undertaken at an individual level. However when participants 
began to describe their reasonings for being identified as at increased CVR 
individually and collectively, interpreting it (individual and communal specification) 
began to play bigger roles. Participants synthesised knowledge about their perceived 
current health status, their family history, knowledge about their wider social 
networks, media representations of CVR factors, and evidence gained from health 
professionals to construct their understanding of CVR and what its implications (or 
not) may be for them in real terms. 
 
There was often a tension described between a participant’s individual interpretation 
(individual specification) of their candidacy for CVD which was based upon the 
synthesis of many sources of evidence and the interpretation presented by the health 
professional which was based upon the aggregation of surrogate markers for CVD. 
The outcomes of the processes identified by the construct making sense of it 
(coherence) and its subordinate working mechanisms were good indicators to how 
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engaged (or not) participants would become with aspects of the NHSHC programme 
that required them to make significant changes to their lifestyles (chapter 7).  
 
Chapter 6 has explored participant’s perceptions and experiences of their initial 
engagement with the NHSHC programme and their initial assessment for CVR. The 
following chapter will explore participants’ experiences of trying to make changes to 
their lifestyle, being prescribed prophylactic medications, and engagement with the 
annual review process.
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7 Findings – doing it and reflecting on it  
Chapter 7 presents findings that relate to the patient ‘work’ involved in making 
changes to their lifestyle through implementing changes to their diet, physical 
activity levels, alcohol consumption, and smoking or through taking medications to 
reduce CVR. This is illustrated by exploring findings through the lens of NPT’s 
construct doing it (collective action). Secondly, findings that relate to engagement in 
reflection and monitoring work through participation in the annual review can be 
explored through the lens of NPT’s construct reflecting on it (reflexive monitoring). 
These themes represent the latter stages of the patient journey through the NHSHC 
programme. 
 
Section 7.1 explores participants’ reactions to making (or not) lifestyle changes 
based upon their CVR assessment. Section 7.2 unpacks participants’ reactions to 
taking statins for the purposes of CVR prevention. Finally, section 7.3 explores 
participation in surveillance and monitoring activity. 
 
7.1 Lifestyle advice and intervention 
7.1.1 Patient adherence with advised lifestyle changes 
Promotion of lifestyle changes e.g. making healthy dietary choices, reducing 
sedentary behaviour, reducing alcohol consumption, and smoking cessation, are all 
integral to the NHSHC. In order for it to be judged a success and if it is to reach the 
longer term targets set out in chapter 2, it is felt that those delivering the NHSHC 
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assessment and intervention should engage with those identified as at high CVR, 
convince them that they should, and can, make positive changes to their lifestyle and 
facilitate long term and sustained engagement with the changes. In terms of NPT, 
professionals are required to facilitate the implementation, embedding, and 
integration of lifestyle changes. The activation of behaviour change cannot be the 
sole focus here, there also have to be appropriate and accessible services and 
intervention pathways available to individuals, if the NHSHC programme is to 
support behaviour change. In terms of NPT this is the stage where making sense of it 
(coherence) and working out participation (cognitive participation) come into 
fruition (or not) and the work of doing it (collective action) and reflection on it 
become activated. 
 
During the interviews, all participants were asked to cast their mind back to the 
initial assessment that they had received, which for some participants had been as 
long as two years prior to interview. Participants were asked to recall if the health 
professional had discussed diet, physical activity, alcohol consumption, and smoking. 
Tables 19 and 20 show the distribution of participant’s responses. Findings that relate 
to adherence with lifestyle and prophylactic medications are reported in 
(McNaughton and Shucksmith, 2015) (Appendix 11.1). It was clear that participants 
understood the link of ‘unhealthy behaviours’ to their current and future health, and 
valued the impact that adopting a healthier lifestyle could have on their CVR. Some 
even discussed how the NHSHC assessment and news that they were at increased 
risk had acted as a catalyst to begin considering the impact of lifestyle on CVR: 
I wouldn't say it was frightening, the very first meeting I had, but 
when they sort of lay it out - what's happening to your body 
basically through taking all these fats in -  it does sort of make you 
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think …maybe I need to do something different that I haven't done 
in the last 30 or 40 years (Phillip, 65). 
 
7.1.2 Discussions about diet 
The majority of participants (n=22) did recall having a discussion about their diet 
with the health professional after they had been identified as high CVR (Table 19). 
Of these, 14 individuals felt they had taken on board the advice given to them as part 
of the assessment, and had made changes to the way they shopped for, prepared, and 
consumed food. Eight participants recalled being given dietary advice but had not 
made any changes to their diet as a result of the discussions, and four did not recall 
having a discussion about diet at all. None of the participants within this sample 
recalled being offered a referral to weight management services, either provided by 
the GP practice or in the community. 
 
Discussions about diet and weight management can be difficult for those on the 
receiving end. The medical terminology used has the potential to offend individuals. 
Navigating the clinical encounter and receiving news that you are defined as 
clinically obese can be shocking. Barbara describes how she felt after her initial 
assessment, when she was told that she was obese: 
 
 
Barbara: I must admit when she said to me that I was ‘obese’ 
I was devastated 
Interviewer: Were you? 
Barbara: Yes. It really shocked me, didn’t it? [Husband 
nods] And I couldn’t get over it. I was really like, 
“I can’t believe I'm obese.” But then we got a Wii 
and I got weighed on the Wii and according to that 
I am ‘obese’! (Barbara, 66) 
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Barbara describes the processes of collectively and individually interpreting her 
weight status (communal and individual specification) that she went through by 
being told by a health professional that she was obese and then double checking this 
for herself when she got home. Both sources of information that she sought out were 
congruent with each other, confirming she was in fact classified as clinically ‘obese’. 
 
Discussions about diet within the clinical encounter had prompted many individuals 
to make changes to their diet. These changes were normally in line with heavily 
promoted guidelines such as reducing saturated fat and salt. For these participants the 
NHSHC assessment had provided a catalyst to engage in making sense of it 
(coherence) and working out participation (cognitive participation) work to 
subsequently spur doing it (collective action) work: 
I don’t think I eat unhealthily, so I suppose it was a bit of a 
surprise. So, I just said ‘right, well that is fair enough then’ and the 
things I cut down on – cheese and milk and chips and stuff like that 
(Tom, 66). 
Participants who had made changes to their diet demonstrated how they were 
supported in their changes by family, normally spouses, supporting the notions of 
working with and trusting the work of others (relational integration) and appropriate 
division of tasks (skill set workability) by engaging those within the household who 
held responsibility for preparation of food: 
I used to have a lot of salt at that stage but I've cut that down to 
zero, I don't have any salt now on my food and my wife doesn't 
cook with it.  And I didn't eat a great lot of fatty food but I've 
reduced that as well, you know.  I'm taking more exercise than 
what I did, I have lost weight (Jim, 61). 
The engagement of others in carrying out the behaviour changes was integral 
to the success of implementation and embedding of these new ways of 
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working, which often led to increased work when shopping for and 
preparing food: 
Like my wife says, the shopping takes about three hours longer 
because you now start to read the labels on food. Whereas you 
didn't bother looking for saturated fat before, we now look for very 
low fat, we eat low fat cheese most of the time, try to get foods that 
haven't got a high content of fat (Phillip, 65). 
For others, to engage in new behaviours that were sustainable and easily integrated 
into their daily lives, portion control, rather than making changes to the ingredients 
was the key to successful integration of dietary changes: 
Interviewer: So, have you had to make any changes to the way 
that you eat? 
Barbara: Just to cut down on portions – that’s all we have 
done really. We do eat a lot of… 
Alex: …good stuff really. We don’t eat pies and things like 
that. 
Barbara: Or processed food (Alex, 67. Barbara, 66). 
 
This concept of ‘balance’ when making dietary choices, and any choices that were 
made needing to be achievable and sustainable, was a common thread through 
discussions of diet. This links to the notion of allocating resources (contextual 
integration); participants were in many cases reluctant to make huge changes to their 
diet and instead opted for consumption in moderation:  
I eat everything.  I don’t have eggs every day. I maybe have them 
twice a week.  I don’t have bacon sandwiches every day; I maybe 
have it once a week.  I eat veg, I eat fruit, I had a pear this morning 
for my breakfast – that kind of thing (Jeff, 71). 
The fact that any dietary changes had to work for all members of the household 
became an obstacle for some. The importance of eating a healthy balanced diet that 
included fresh fruits and vegetables could be a barrier, if all members of the 
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household did not like the new menu. If everyone within a household was not on 
board (believing the practice is valid/ legitimation) and engaged, it had practical 
implications for the dietary choices of individuals. Colin describes the difficulties of 
eating fresh fruits and vegetables in his household, because there is only him that 
enjoys them. He had to incorporate different techniques to satisfy both his agenda 
and his wife’s palate whilst not being wasteful of resources of food and money, 
highlighting the importance of appropriate allocation of resources (contextual 
integration):  
Because with the wife not eating all veg, we don't buy fresh veg 
because it goes off. I mean there's no point buying a pound of 
carrots because I don't eat that many, though I like them (Colin, 
57). 
Those participants who had made a choice to not engage in dietary change activity 
cited dietary change as unnecessary. The internal processes of making sense of it 
(coherence) and working out participation (cognitive participation) had, in these 
cases, not acted as a catalyst for change. Rather, they had provided the individual 
with a reason not to engage in behaviour change: 
You know, I’m 72 in this year and you think to yourself, ‘Oh 
crumbs.  I am done!’  I am eating everything right.  We both have a 
drink - we like a drink - but if my main doctor says, “Just go and 
live your life,”, that’s what I do (Ken).  
Despite the efforts of health professionals to come to a communal place where 
individuals understood the importance of making lifestyle changes, some participants 
had not internalised that there was anything to gain by making changes and instead 
carried on as before: 
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Interviewer: So, did she give you any advice about, sort of, losing 
weight or anything like that? 
Harry: Why, she gave me some paraphernalia, but it was a 
waste of money giving me that, because I didn’t 
bother with it, because I’m quite happy (Harry, 75).   
The transient nature of health advice and current trends in health promotion activity 
were acknowledged by some, providing support for their non-engagement with 
lifestyle changes. Participants noted that there were often conflicting messages 
around foods and consumption, which made them reluctant to make significant 
changes to lifestyle and internalise the advice they were presented with: 
I don’t believe in all this stuff… when you read all this stuff about... 
don’t do this.  And years ago, potatoes, they were taboo.  Don’t eat 
them!  Though, it is what you do with them that causes you 
problems (Ken).  
This distrust in the advice that is given, because within living memory advice 
has been subject to change, led some participants to be more cautious when 
being asked to change their diet: 
 
They say eat margarine; then butter is better for you, don’t eat 
margarine.   That’s what I am saying, I don’t take any notice of all 
these “you must eat this” because two years later they are saying it 
is no good for you.  You know … at one time eggs was bad for you, 
do you remember?  Then they decided no, eggs are good for you 
(Jeff, 71). 
 
 
7.1.3 Discussions about physical activity 
Participants recalled discussions about physical activity much less frequently than 
discussions about diet and healthy eating. Nine participants recalled having a 
discussion about physical activity during the NHSHC assessment consultation, 
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however, only two participants stated that they had made any changes to their 
physical activity levels on the basis of being identified as high CVR. The majority 
(n=17) did not recall being offered any advice about physical activity levels. One 
participant recalled being offered exercise on prescription (but had not attended). The 
rest of the participants did not recall being offered a referral to physical activity 
intervention at either the GP practice that they were registered at or in a community 
setting. As such, there was very limited discussion about the interaction between 
health professional and outcomes of the assessment on physical activity.  
 
Regardless of CVR identification, some participants identified how they had begun 
to be more physically active as a result of having more free time after retirement:  
Well when I retired - actually I worked part time for the last two 
years and I have been fully retired now for two years - I have just 
had much more free time. So I took up swimming. I go three 
mornings a week (Keith, 60). 
The population targeted in the NHSHC is aging (40-74 years old); the age range of 
participants interviewed in this study represented the older end of the spectrum. 
Participants acknowledged the aging process and the impact it had on them 
physically. Many participants were unable to engage in strenuous activity, as they 
once had:  
I don't feel old, but then my body is telling me I am.  I try running, 
because I used to do cross country at school, but now I couldn't run 
five yards and that's my body telling me I'm old. I only feel 19, but 
then when I try doing something, I know I'm not (Colin, 57). 
Often, engagement in physical activity was restricted by comorbidities, 
demonstrating the importance of being physically capable to undertake the 
recommended physical activity to reduce CVR (having the skills to engage 
(initiation)): 
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I can’t do much.  I can garden and that but I have got arthritis and 
so I battle a bit.  I have got a thing that I kneel on to get up and 
down like that, but if I go on the floor and need to get up then I 
crawl to something to get hold of and things like that.  And I need 
help with getting in the bath and things like that.  But otherwise I 
am fine.  So it would have to be gentle exercise (Maureen, 58). 
Physical activity was described by most as a form of leisure and of gaining pleasure, 
rather than something that was engaged with for the purposes of improving fitness 
levels or specifically losing weight:  
She asked about what I do. Well I mean I don't do any. I mean I 
bowl twice a week, green bowling, lawn bowling, and in the 
wintertime it's once a week because we do carpet bowls.  And I 
walk up and down the village every day and I go swimming about 
once a week and we go dancing once a week, so she said that was 
all....She said about housework and I said, “Well I do my own 
housework and my own gardening;  nobody else will do it!” 
[Laughs] (Fran, 70). 
 
Few participants had taken up organised activities but, when they had, they were 
social activities undertaken in groups: 
On average I walk four miles a day.  I go on the hills, climb.  I have 
the Ordnance Survey map with all these walks and so for the walks 
I go seven to ten [miles] up on the moors, everywhere.  And then I 
joined a walking club for no reason, other than I walk on my own 
(Jeff, 71). 
 
 
7.1.4 Discussions about alcohol consumption 
When asked to recall discussions about alcohol consumption and recommended 
limits, the vast majority of participants (n=22) could not recall any discussion. Four 
participants recalled having a discussion about alcohol consumption and of those, 
one had made a change to consumption of alcohol as a result.  
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For the most part, participants felt their alcohol consumption was within acceptable 
limits. Like discussions about dietary choices, participants discussed alcohol 
consumption in terms of moderation, rather than exclusion. When considering 
moderation, participants tended to take a holistic view of their behaviours and 
lifestyles and began trading between behaviours.  Nigel describes his alcohol 
consumption: 
I love wine, I drink wine, but I don’t drink a bottle at a time. I’ll 
have a glass or I’m more within limits, and I don’t smoke - never 
smoked - and I exercise (Nigel, 72).  
Some participants, who had made a conscious decision not to change their alcohol 
consumption, described a process of negotiation (collectively interpreting it/ 
communal specification and believing the practice is valid/ legitimation) within the 
NHSHC consultation. Linda was clear about her drinking habits and how they were 
entwined with her social life. The pleasure derived from the social aspects of alcohol 
overrode the perceived gains from reducing her consumption: 
 
Linda: Yeah, I have a drink every night, yeah. 
Interviewer: And did she advise you to stop doing that? 
Linda: Oh yes, [the nurse said], “I think you should have 
two nights off.”  Ohhh ! So I said, “Which nights 
would they be [nurse’s name]?”  [The nurse said] 
“Monday and Sunday?” [I said] “No, after line 
dancing it's my cricket club [night].  [The nurse 
said] “And Tuesday?” [I said] “Oh no, after I've 
been to my Aquafit I have my cider.” She said, 
“you're not going to, are you?” I said, “No, I was 
young in the 60s, [nurse’s name]. Nobody told you 
anything was bad for you in those days. Even when 
you were pregnant they didn't say stop drinking, like 
the silly things do in this day and age (Linda, 66). 
Some participants described discussions with health professionals that indicated their 
alcohol consumption was well within the recommended limits and therefore through 
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the process of individual and communal specification process came to the conclusion 
that alcohol reduction was not needed to reduce CVR: 
She said I was quite in the limit of what I drank, you know, because 
we have wine on the Sunday and a couple of brandies sometimes, 
not two on a night but one on a night a couple of times a week.  But 
yeah, she said it was within the limit (Fran, 70).  
The limited discussions about alcohol consumption demonstrated how limits and 
thresholds for ‘sensible drinking’ limits were negotiated through interaction with 
health professionals but needed to be acknowledged within the wider social context 
of the individual’s life. Lifestyle changes, whether dietary, physical activity, or 
alcohol consumption cannot be viewed in isolation. 
  
7.1.5 Discussions about smoking 
When asked about smoking habits, the majority of participants had either never 
smoked (n=10) or had stopped smoking many years before attending an NHSHC 
(n=13). Two participants were smokers at the time of assessment. Of those, one had 
decided to quit smoking after discussions within the NHSHC consultation and one 
was still smoking at the time of interview. 
Gary was the only current smoker within the sample. He described the process of 
individual interpretation (individual specification) that he had gone through in 
making a decision to carry on smoking. For Gary, at this point in his life, he felt that 
it was a futile activity to engage with smoking cessation, as the effects would not be 
experienced for quite some time. This lack of perceived coherence around smoking 
cessation led him to make a mindful decision to carry on: 
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Interviewer:  So do you think that it’s a pointless activity giving 
up smoking now then? 
Gary:  Well it is now for me …it’s too late, yeah.  It’s far 
too late, I mean sixty seven… Say I live another 
twenty year, eighty seven, which would be brilliant, 
but it would take twenty year minimum for my lungs 
to get clear, minimum (Gary, 67). 
Evidence from discussion about lifestyle changes demonstrates a relationship 
between knowing and acknowledging being identified as at increased risk of 
cardiovascular disease and putting into action behaviours to tackle or reduce it. There 
seems to be a delicate interplay between and within the constructs of NPT in that 
equal weighting is not given to each working mechanism. The collective 
interpretation (communal specification), the negotiation work that takes place 
between health professional and individual is not afforded as much credibility or 
weight as the individual interpretation work (individual specification) work that 
people undertake, drawing in knowledges about their wider lives and social contexts. 
It would seem, again, that the first construct, making sense of it (coherence) is the 
most important initial step and that the coming to a conclusion (internalisation) 
process is crucial to instigating action(s).  
 
7.2 Statins promotion and adherence 
The majority of participants, in the sample, could recall being offered statins for the 
purposes of prevention. Twenty one participants had initially accepted the offer of 
statins as a direct result of their NHSHC CVR assessment. Of these, 17 were still 
continuing statin treatment at the time of interview, and four had decided to 
discontinue treatment due to unpleasant side effects that they found intolerable. 
There were four participants who had been offered statins but had refused outright to 
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commence treatment at the time of assessment. Finally, one participant had not been 
offered statins, despite being identified as being at increased risk of CVR.  
 
7.2.1 Prescription of medication 
All participants were aware that they had been identified as at increased CVR and 
that as a result of this assessment, they were advised to take statins for the purposes 
of preventing a possible future event. Although participants recalled discussions 
about healthy lifestyles and the impact ‘being healthy’ could have on their CVR, 
cholesterol and cholesterol management became the focus for many when weighing 
up the concept of risk: 
I was advised, last year, to go on statins, because when they did 
my cholesterol check and everything, it [cholesterol] was higher 
that what it should be at my age, and everything. I had a, I can’t 
remember, it was a 60% or a 40% chance of having a heart 
attack, or stroke, or whatever (Jim, 61). 
Individual and collective interpretations (individual and communal specification) 
about the need for intervention with statins were, in some cases, at odds with one 
another. Health professionals promoted the use of statins and their prophylactic 
capabilities in what is deemed a population with elevated CVR. However, it is not 
always as clear cut on the part of the individual patient, and this importance is not 
built in a shared understanding of CVR. There can be a lack of understanding of the 
purpose of engaging with medication, because the risk of CVR does not become 
internalised (coming to a conclusion (internalisation)) to an extent that becomes a 
catalyst for action: 
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She told me that my cholesterol was the main thing they were 
worried about. It was not really high, but it was high, and there 
was a higher risk of stroke or heart attack, or whatever, you 
know. She gave me some tablets and said “you need to start 
taking these tablets”. I can’t remember what they are. I don’t 
bother taking them to be honest with you (Paul, 63). 
Many participants were aware that the thresholds and cut offs for what constitutes 
high cholesterol were subject to change, and had indeed changed during the time of 
assessment and annual review, for many. Whilst recommendations are to offer statins 
for the purposes of prevention, regardless of cholesterol levels, patients clung to the 
common concept of high and low cholesterol as a marker of CVR. These changing 
thresholds were rarely acknowledged by the health professional delivering the 
assessment, and only one participant discussed this in interview:  
The results came through at something like 4.5 for my cholesterol 
so the doctor just said, “You don’t really need statins.”  He did say 
though that the government keep changing the rules as to what the 
levels should be. He said it was up to me, but I said I don’t want 
them …full stop!  I take enough tablets as it is! (Alex, 67). 
These shifting thresholds and concepts of cholesterol within limits were further 
exacerbated by discussions of ‘good’ (HDL) and ‘bad’ (LDL) cholesterol. Whilst 
health professionals were seen to recommend statins for patients with increased 
LDL cholesterol, these conversations only served to muddy the waters and make 
participants question their own knowledge: 
I was aware of my cholesterol, and have been for over fifteen 
years… [It’s] about 3.5. That’s about what my cholesterol is you 
know, always has been.  She [the nurse] said, “Yeah but your bad 
cholesterol is higher than your good cholesterol.”  I thought, 
what’s she on? Where’s she coming from?  Bad cholesterol, good 
cholesterol …never heard of it (Gary, 67). 
The concept of preventative medicine was familiar but not always valued by 
participants. In an ideal world, it would be unnecessary to embark on medical 
treatment. However, a few participants noted that, whilst they would prefer to be free 
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of medication, they were unsure if they were able to put in the work to mean that it 
was unneeded: 
All things being equal, and in a perfect world, you don’t want to be 
taking tablets.  So, it would be nice to think I wouldn’t have to take 
them, and I wonder sometimes if I am doing enough to bring that to 
an end, but I don’t know… perhaps it is something I will have to 
live with (Tom, 66). 
Six participants within the sample had, after discussions with the health professional 
conducting their assessment, decided that they would like to try and reduce their 
CVR by tackling lifestyle factors before embarking on a medication regimen:  
At the beginning I said, “Look, rather than take tablets I will 
change my lifestyle”.  I am a social drinker. I don’t drink a lot, 
never have.  In fact, my grandson said to me (he’s 14), “Grandad, I 
have never seen you drunk” and I said “No, and you never will see 
me drunk”.  I mean I like a glass of wine or a couple of pints of 
beer, but I’m not a heavy drinker.  I said “I will cut back and I will 
eat better, rather than take tablets” (Jeff, 71). 
Again, this demonstrates the importance of collectively interpreting it (communal 
specification) within the NHSHC, to provide an opportunity to come to a shared 
understanding of the work that the patient is expected to undertake to reduce their 
CVR. The processes of individually and collectively interpreting it (individual and 
communal specification) led, in these cases to taking positive action to reduce CVR 
through lifestyle. However, when the individual returned to the GP practice to assess 
the effects of their lifestyle changes and have a repeat assessment, it was clear in 
their results that their efforts had not been sufficient to make a great impact on their 
CVR. This cycle of engaging in the work of making sense of it (coherence), working 
out participation (cognitive participation), doing it (collective action), and reflecting 
on it (reflexive monitoring) encouraged these participants to embark on medical 
intervention to reduce risk: 
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I wouldn’t take paracetamol unless I was nearly dying [laughs].  
So I've an aversion, I've always had [it] to taking my tablets…  I'd 
much sooner try and do it without them, you know. Because the 
first time that it was suggested that I went on the statins, I did 
decline it and I said I'll try and do it by myself, you know, by losing 
a bit of weight, getting rid of the salt and things like that, but then 
when I went for the review my cholesterol, my bad cholesterol, had 
gone up a bit, so I was advised to take them then, so I did (Jim, 61). 
There was acknowledgement that whilst making changes to their lifestyle was 
helpful and did make a difference to ‘risk scores’, these changes were not enough to 
make the same impact on cholesterol as medications: 
 
Keith: Yeah. I tried without [statins] for three months. 
Interviewer: Oh, did you? 
Keith: …and it knocked it down a fraction, so on that level 
it would have taken me about 20 years to get it down 
to the level it needed to be [Laughs]. (Keith, 60) 
However, for one participant, going through the process of trying to reduce 
CVR through lifestyle and seeing, at reassessment, that her cholesterol had 
reduced, albeit marginally, was enough validation to continue in the same 
vein, rather than commence medical intervention: 
It was part of the check [reassessment of cholesterol], both in the 
first one and the second one I had about a month ago. We 
[participant and nurse] couldn’t work it out [why CVR was ‘high’] 
because I was eating no butter or margarine or cream at all. I had 
dry toast with a bit of marmalade on! I don’t eat a lot of pastries, 
you know I eat everything in moderation. The only thing we could 
come to was that I eat too much cheese and chocolate. So now I eat 
very little cheese and my cholesterol has gone down from 5.3 to 5.0 
in the year, so it has gone down! (Kate, 68).  
There was some discussion about the role of medications in the prevention and 
reduction of cardiovascular risk. In some cases, participants felt that, once on statins 
for prophylactic reasons, they could pass over responsibility for keeping risk ‘in 
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check’ to medical science. Risk was therefore not something that had to be 
monitored by the individual, rather, it was monitored by the daily medication they 
were consuming. The relationship between statins use and cholesterol reduction is 
well known in the UK population. Its use is often covered in the UK press and 
media. It is therefore understandable that this became the focus for many people – 
the NHSHC assessment and programme was not focussed on as a risk reduction 
programme, rather as a means of keeping one’s cholesterol levels under observation 
and surveillance. In the extract below, Phillip describes how he could easily be 
tempted to engage in what he deems unhealthy behaviours and allow the medication 
to take responsibility for his actions but he tries to keep himself under surveillance as 
well: 
The one thing that you have to watch, I found out, when you take 
these tablets, it can sort of plant into your mind maybe I could have 
that big cream cake? I’m taking a tablet that will combat it. But, 
you can’t do that because it might keep your cholesterol down but 
it knocks your weight back up and I think the two are linked. So 
yeah, you’ve got to sort of look the other way when you walk past 
the cream cakes (Phillip, 65).  
Similarly, Brian describes how he has not made significant changes to the way he 
lives his life, the only difference that he could define was that he was now on a daily 
medication, which was the sole step to reducing cardiovascular risk: 
Really, I would say I am doing exactly what I was doing before, 
just that now I am taking the tablets (Brian, 66). 
Some people grappled with the idea that they were being asked to take medications 
for the prevention of an uncertain outcome. They had not been offered medication 
for the treatment of an existing condition, in which case medication could be 
lifesaving. This differentiation between physical illness and projections of 
uncertainty were pertinent to some people. As Linda explains: 
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Linda: If I had high blood pressure and she offered 
tablets specifically for high blood pressure, 
I might take them, but the statin isn't for 
that, is it? It's not for high blood pressure. 
Interviewer: No. It's marketed, as far as I know, for high 
cholesterol  
Linda: So, if she thought my blood pressure was 
very high and say oooh, after monitoring it 
a few times, if she said "You’d better have 
some tablets" or the doctor did, I might take 
them to keep it low (Linda, 66).  
Likewise, Kate felt that life itself is uncertain, a lottery. She was unhappy taking 
medications based on risk: 
 
Interviewer: So, if you had some sort of event, like a 
heart attack or stroke, would you be happy 
to take them [medication]? 
Kate: Yes. Because then it could be lifesaving! But 
I'm not so sure about just for prevention? I 
mean there is no way that I would go and 
have a double breast operation, removal, 
just because I am at high risk of breast 
cancer. I just wouldn’t do it! Life is a 
lottery, it is. It’s a lottery. And, nobody is 
going to live forever and would you want 
to? (Kate, 68). 
Linda highlighted, again, how she felt unnecessarily steered down the path of 
medications for preventing something that, in her mind did not exist: 
So your blood sample comes back. Cholesterol is low. Your liver's 
good [nurse says] can't believe you drink that much and your 
liver's still good! And, they’ve tested for all these and your blood 
samples come back great, great, great and then she says family 
history and talks through it. "Oh well, I think you're high risk. I 
went "But you’ve just taken my blood pressure, and that was fine". 
"Yes, it’s very good for your age". "Right, and you’ve done all that, 
why would I wanna take tablets?" "Well it might prevent…" I said, 
“There's nothing to say, in any of the results, that I'm in danger - is 
there? "Well, no…" (Linda, 66).  
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Adverse side effects from taking statins were discussed by all participants, regardless 
of whether they were taking statins or not. Participants noted multiple sources of 
information about side effects, from personal experience, experience of family and 
friends, and stories in the British media. Whilst clinical trials of statins suggest that 
side effects are rare and tolerable, anecdotal evidence points to the contrary.  The 
bombardment of evidence from multiple sources understandably creates doubt in the 
mind of those who are recommended to take them. The robustness of the evidence 
presented in the media was sometimes questioned: 
The Saga magazine – they did a big article about people who are 
on the statins and the results, and there were a lot of people who 
had a lot of problems with them. I don’t know if there had been 
some sort of official medical follow up with the side effects of 
statins (Kate, 68).  
However, information about side effects had a clear impact on participant’s decision-
making processes when considering whether to engage with medical intervention: 
Well, you hear that many horror stories with Simvastatin, the side 
effects. I am not a tablet person.  I would rather put up with pain 
than take tablets, I must admit that (Jeff, 71). 
Awareness of side effects did, in some cases, prompt a discussion between the 
patient and their GP. It allowed a dialogue to take place that enabled the GP to allay 
fears about serious side effects before the individual agreed to take medication: 
I started taking the statins. Well, actually not straightaway, 
because I thought I’ve been reading about it in the papers. I was 
slightly concerned, because there’s a report of all sorts of side 
effects. So, what happened?  I made an appointment with one of the 
doctors and I went and quizzed him about it.  He said, “Oh yes, 
well there are things could happen - like the main thing is kidney 
failure, right”.  Well he hasn’t seen anybody like that, he said 
(Nigel, 72). 
All participants were asymptomatic at the point of assessment and CVR 
identification. Some participants, who had refused to take statins, felt adamant that 
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there was no clinical need to take medication, especially medication that had the 
potential to cause unwanted side effects when they had felt fit and well prior to 
assessment: 
Linda: It might reduce the risk of whatever, stroke or I don't 
know, but it has some terrible side effects 'cause I've 
heard about the side effects. 
Interviewer: Where have you heard that? 
Linda: I can't remember them all now.  There's all different 
side effects to these tablets but I don't agree that 
they should offer you tablets when you're quite 
healthy, really and truthfully (Linda, 66). 
Many participants, who had embarked on a pharmaceutically aided journey reported 
side effects. These ranged from mild effects that were tolerable such as a little gastric 
discomfort to side effects that were intolerable:  
Interviewer: How are you finding them? 
Fran: They're fine, I mean I take it before I go to bed at 
night but [laughs] it's when you get to bed … it 
bubbles in here [pats tummy]. 
Interviewer: Does it? 
Fran: I get wind, terrible wind, just bubbling away in here and 
seemingly that's a side effect of them (Fran, 70).  
Experience of side effects often led the individual to revisit their GP to discuss the 
treatment plan and allay any fears. In many cases, these discussions led to a 
reconfiguration of treatment (changing the way things are done (reconfiguration)), 
whereby the health professional would prescribe a different brand of statins which 
the patient found easier to tolerate. This was the case for Phillip, below: 
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Well they [legs] stiffened up. It felt as though you'd been stood in a 
bucket of concrete! And I got diarrhoea and I felt sick and had a 
fuzzy head with them and they said, “Well you usually get this over 
the first three months.”  Well I took them for three months and it 
didn't ease off and I thought, well I felt perfectly well before I went 
on these, I'd like to come off them, so I came off them (Phillip, 65). 
David described a similar journey of experiencing side effects which later resulted in 
the reconfiguration of his treatment: 
David: The doctor then gave me statin which I couldn’t take 
because it affected me very, very badly. I couldn’t 
move my arms. 
Interviewer:  Really? 
David: I was in that much pain, I couldn’t move my arm…They took 
literally nine months to a year to get rid of it out of my system 
(David, 62). 
There were a small number of participants who had experienced side effects and 
come to the decision to discontinue treatment of their own accord. These participants 
had not sought the opinion of a health professional or sought reconfiguration of 
treatment. For these participants, the experience of side effects and knowledge of 
side effects from other sources led to the discontinuation of treatment: 
I went in [to the GP surgery] and got them [statins] and she gave 
me a supply. I started taking them and all the muscles in my back 
started jumping about like that.  ‘I can’t go on like this’ and so 
rang up and said, “I am not taking them.”  But as you get older 
you are bumping into friends and they are all the same age as you, 
and everyone I have known, they have all got bad backs because of 
these cholesterol things.  So I thought ‘I am not taking them’, and 
so I wouldn’t take them (Ken, 74).  
The possibility of a ‘prescription waterfall’, whereby preventative treatment could 
lead to side effects that subsequently needed treating with other intervention was 
acknowledged by some as a valid reason not to engage with medical intervention, 
when they were asymptomatic in the first place:  
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It [statin] may protect you from one thing but you may end up 
getting something else, it could cause something else. You could get 
onto this sort of treadmill of taking one medication and having to 
take something else to counteract it and something else to 
counteract that! (Kate, 68).  
Refusers were resolute in their decision. They had synthesised knowledge of their 
family history, own personal health history, and current health status to arrive at a 
decision not to embark on a journey that included prophylactic medication. These 
participants showed sophisticated reasoning and articulated it well. This highlights 
how, if an individual is resolute in their own individual interpretation of it 
(individual specification), about the importance of CVR and their knowledge of 
treatment options, the process of collective interpretation (communal specification), 
whereby the health professional attempts to change their mind, is futile: 
Linda: I mean my cholesterol's low, my weight's low, in fact 
she [the nurse] reckons I've lost weight since last 
year! I said, “No, your scales are wrong.”  She 
wanted to put me on those, is it stats? 
Interviewer: Statins? 
Linda: Yeah, I said “[nurse’s name], I don't take tablets”.  I 
said, “If I have a headache I won't take painkillers.  
I don't believe in tablets” (Linda, 66). 
Refusers drew a distinct difference between medicating for secondary prevention and 
primary prevention. The lack of diagnosis of a clinical condition but rather a 
prediction of a possible future event was central to their decision to refuse medical 
intervention at this time point. 
 
 
7.3 Surveillance and annual review 
After an individual has been identified as at increased CVR and offered lifestyle 
advice and/ or treatment, they are entered into an annual recall system. Each year 
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they are offered a review appointment which, in theory, provides a space for 
reflecting, monitoring and mapping progress in collaboration with a trained health 
professional. This annual review could provide an opportunity to renegotiate, 
collectively, treatment options and to discuss what is working and what is not 
(reflecting on it (reflexive monitoring)).  
 
Generally, the annual review was seen as a positive part of the NHSHC programme, 
in that it was preferable to have health professionals monitoring progress alongside 
any self-surveillance (discussed later in this chapter) to give validity and legitimacy 
to changes that had been undertaken by the individual and their effects in reducing or 
managing overall CVR: 
I also think it is good how I go back every year and someone is 
monitoring it and also them identifying it [CVR] because I would 
have lived oblivious to it! (Keith, 60).  
Another participant added: 
Well it's no hardship is it?  If it [review appointment] was every six 
months I'd do it, because, at the end of the day, who is it 
benefitting?  It’s for my benefit, so I have no problems that way 
(Colin, 57). 
It was, however, acknowledged that the annual review was not necessarily tailored to 
individual needs. Participants wanted an individualised service that was relevant to 
them and their lifestyles, instead of feeling like they were on a conveyer belt just 
being pushed along, through a generic pathway: 
It’s alright to say at a population level to be just going through the 
motions and making everyone do it [attend and NHSHC, make and 
sustain changes], but as an individual you want an individual 
service (Dennis, 65). 
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Moreover, the time allocated to the annual review process was not deemed as 
particularly conducive to providing a shared space for reflection and often the health 
professional’s approach to the annual review was seen as being ‘soft touch’ rather 
than providing practical support and guidance to facilitate an individual’s adherence 
to the programme’s values: 
It [review appointment] was only really a few minutes. They didn’t 
really ‘push it’, they said you should do this, you should do that, 
there was nothing really that you could disagree with – it is just in 
practice, doing it! (Keith, 60). 
Added to this, the experience and confidence of the health professional had the 
power to change the dynamic of the annual review consultation and ultimately the 
usefulness of the annual review appointment: 
You don’t want to go in and see these nurses and them grill you like 
the Third Reich [such as] “you shouldn’t eat these”, ahhh pffft! 
You don’t need them to scold you, because you wouldn’t have 
people going back. But, on the other side [of it] I remember two 
[different health professionals who have carried out an annual 
review], the one I have just been to, she was a bit shy, I think? She 
did the basics and I was out. The one the year before was a bit of 
an older woman and there was a bit more interaction! (Keith, 60). 
Some participants used the opportunity to attend an annual review as an opportunity 
to set achievable goals for themselves: 
I'm trying to lose a bit more weight. I'd like to go, it'll be in April I 
think [annual review], March or April. I'd like to go and sort of be 
able to get on the scales and see that I've lost a little bit more 
weight as well.  I know my cholesterol will be down because I'm 
taking the medication, that's going to take care of that, I don't have 
any worry on that (Phillip, 65). 
The annual review was also used as an opportunity to seek reassurance, from a health 
professional, that CVR had not increased substantially over the past year: 
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[at the annual review] when they tell you things you know, you feel 
fifty times better – or more – when you come out of the 
doctors…But she [the nurse] said if there is ‘owt wrong then they 
will phone me.  There can’t be ‘owt wrong with me up until now 
since I went on Friday and I’ve heard nowt (Jenny). 
However, whilst the annual review was valued as a space to reflect on progress, by 
some, it could also be an opportunity to reflect on how CVR was a continual process 
that each year, by virtue of aging, increases regardless: 
I think it is good that there’s a follow-up. I can’t see the point in 
them sending for you one year and never following up…[but] I 
mean, it’s a bit shattering when you say you have done all these 
things [made changes], and she tells you that you at higher risk 
because you are another year older! (Kate, 68). 
The opportunity to engage in an annual review appointment was seen by some 
participants as an opportunity to impress the health professional with their progress 
over the last year and receive validation from the health professional that any efforts 
to make quantifiable differences to their physical selves had not been in vain: 
I’d put half a stone on since the time before…so when I go back 
and see her next time, she will see a big difference, wont she! 
(Paula, 57). 
Another participant noted: 
I was pleased because I had lost the weight and my blood pressure 
was down a little; it wasn’t down a lot but it was down a little. It 
was nice to chat to her [the nurse]…it’s nice to talk to someone 
who isn’t telling you all doom and gloom (Fran, 70). 
The annual review, in some circumstances, provided a space to reflect on individual 
markers for CVR, such as cholesterol and how an individual lifestyle may impact on 
the numerical values afforded to such markers. This process of communal reflection 
was useful, to those who experienced it, in trying to unpick what changes they could 
make and what might be effective in reducing their individual CVR: 
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7.3.1 Self-surveillance and engaging the family 
Alongside the annual review appointment, people noted how they had taken on the 
role of self-surveillance as a result of being identified as at increased CVR. The 
extent to which individuals took on this monitoring role varied from person to 
person, and what they monitored varied too. Depending on what measurement they 
felt was the causal factor for their increased risk, this became the fixation for the self-
monitoring. 
 
Technologies to facilitate monitoring of markers, such as cholesterol, can be obtained 
freely and carried out in the comfort of one’s own home – for a price. The 
availability of such technologies can facilitate self-monitoring between annual 
review appointments and allow for individuals to map their own progress against the 
baseline provided at assessment. Having the opportunity to monitor cholesterol at 
home, in Phillip’s case, facilitated the decision to take statins to manage cholesterol: 
I used to buy the little Boots cholesterol checks. They’re 
expensive though, they’re about £11. You just prick the end of 
your finger and run it [the blood] onto a card and it gives you a 
basic reading. It’s not a million miles out from what the hospital 
one is [results are comparable to those provided in a clinical 
setting]. So I monitored myself two or three times over the year, 
with that, but I couldn’t get it down to below 5.6 or 5.7. So I said 
I would give the medical treatment a try (Phillip, 65). 
Self-surveillance of weight was common, with many participants commenting that 
they had begun to weigh themselves more regularly since their risk assessment: 
I have put on half a stone since the last time I went in [for 
annual review]. Even with the exercise, which I was 
disappointed in. I knew it was creeping up because I weigh 
myself every Monday so I can keep a check on my weight (Keith, 
60).  
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In some cases, self-monitoring was facilitated by engaging with other members of 
the family, who had clinical expertise, to supplement the information captured within 
the consultations: 
My blood pressure was on the high side [at the time of 
assessment]…so my daughter [who is a nurse] said “when I 
come I’ll take it for you”…so over a period of two months she 
took my blood pressure and I wrote it all down and took it in for 
him [the GP]. Every reading was normal. It was all quite low 
(Dennis, 65). 
Partners also had a role to play in monitoring certain behaviours; they became 
enrolled in the task of surveillance: 
We tell each other “look, we have been drinking three nights this 
week” then we have cocoa instead of drinking [alcohol] on a 
night time (Ken).  
 
7.3.2 How do I know if it is working? 
The annual review appointment should provide an opportunity to map progress, year 
on year, against the baseline risk assessment in the first year. However, not all annual 
reviews were conducted to the same specification, across the sites from which the 
participants were sampled from. Cholesterol screening, as mentioned previously, was 
used as a marker by many participants as something that indicated CVR and was a 
common concept that had a numerical value that could be influenced through 
lifestyle changes and adherence with lipid lowering medications (statins). 
Cholesterol was, however, not reassessed in all annual review consultations (under 
national guidance), though this reassessment was an expectation as a way of 
monitoring their progress over the last year. This led to disappointment for some 
participants as it made them question the validity of the changes they had been trying 
to make: 
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She said “Oh no, we don’t check that [cholesterol], we just check 
the liver function”. So, I thought, “What’s the point if I don’t know 
whether it’s working?” (Nigel, 72). 
Another participant added: 
I said to her, you know, “Are you taking the cholesterol [again]”? 
She said, “There’s no need to, with you taking them tablets 
[statins]”. Them tablets obviously keep your cholesterol down, but 
I would have liked to know what it was; if it had come down, or if 
I’m wasting my time taking them? (Carol, 75).  
In other cases, however, the annual review served as a perfunctory occasion where 
there was little opportunity to engage in shared reflection: 
[At the review] they give you the test and blood test and she said, 
“If we have a problem, we will get back to you”. They have never 
got back to me so I just assume that everything is alright. They 
don’t actually go through anything again…it’s over a fortnight 
now, so I just assume everything is OK? (Brian, 66). 
Whilst the work undertaken to engage with the aspects of the NHSHC programme 
that require participants to make changes to their lifestyle, take medications, and 
reflect on the programme relate mainly to the NPT constructs doing it (collective 
action) and reflecting on it (reflexive monitoring) clearly, processes from each NPT 
construct are activated. Sense making work, thinking it through and organising work, 
actually actioning behaviours, and reflecting on results occur in parallel. The 
processes identified through the NPT constructs are not linear (though it is easier to 
describe them that way for clarity). Rather they interact with each other in a 
symbiotic relationship. 
 
 Chapters 6 and 7 have presented findings from the study that relate to stages of the 
patient journey through the NHSHC programme. Furthermore these chapters 
highlighted how NPT constructs can be used to explore and explain how people 
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make sense of and engage with each stage of that journey. In the following chapter, 
chapter 8, a deeper conceptual discussion about how each of the NPT constructs and 
their subordinate working mechanisms can be used to explore the findings is 
presented. 
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8 Discussion  
This thesis set out with the intention of exploring the factors that influence the 
experience of those people identified as at-risk of adverse cardiovascular events 
through the NHSHC programme. To achieve this, the journey that people embarked 
on from invitation to attend an NHSHC, through their diagnosis of risk, adherence 
(or not) to lifestyle advice and lipid lowering medication, to their experience of 
engaging with the annual review process was explored.  
 
Two distinct research questions were posed and the following chapter intends to 
demonstrate how these questions were answered and how aims and objectives were 
met. 
Research question one 
What factors influence high-risk individuals’ engagement with the NHSHC 
programme? 
 
Aim To understand and explore at-risk individual’s 
experience of engaging with the NHSHC programme 
to identify factors that promote or inhibit engagement 
with assessment, risk identification, intervention, and 
sustained engagement over the longer term (1year+). 
Objectives 1. To examine how individuals make sense of the 
NHSHC programme 
2. To understand how individuals interpret being at-
risk of a cardiovascular event 
3. To explore how individuals make sense of lifestyle 
advice and/or intervention 
4. To catalogue how individuals make sense of the 
prescription of prophylactic medications 
5. To discover how individuals integrate and sustain 
lifestyle changes and/or prophylactic medications 
6. To determine how individuals engage with ongoing 
monitoring of risk 
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Research question two 
Can NPT provide insight into engagement with the NHSHC programme? 
 
Aim To utilise the constructs of NPT to unpack and explore 
reported engagement with the NHSHC programme. 
Objectives; 
to explore NPT’s 
appropriateness to 
explain experience of: 
To explore the appropriateness of NPT to explain 
people’s understanding of and engagement with 
various stages of the patient journey towards living 
with a diagnosis of risk, i.e. 
6. Invitation to attend assessment 
7. Receiving a diagnosis of cardiovascular risk (CVR) 
8. Engagement with lifestyle advice and/or 
intervention 
9. Engagement with prophylactic medication 
10. Engagement with ongoing monitoring over the 
longer term 
 
This chapter therefore synthesises the themes generated through data analysis and 
integrates them with the core concepts of NPT to show whether NPT was helpful, or 
not, in providing a lens to view the data. By interpreting and then extrapolating the 
data against the NPT constructs, implications for theory, policy and practice, 
training, support, and education, and research can be abstracted (chapter 9). Such an 
analysis can help to provide insight as to how programmes such as the NHSHC 
should be constructed and implemented, as well as providing insight into how this 
particular theory can be utilised in contexts for which it was not originally intended. 
Generally, the NHSHC assessment and subsequent journey can be divided into two 
fundamental categories, much like NPT itself. The first being the making sense of it 
(coherence) and working out participation (cognitive participation) work that 
patients must undertake to get on board with participating in the NHSHC. Secondly 
the work undertaken to implement the practices necessary to participate in the 
NHSHC and engage with making lifestyle changes and taking lipid lowering 
medications, and engage with surveillance and monitoring activity.  
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This discussion chapter is broken down into two main sections. Firstly, the findings 
are considered in relation to the constructs of NPT and secondly, the findings are 
compared to existing literature.   
 
8.1 How Normalisation Process Theory provides insight into engagement 
On the following pages, each construct of NPT is discussed in turn. Each section 
begins with a table that presents definitions for each core construct of NPT and its 
related four working mechanisms to refresh the reader’s memory before we turn to 
discuss each stage of engagement, or not, with the NHSHC programme and how 
NPT’s constructs were helpful, or not, in explaining the NHSHC journey for this 
group of individuals. 
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8.1.1 Making sense of it 
 
Making sense of it 
(Coherence) 
The process of sense making and understanding that individuals have to go through in 
order to promote or inhibit the routine embedding of a practice to its users. These 
processes are energised by investments of meaning made by participants (Finch et al., 
2012). 
Working mechanisms 
Understanding the uniqueness of it 
(Differentiation) 
Collectively interpreting it 
(Communal Specification) 
An important element of sense-making work 
is to understand how a set of practices and 
their objects are different from each other. 
Sense making relies on people working 
together to build a shared understanding of 
the aims, objectives and expected benefits 
of a set of practices. 
Individually interpreting it 
(Individual Specification) 
Coming to a conclusion 
(Internalisation) 
Sense making has an individual component 
too. Here participants in coherence work 
need to do things that will help them 
understand their specific tasks and 
responsibilities around a set of practices. 
Finally, sense-making involves people in 
work that is about understanding the value, 
benefits and importance of a set of 
practices. 
 
The offer of an NHSHC assessment, at the programme level, was not interpreted by 
participants as anything out of the ordinary. Unlike the study conducted by Cheong 
et al. (2016) that concluded participants had attended NHSHCs based upon their 
readiness to face the outcome of the risk assessment. Rather, participants in this 
study discussed how they had attended because they thought it was a routine 
offering. What was being offered to them was not initially distinct, and therefore 
differentiation from other offers of general check-ups was not achieved. This lack of 
distinction, at least for this cohort of participants who were engaged in the 
programme, worked in its favour, as it had driven these participants to attend the 
initial assessment. Of course, the population from which this sample was drawn was 
quite specific. All participants within the sample had undergone a full NHSHC at 
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their GP practice, been identified as at increased CVR, been given intervention, and 
attended at least one annual review. Therefore, this sample were already engaged and 
compliant to some extent. No comment can be made about why individuals do not 
engage with the NHSHC from the outset, or about those who attend assessment but 
do not return for intervention and/or annual review because they were not included 
within the sample for this study. 
 
None of the participants in this sample had sought out the assessment because they 
were experiencing signs and symptoms of CVD, from seeing advertisements, or 
word of mouth. Rather, they had all been contacted by their GP practice and invited 
to attend assessment. Participants interpreted this offer as commonplace, normal, 
routine. It could be postulated that general check-ups and surveillance activity have 
already become normalised in a UK population. Many general health checks and 
screening opportunities exist and these offers have already become routinised 
behaviour for many. Of course, it should be highlighted that this group of 
participants were already engaged in the NHSHC programme for at least one year 
post assessment, so represent only a small cohort of those eligible for an NHSHC. 
That said, the NHSHC offer was understood to be just another one of those things 
offered to people, because of their age; an MOT check-up that aimed to assess their 
general health and wellbeing.  
 
Many participants were confused about how long they had been engaged in the 
NHSHC programme, noting that they had been attending assessment and review for 
much longer than was possible – in many cases prior to the inception and roll out of 
the NHSHC. This may be explained by them misremembering how long had passed 
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since assessment, or again could be a symptom of lack of understanding the 
uniqueness (differentiation) of the NHSHC from other routine check-ups they may 
have attended. It seemed that none of the participants had considered, prior to the 
assessment what the burden of being identified as at high risk of CVD would actually 
mean, and the changes that would be necessary to adhere to the suggested 
intervention that ensued ((May et al., 2014a, May et al., 2009b, Montori et al., 2006). 
 
This lack of distinctness continued when they presented for assessment. The testing 
that was offered to them, the measurements that were taken, and the family history, 
were again routine. Again, this could be interpreted as a positive part of the NHSHC 
programme, as these types of testing are already routinised, for this population. 
However, the outcome of the tests, in particular the cholesterol screening, had been 
somewhat repurposed. Cholesterol screening is commonplace in the UK and the 
concept of total cholesterol, and its relevant thresholds, are firmly embedded in the 
public consciousness. Many products on the supermarket shelves, such as cereals, 
yoghurt drinks, dairy spreads and even breads are marketed as ‘heart healthy’ and as 
having the ability to help keep cholesterol levels within what is deemed as ‘normal’ 
levels (Sainsbury's, 2017). Products for home surveillance of cholesterol levels are 
also available for a price (Boots WebMD, 2017). Over the counter medications, such 
as statins, are familiar pharmaceutical products to reduce total cholesterol. However, 
as a result of cholesterol screening for the NHSHC, total cholesterol levels were, in 
many cases, disregarded and new concepts of LDL and HDL cholesterol were 
introduced as a way of promoting the initiation of statins therapy, for the purposes of 
prevention. This is distinctly different from usual ways of working and is something 
many participants struggled to make sense of, both individually and in conjunction 
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with the health professional. Participants felt that they already had a good grasp on 
the concept of cholesterol and cholesterol management. In some cases the health 
professionals used this opportunity of collective interpretation through the co-
construction of the ‘problem of CVR’ to use LDL and HDL cholesterol to their 
advantage. Essentially the health professionals took a familiar concept but turned the 
introduction of good and bad cholesterol concepts to their advantage as a tool to 
convince patients to engage in the repurposing, or prophylactic properties, of a drug 
that was understood to be used in cases of elevated total cholesterol. However, 
findings showed a tension between the two constructs – individual interpretation and 
collective interpretation in that participants used their own knowledge and 
understanding of cholesterol (as problematic or not) to build a picture of what level 
of cholesterol constituted a need for intervention. However, this was often different 
from the interpretation of the health professional. The process of collective 
interpretation could be used as a tool to change participant’s views about the need for 
intervention with medications; however, this did not always happen. 
 
The use of data collected during the NHSHC assessment is used for a predictive 
purpose. It is utilised to feed a calculation that results in the percentage chance of the 
tested individual suffering an adverse CVD related event in the next ten years 
(Davies et al., 2012, Joint British Societies for the prevention of cardiovascular 
diseases, 2014). This concept of a risk diagnosis is distinctly different from other 
clinical testing that aims to identify signs and symptoms of a pre-existing condition – 
which could then be treated and managed by medical intervention. Instead it sets the 
NHSHC alongside other screening programmes and new forms of genetic testing, 
which focus on potential risk. As such, it has not been adopted by the UK Screening 
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Committee, as it does not meet the stringent criteria set out for a screening 
programme (UK National Screening Committee, 2013) (see Appendix 11.2). 
Nevertheless, the NHSHC programme, as a risk identification, management, and 
reduction tool, necessitates the communication of the potential risk of illness that has 
been projected many years into the future. The communication of a numerical risk 
score is intended, through a process of communal interpretation, to convince the 
individual that internalisation of risk is to be prioritised. However, findings 
demonstrate that participants do not always go on to internalise their CVR and adopt 
a patient identity (Karp, 1994). 
 
Risk communication is fraught, and well documented as an area that health 
professionals struggle to articulate (Spiegelhalter and Riesch, 2011, Edwards and 
Elwyn, 2009, Edwards et al., 2002). Many participants were unaware of their actual 
risk ‘score’ and instead were just told that their risk was ‘high’, meaning they could 
not assess the likelihood or extent of the CVR. There was also a tension described 
between an individual being told that they were at high CVR, being asymptomatic, 
and being told by the health professional that they were currently in good health. 
This often resulted in participants feeling reassured about their current health status, 
rather than poised for action. 
 
There was evidence that some participants had struggled to make sense and 
internalise the notion of risk and make sense of how their individual risk score had 
been constructed and arrived at. The assessment provided an opportunity for 
participants to engage in a process of both communal and individual interpretation. It 
was an opportunity, after risk identification, to co-construct a ‘problem’ of CVR, 
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which could then be internalised as something that necessitated action and also could 
be treated, and therefore reduced. However, some participants (those who went on to 
refuse medical intervention) highlighted how the NHSHC had failed to identify, 
classify, or provide a name for any tangible condition or illness that should or could 
be treated through medical intervention (Armstrong, 2011, Armstrong and Eborall, 
2012). This demonstrates how the working mechanisms of communal and individual 
interpretation can work together to produce a negative conclusion about engaging 
with the NHSHC.  
 
Refusers displayed an active resistance to reconstructing their self-image and 
narrative of past, present and future selves in a way that positioned them as a patient 
or as someone in need of intervention (Bury, 1984, Bury, 2001). This apparent lack 
of coherence, for the group who refused medical intervention, had a detrimental 
impact on their engagement with the NHSHC programme overall. This process 
demonstrates the importance of engaging in collective interpretation to come to a 
shared understanding of the ‘problem’, and in some respects working with and 
trusting the work of others (relational integration) and how that can impact on 
individual interpretation (individual specification) and subsequently coming to a 
conclusion (internalisation) about the ‘problem’. For this group of participants, the 
processes of making sense of CVR had failed to provide a catalyst to engage with the 
next construct or process of working out participation (cognitive participation), 
specifically the believing the practice is valid mechanism. 
 
Participants actively sought out collective interpretation, in cases where risk and how 
the risk calculation had been arrived at was confusing and not immediately clear 
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from the individual’s own construction (individual interpretation) of CVR, in 
relation to their lifestyle. Some participants recounted asking the health professionals 
to go through their ‘risk factors’ to try and pin point what it was exactly that had 
identified them as at increased CVR, seeking collective interpretation to justify and 
provide a causal link between a surrogate marker and CVR. This was demonstrated 
by those participants who went through their diet step-by-step with the health 
professional to identify what was responsible for their CVR. In many cases, 
participants were left unable to explain why they were at increased risk. Several 
participants were able to move past this apparent lack of coherence and go on to 
engage further with the programme. However, for those who refused to take statins, 
this lack of coherence was all the information that they needed to justify their 
disregard for engagement with the programme and subsequently non-acceptance of 
medications.  
 
A small number of participants recalled the health professional who was delivering 
the assessment working hard to build a shared understanding (collective 
interpretation) with them about CVR and its potential physiological complications, 
in order to facilitate the internalisation (coming to a conclusion) of CVR being a 
problem that could be attended to and essentially the prevention of CVD. The use of 
demonstration aides (models of arteries clogged with cholesterol) were effective 
tools to help participants to visualise the processes that might be taking place within 
their bodies. In these cases, the work of collectively interpreting CVR led to the 
internalisation of risk and subsequently adherence with programme interventions. 
This demonstrates the importance of collective interpretation with sustained 
engagement with the NHSHC programme and its constituent parts. 
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The concept of candidacy for CVD (Davison et al., 1991) came out strongly, as 
participants explored how they had made sense of the NHSHC in relation to their 
specific personal circumstances, and as they made sense of the news that they were 
classified as at increased CVR. This concept of candidacy was strongly linked to the 
processes of collective and individual interpretation (communal and internal 
specification), and eventually coming to a conclusion (internalisation) about the 
concept of risk. Participants discussed drawing on multiple sources of knowledge to 
make sense of their candidacy for CVD, either knowledge that would explain their 
candidacy, such as family history, and lifestyle factors, or knowledge that 
highlighted exceptions to the rules and exploring the apparent random nature of 
CVD.  
 
Much like the findings of Cheong et al. (2016), the use of genetic information, the 
hereditary nature of CVD, to make sense of CVR and its potential threat to future 
health was used by participants to make sense and internalise risk in two very distinct 
ways. The first way that this information was used was to provide justification for 
engaging with the NHSHC and preventative intervention. However, this information 
was also used, by those who actively refused to participate in the programme, to 
rationalise their non-engagement. This was done through a process of individually 
interpreting it (individual specification) and understanding the uniqueness of it 
(differentiation) of the NHSHC, in that it was acknowledged that current ways of 
living are very different from that of participants’ parents and grandparents. These 
participants believed that they were not at-risk of CVD to the same extent as 
previous generations and therefore lacked motivation to engage. 
 
202 
 
The concept of candidacy for CVD was linked to the working mechanisms of 
collectively interpreting it (communal specification) and coming to a conclusion 
(internalisation), in that participants described individuals, other than themselves, 
that would benefit from the NHSHC intervention because of their apparent candidacy 
for CVD. Likewise, participants described exceptions to their perception of CVD 
candidates who were apparently able to flout the rules by being able to eat cake and 
butter but not be at increased risk of CVD, similar to the work of Davison et al. 
(1991). Whilst, it can be seen from previous discussion, that the information that 
individuals utilise to construct the problem of CVR and their perceived candidacy for 
CVD, it would seem that the role of the health professional is central to the co-
construction of the problem. Those health professionals who can articulate risk and 
translate it as a relevant concept, regardless of the patient’s asymptomatic 
presentation, facilitate the ‘ignition’ of internalisation of a problem. 
The construct of making sense of it (coherence), in the context of understanding the 
processes participants engaged with and progressed through to form an opinion about 
the relevance of CVR in the context of their lives, was a helpful tool. It illuminated 
the sense-making work that individuals undertake at different stages of the NHSHC 
programme. The working mechanisms of understanding the uniqueness of it 
(differentiation), collectively interpreting it, and individually interpreting it 
(individual specification) can be identified as precursors to the working out 
participation (cognitive participation) work that followed. However, it would seem 
that those three working mechanisms can work independently and are essentially 
prerequisites for coming to a conclusion (internalisation). Those participants who 
displayed a lack of internalisation of a ‘problem’ that could and should be attended to 
by engagement with the NHSHC programme, went on to actively resist taking on an 
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‘at-risk identity’ and subsequently engaging with lifestyle and medication regimens. 
If the process of coming to a conclusion (internalisation) does not take place, it 
cannot act as a catalyst for change, or activation. The processes, or mechanisms, of 
understanding the uniqueness of it (differentiation), collectively interpreting it 
(communal specification), and individually interpreting it (individual specification) 
can be understood to provide the material that is needed to ignite the process of 
internalisation, recognising either that something needs action, or concluding that it 
does not, generating resistance. From the evidence explored in this chapter it could 
be argued that the coming to a conclusion (internalisation) construct is not an 
independent mechanism, as the theory suggests (May, 2013b), rather it is a product 
of the other three. 
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8.1.2 Working out participation 
Working out participation 
(Cognitive Participation) 
The process that individuals and organisations go through in order to enrol individuals to 
engage with a new practice. These processes are energised by investments of commitment 
made by participants (Finch et al., 2012). 
Working mechanisms 
Having the skills to engage 
(Initiation) 
Organising people 
(Enrolment) 
When a set of practices is new or modified, 
a core problem is whether or not key 
participants are working to drive them 
forward. 
Participants may need to organise or 
reorganise themselves and others to 
collectively contribute to the work that may 
involve rethinking group relationships 
between people and things. 
Believing practice is valid 
(Legitimation) 
Defining actions 
(Activation) 
An important component of relational work 
around participation is the work of ensuring 
that other participants believe it is right for 
them to be involved, and they can make a 
valid contribution to it. 
Once it is underway, participants need to 
collectively define the actions and 
procedures needed to sustain a practice and 
stay involved. 
 
The second phase of work that takes place, after making sense of the NHSHC offer 
and being at-risk, can be explored though the working out participation (cognitive 
participation) construct. This is the organisational work that people undertake to 
understand wat is required of them to participate, or not, in the programme. It can be 
understood to be the organisational work to be undertaken before taking physical 
action (doing it (collective action)). 
 
In the thesis, this has been identified as appropriate to explain the work that 
participants undertook to organise themselves and others around any intervention 
offered, or participants’ identification of lack of intervention offer. From the data 
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derived from this study, the working out participation (cognitive participation) 
construct was helpful in highlighting gaps in the provision of services for 
participants. We have seen how this particular cohort of patients were routinely 
offered lipid lowering medications for the purposes of prevention, and, in some 
cases, struggled to understand the repurposing of this medication to reduce risk in a 
population that displays cholesterol levels which are within the thresholds for 
‘normal’ total cholesterol levels. If participants made sense of this and internalised 
and valued the need for this preventative medication, working out participation 
(cognitive participation), with its focus on organisation, skills, and accessing 
medication was not very helpful in exploring the patient’s journey. What this 
construct did offer, however, was a framework to think through other intervention 
pathways around diet, physical activity, alcohol consumption and smoking cessation 
– all of which are at the NHSHC core.  
 
 
When asked to recall what advice had been offered about healthy eating, physical 
activity, alcohol consumption, and smoking cessation, participants recalled these 
offers only sporadically (McNaughton and Shucksmith, 2015). Conversations about 
diet happened frequently but other modifiable risk factors that the NHSHC 
programme is concerned with were less frequently discussed. No participants 
recalled being offered access to services to facilitate change of these risk factors, 
either in house at the GP surgery or in a community based setting (McNaughton and 
Shucksmith, 2015). The task of tackling weight management and sedentary 
behaviour was placed firmly in the hands of the individual.  
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The concept of having the skills to engage (initiation) highlights the importance of 
having the right skills in place to engage with the NHSHC programme, such as 
knowing how to source, prepare and eat appropriate food, to locate and participate in 
appropriate physical activity. This could highlight another point at which the 
programme could increase inequalities through the differential ability to respond to 
the at-risk ‘diagnosis’. NHSHC guidance suggests that intervention should be offered 
to those classified as at increased CVR to facilitate change of the modifiable 
behavioural factors associated with increased CVR. Individuals were not offered this 
opportunity of intervention, rather they were offered brief advice within the 
assessment appointment and followed up at the annual review. This lack of an 
intervention offer highlights a huge missed opportunity to facilitate the journey of 
each individual towards healthier behaviours which could have had a positive impact 
on morbidity and early mortality.  
 
Some participants showed their resourcefulness in making what they deemed 
positive changes to their food consumption. However, for physical activity, alcohol 
consumption and smoking cessation there as very little acknowledgement in the data 
of being offered intervention or seeking it out of their own accord. This suggests that 
participants did not engage in organising themselves or others in activities to 
instigate change for these modifiable risk factors.  
 
The lack of intervention from an external source, the GP practice in this case, raises 
an ethical question around the identification of increased CVR with a lack of positive 
intervention to change it. As already discussed, participants had not sought an 
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NHSHC assessment, it had been offered. Yet participants were left in a state where 
they were navigating a potentially very worrying journey without professional 
guidance. In the case of many of the identified risk factors, they did not feel they had 
the skills to engage with or the capacity to define the actions needed to instigate 
change, and so they simply did not embark on changing these behaviours. This 
finding could indicate a role for health trainers who may be able to offer support 
outside of the assessment appointments as discussed as a success in (Visram et al., 
2014). 
 
There was evidence that participants enrolled the help of family members at many 
points in the process of engaging with the NHSHC programme, as did those in the 
study conducted by Cheong et al. (2016). One of the first instances of note was when 
they were considering whether or not to embark on a pharmaceutically aided journey 
or not. This reliance on family members to help make a decision links to the 
mechanism of believing a practice is valid and the earlier constructs of collectively 
interpreting it (communal specification), showing the influence of extended social 
networks in engagement with the NHSHC. 
 
Families were also engaged in incorporating changes into daily lives, especially if it 
was deemed to be within the remit of that family member’s realm of labour within 
the family. For example, it was common for the men in the sample to identify their 
wives as having the prerequisite skills to shop for and prepare healthier food. 
Therefore, the men in the sample described their wives taking responsibility for 
organising, managing, and subsequently carrying out dietary changes (appropriate 
division of tasks (skill set workability)). The enrolment of others to perform the tasks 
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of making lifestyle changes was integral to the success they felt they had achieved. 
This either worked positively, in cases where wives had incorporated dietary changes 
to support their husband’s journey, or negatively, where one husband described not 
engaging fully with the programme because his wife would not eat or cook 
vegetables. Again, this demonstrates the importance of engaging wider social 
networks of the individual in engaging with the programme, as these ‘relevant 
others’ provide a system of support for those who are actively trying to make 
changes to their lifestyle. 
 
The conceptualisation of engagement with the NHSHC as practice that is valid 
impacted on at-risk individuals’ participation with the programme. This was 
demonstrated most strongly by those participants who had refused to take, or 
discontinued their lipid lowering medications. For these people, the assessing health 
professional had failed to build a shared understanding of CVR so that the participant 
had afforded meaning to it and therefore they did not cognitively enrol with the 
programme. This type of buy in to the programme’s aims and objectives would be 
necessary to begin to identify as an at-risk individual and build an ‘at-risk/ illness 
identity (Karp, 1994, Kenen, 1996, Goldstein-Jutel, 2011). 
 
  
209 
 
8.1.3 Doing it 
Doing it 
(Collective Action) 
The work that individuals and organisations have to do to enact the new practice. These 
processes are energised by investments of effort made by participants (Finch et al., 2012). 
Working mechanisms 
Performing the actions 
(Interactional Workability) 
Working with and trusting the work of 
others 
(Relational Integration) 
The interactional work that people do with 
each other, with artefacts, and with other 
elements of a set of practices, when they 
seek to operationalize them in everyday 
settings. 
The knowledge work that people do to 
build accountability and maintain 
confidence in a set of practices and in each 
other as they use them. 
Appropriate division of tasks 
(Skill Set Workability) 
Allocating resources 
(Contextual Integration) 
The allocation work that underpins the 
division of labour that is built up around a 
set of practices as they are operationalized 
in the real world. 
The resource work - managing a set of 
practices through the allocation of different 
kinds of resources and the execution of 
protocols, policies and procedures. 
 
 
When discussing the work of actually enacting changes to lifestyle and taking lipid 
lowering medications, NPT served to highlight the processes individuals undertook. 
The vast majority of participants had recalled conversations with the health 
professionals about making changes to their diet in order to reduce their CVR and 
many participants (n=14) discussed how they had gone on to make changes to what 
they ate. Changes to diet were most popular out of all potential changes that could be 
made, perhaps as it was the lowest threshold activity that they could control. 
However, again, the enrolment of family members in achieving this goal was pivotal 
to its success. The responsibility for preparing healthier alternatives was devolved to 
the person within the family with responsibility to prepare meals – normally the wife. 
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Moreover, family members had the potential to derail health focussed activity if they 
did not like the healthier options.  
 
Whilst participants were, for the most part, willing to make dietary changes, there 
was acknowledgement that what is deemed as ‘healthy’ now is subject to change 
citing examples of how dietary advice has changed over the years resulting in 
conflicting messages, demonstrating a lack of trust in the system. Instead, 
participants discussed opting to make small but sustainable changes to their diet such 
as exercising portion control and eating in moderation.  
 
A small number of participants did not make changes to their lifestyle as a 
consequence of the NHSHC assessment. These participants cited that making these 
changes was unnecessary for them as they were already doing all they could to stay 
fit and well. This highlights how the processes of making sense of it (coherence) and 
working out participation (cognitive participation) had not acted as a catalyst for 
change. A number of participants did not recall having discussions about diet 
representing a small cohort of participants who either did have a conversation about 
diet and had forgotten or a missed opportunity for health promotion. 
 
Engaging with increased physical activity was cited as problematic for some 
participants. Comorbidities were often restrictive and they felt they could not engage 
in activity as they once had when they were younger. This demonstrates an 
opportunity for intervention by health professionals at the point of assessment to 
discuss options for physical activity that are appropriate to this population and 
signpost them to available services in their local area. Few participants stated that 
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they did not need to increase their activity levels as they were already engaged in 
regular activities.  
 
The vast majority did not recall discussions about either alcohol consumption or 
smoking cessation representing missed health promotion opportunities. However, the 
majority of participants had been offered a lipid lowering medication. 
 
When it came to working with and trusting the work of others (relational integration) 
the way in which the assessment and monitoring components of the programme are 
constructed does not facilitate relationship building in that the individual is offered 
two ten minute appointments at assessment and another at annual review. This does 
not afford enough time to really do the work of building relationships where people 
can explore the options available to them and raise questions and concerns with the 
health professional. The use of props and visual aids, as highlighted earlier, did 
facilitate the work of building trust in the expertise of the health professional’s 
knowledge and build confidence. 
 
The NHSHC programme does, for the most part, divide tasks appropriately – in that 
the at-risk individual is expected to carry out tasks that should be within their skillset 
e.g. making changes to their particular lifestyle. However, this relies on the 
assumption that they have these skills to prepare and cook food, increase physical 
activity etc… At the time of undertaking this study there were very few (if any) 
lifestyle interventions that participants were signposted to in order to facilitate 
gaining skills to make changes. This was noted by many participants as an area that 
needed improvement as they had felt unsupported after assessment. The division of 
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tasks to make lifestyle changes was often devolved to other members of the family. 
For example, in most cases for the male participants it was their spouse who was 
responsible for preparing meals. Therefore, this task was entrusted to them in order 
to make and sustain changes. This again. Highlights the importance of engaging the 
individuals’ wider networks of support to achieve the aims of the programme. 
 
Participants were expected to allocate resources both financially and in giving time 
to reduce their CVR. Whilst no one discussed paying for medications, probably by 
virtue of all participants being older and eligible for free prescriptions, younger 
participants in the programme may well have to pay for medications which may 
impact on their adherence to them. Participants were, however, expected to invest 
financially in making dietary changes. Some people noted that they were not willing 
to start buying separate foods that were deemed to be healthy, such as fruits and 
vegetables, as they were not popular with other members of the family, representing 
an investment that might go to waste.  Only two participants discussed that they had 
made changes to their physical activity levels as a result of the NHSHC. These 
participants (a married couple) had invested, financially, in a Nintendo Wii to 
exercise and monitor weight after being motivated to do so after being called obese. 
Regardless of the financial investment in making changes, these changes had to be 
appropriate to the individual and sustainable in the context of their everyday life. 
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8.1.4 Reflecting on it 
Reflecting on it 
(Reflexive Monitoring) 
The informal and informal appraisal of a new practice once it is in use, in order to assess 
its advantages or disadvantages and which develops user’s comprehension of the effects 
of a practice. These processes are energised by investments in appraisal made by 
participants (Finch et al., 2012). 
Working mechanisms 
Collecting feedback information 
(Systematisation) 
Collectively evaluating it 
(Communal Appraisal) 
Participants in any set of practices may seek 
to determine how effective and useful it is 
for them and for others, and this involves 
the work of collecting information in a 
variety of ways. 
Participants work together - sometimes in 
formal collaboratives, sometimes in 
informal groups to evaluate the worth of a 
set of practices. They may use many 
different means to do this drawing on a 
variety of experiential and systematized 
information. 
Individually evaluating it 
(Individual Appraisal) 
Changing the way things are done 
(Reconfiguration) 
Participants in a new set of practices also 
work experientially as individuals to 
appraise its effects on them and the contexts 
in which they are set. From this work stem 
actions through which individuals express 
their personal relationships to new 
technologies or complex interventions. 
Appraisal work by individuals or groups 
may lead to attempts to redefine procedures 
or modify practices - and even to change 
the shape of a new technology itself. 
 
Evidence from the findings shows that participants engaged in reflexive work in 
many different respects. They reflected upon their progress, their medications, the 
annual review process, and their relationships with the health professionals. 
 
Participants described processes by which they performed self-surveillance to assess 
their progress to reduce CVR whereby they collected feedback information. For 
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those that were engaged with the programme, some did this by monitoring their 
weight at regular intervals, purchasing exercise equipment such as a Wii, or by 
purchasing equipment to monitor cholesterol levels at home as a way of individually 
evaluating it (individual appraisal) progress. These activities necessitated allocation 
of resources of time or money. This process of self-surveillance demonstrates how 
some participants were highly engaged with the work of ‘being at-risk’, had 
incorporated concepts of risk into their identity, and normalised/ embedded these 
practices into their everyday life (Jani et al., 2013, May et al., 2014b, Gallacher et al., 
2011).  
 
Experiences of the annual review process varied between participants. This review 
should act as a point in time where the individual can come together with the health 
professional and engage in a process of collectively evaluating it (communal 
appraisal) progress. In some instances, participants had a reassessment of cholesterol 
levels and for these people it served as an opportunity to monitor the effects of the 
work they had undertaken making lifestyle changes or taking lipid lowering 
medications. However, many participants noted that this was not the case for them 
and they noted that they would have appreciated the opportunity to monitor and track 
their progress, or not, in this way. This lack of opportunity to quantify progress led 
many to believe that any efforts they had made to reduce their CVR had been in vain. 
However, in reality, overall risk scores may have increased by virtue of being 
another year older but the introduction of chances to monitor changes in surrogate 
markers such as weight and cholesterol may encourage sustained engagement over 
the longer term. 
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Moreover, participants discussed how opportunities for collective evaluation were 
essentially missed within the construction and delivery of the NHSHC. Whilst 
discussing treatment options, many participants felt that they had been steered down 
a pathway that assumed that prophylactic lipid lowering medications were the first 
course of action. Some felt that they would have liked to reduce their CVR without 
the aid of prescribed medications by changing their lifestyle in the first instance. 
However, for many, there was no offer of community-based or in-house 
interventions that they could participate in to be supported in making lifestyle 
changes in the first instance, demonstrating the need for these types of services to be 
available. The advice that was offered to people was cited as being generic and CVR 
focussed, as discussed in previous sections. 
 
Many opportunities for changing the way things are done (reconfiguration) 
presented. A cohort of participants had returned to the GP practice to discuss 
treatment options after experiencing side effects from medications. As discussed, all 
of the participants who had been offered alternative brands of medications had gone 
on to sustain their adherence over the longer term and reported no further side 
effects. However, for the small number of participants who had approached their 
healthcare providers about alternative treatment options and been refused them, all 
went on to discontinue treatment. Changing treatment options, without the say so of a 
health professional who is responsible for prescription, is not an option for the 
individual. Health professionals are the gatekeepers to medical intervention (Turner, 
1995) and hold the power to impact on the success, or not, of each individual who 
seeks to change their regimen. The way in which these requests are handled could 
have implications for the success of the programme at the individual level. Without 
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this engagement of health professionals there is limited scope for the individual to 
reconfigure treatment to fit into their lifestyle so that it is workable for them 
personally.  
 
Individuals who seek this reconfiguration of treatment represent a cohort of patients 
who are willing to comply, have internalised the CVR and the importance of 
engaging with the programme and could be convinced to be compliant/ adherent over 
the longer term if they are given access to treatments that are tolerable. Those who 
discontinued with treatment also represent a cohort of individuals that were willing 
to engage with all aspects of the programme, if it fits into their lives and does not 
make them feel unwell. If they had not experienced side effects than they might have 
continued with lipid lowering medications.  
 
As previously discussed, NPT was used across the life course of the study (section 
5.1.6) and I found it more helpful in some stages than others. Below is a more 
general discussion about the usefulness of NPT at specific stages of the study. 
 
Planning: in the planning stages of the study NPT acted as a tool that could sensitise 
me to issues that are important when thinking through people’s engagement in the 
work required to implement, embed, and integrate knowledge and practices. As such, 
the constructs and their subordinate working mechanisms helped me to brainstorm 
possible questions for the development of the interview guide (section 5.2.3). 
However, initially I found the language that is used to describe the constructs and the 
subordinate working mechanisms a barrier to engaging with the constructs. To 
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overcome this I undertook a significant amount of re-interpretation and re-labelling 
work to ensure that I could contextualise the constructs and working mechanisms to 
the specific setting I was interested in (chapter 4). 
 
Analysis: NPT was used at the analysis stages of the project. Initially I had intended 
to use the constructs to undertake a Framework Analysis (section 5.1.6) but this 
proved unsuccessful as I was concerned about imposing a deductive framework on 
the data which was not congruent with the wider approach taken to the study. As 
such the Framework Analysis was abandoned in favour of an inductive approach. 
The NPT constructs were used post hoc in a confirmatory manner and as a 
theoretical lens by which to make sense of the data. 
 
Interpretation: the constructs and subordinate working mechanisms of NPT were 
useful at the interpretation stages of the study. They helped to confirm the results of 
the inductive analysis and helped to think through, critically, the interplay of 
different processes that were taking palace between participants, health care 
professionals, friends and family, technologies, media, and health advice. Whilst all 
constructs were helpful in unpacking each stage of participants’ journeys through the 
NHSHC programme, one construct making sense of it (coherence) was particularly 
helpful as it demonstrated the power to explain why people either engaged with the 
programme in a positive way or actively resisted aspects of it.  
 
Originally, NPT was developed to explore the ways in which innovative practices 
were routinised in organisations. However, I have demonstrated in this study that 
NPT is a valuable tool for exploring engagement with practices outside of the context 
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for which it was intended; in this instance, in relation to the engagement of people 
who were identified as at-risk of cardiovascular disease with the NHSHC 
programme.  
 
 
8.2 How findings link to previous literature 
The modelling exercise undertaken by the DH suggested that, if successfully 
implemented, the NHSHC programme could be cost effective (Department of 
Health, 2008a). The NHSHC programme is being delivered with the intention of 
meeting the following aims (which have been revised since its inception and 
implementation): 
1. Saving 650 lives per year by preventing 1,600 heart attacks 
2. Prevent development of diabetes in over 4,000 people per year 
3. Aid the early detection of at least 20,000 cases of kidney disease and diabetes 
(Public Health England, 2013). 
To achieve these aims it is imperative that the programme not only effectively 
identifies those people within the population who are at-risk of suffering an adverse 
cardiovascular event, but also encourages them to make (and sustain) positive 
lifestyle changes and adhere to prophylactic medications. Evidence suggests that the 
NHSHC is not achieving its targets, with only 25% of the eligible population having 
undergone an assessment (Cook et al., 2016). This is far below the DH’s aspirational 
target of covering 20% of the target population each year until total coverage of the 
eligible population was achieved by 2013 (Department of Health, 2008a). This low 
coverage has been suggested (Cochrane et al, 2013) to indicate a lack of interest in 
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the NHSHC programme in the population. However, evidence is emerging from 
national evaluation of uptake data that participation has increased year-on-year 
(Robson et al., 2016) it is unclear, however, if this means that the NHSHC is 
becoming normalised or if the programme is becoming more efficient at attracting 
people in.  
 
The focus of the NHSHC programme on the so-called lifestyle factors tends to place 
responsibility for CVR at the door of the individual, taking attention away from the 
wider social determinants of health (Dahlgren and Whitehead, 2007). We know that 
in England, the burden of cardiovascular diseases is felt disproportionately in 
disadvantaged communities and therefore structural conditions of class and poverty 
play a role (Raphael, 2003). Cardiovascular disease mortality rates within the 
population as a whole have been falling by around 6% per year. However, this 
reduction is experienced differently between socio-economic groups, meaning that as 
overall mortality rates fall, health inequalities are increasing (Bajekal et al., 2012). 
One danger of universal programmes such as the NHSHC is that it may inadvertently 
increase health inequalities because of differential take up rates between 
demographic groups. 
 
It is worth bearing in mind that members of the eligible population often believe that 
they are fit and well at the point of their initial invitation. They have been offered a 
CVR assessment to predict their future chance of suffering an adverse cardiovascular 
event. For those individuals who have attended a check and been advised that they 
are at high risk (>20% in the next ten years) they have been advised to make 
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preventative changes to their lifestyle, and in most cases prescribed a lipid lowering 
medication for prophylactic purposes. Yet, to re-emphasise, this population is 
asymptomatic.  
 
For those participants in the study, the NHSHC programme did not make clear 
predictive sense (Conrad, 2011, Rosenberg, 2007). Many noted the difference 
between being identified as having a ‘condition’ and being identified as at ‘risk’ of 
something happening in the future.  Pre or proto diseases have been identified as an 
extension to diagnosis and treatment (Armstrong, 2011, Melzer and Zimmern, 2002, 
Rosenberg, 2002): however they are difficult concepts for people to understand and 
therefore take action to avoid. 
 
The act of diagnosis has been noted to be an event that provides a catalyst to change 
(Goldstein-Jutel, 2011, Jutel and Nettleton, 2011), giving access to the sick role 
(Parsons, 1975, Parsons, 1951), and access to treatment and services (Smith, 2002b). 
Previous research into long term and chronic conditions suggests that patients move 
through stages to form an illness identity (Karp, 1994) or to build a new biographical 
narrative (Bury, 1984). However, there has been less discussion as to whether these 
concepts are relevant to those without a diagnosis of a physiological condition but 
only with a diagnosis of risk. (Gillespie, 2012) found that risk identification 
symbolically changed the concept of self and identity and (Hindhede (2014), 
Hindhede and Aagaard-Hansen (2014)) found that communication of risk served to 
incite anxiety and fear. 
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Evidence from early evaluation of engagement of at-risk individuals has found that 
the NHSHC programme has been effective in acting as a catalyst to make changes to 
dietary behaviour (Alford and Perry, 2010, Krska et al., 2014, Perry et al., 2014, 
McNaughton and Shucksmith, 2015). This is mirrored in findings from this thesis. 
Dietary changes were cited most often by participants as a method of reducing CVR 
to achieve weight-loss or to reduce cholesterol intake. Participants were happy to 
discuss diet within the context of the NHSHC assessment. However, the way in 
which the health professional broached the subject of weight and weight-loss had the 
potential to impact on participants’ experience of the assessment. The use of terms 
such as ‘obese’ had the potential to negatively impact the individual. 
 
Making small but sustainable changes to diet such as managing portion control or 
reducing fat and salt intake were preferable, as these were thought more achievable. 
Increased knowledge about risk factors for CVD has been shown to increase 
adherence to lifestyle interventions (Alm-Roijer et al., 2004). People in this study 
were reluctant to make radical changes to their diet and in many cases were cautious 
about cutting out certain food groups, citing how often official guidance on food 
consumption was subject to changes and even reverses. Many participants recounted 
how guidance about the consumption of eggs has changed over their life course from 
being a healthy food, to them being cited as a source of high cholesterol, then being 
declared a healthy option again. 
 
The information provided to at-risk individuals about healthy lifestyles was deemed 
to be too generic and not focussed specifically on CVR reduction. This lack of 
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specific CVR reduction advice left many feeling they were not being supported in 
reducing risk. Many conditions such as diabetes or irritable bowel syndrome have 
specific diets to which patients must adhere to reduce symptoms or disease 
progression. This was not the case for those with increased CVR. The development 
of branded materials with healthy lifestyle advice specifically for those involved in 
the NHSHC programme could provide much needed support and a point of reference 
for people once they have left the GP surgery and are expected to manage dietary 
changes (McNaughton et al., 2013, Krska et al., 2014)  
 
The use of visual aids to explore and explain the physiological effects of high 
cholesterol on the body has been found to be effective (Shaw et al., 2015). Again, 
this was mirrored in findings from this study. Participants who recalled having these 
aids used in assessment consultations felt they understood the processes taking place 
within their body and felt motivated to reduce these effects by engaging in healthier 
lifestyles and taking lipid lowering medications. 
 
The use of lipid lowering medications has been found to be effective in the primary 
prevention of CVD and associated complications (Taylor et al., 2011a). However, 
there is evidence that overall adherence to these medications has been found to be 
low, with only half of those prescribed medications taking them on a daily basis 
(Poluzzi et al., 2008). Patients who have received treatment with lipid lowering 
medications for the purposes of primary prevention, as opposed to secondary 
prevention, have been found to be more likely to discontinue treatment (Ellis et al., 
2004, Jackevicius et al., 2002). The most often cited reason for discontinuation of 
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medications is the development of side effects from taking the medications (Mann et 
al., 2007); this evidence is congruent with findings from this study.  
 
The majority of participants were offered lipid lowering medications, for the 
purposes of prevention. Of those participants offered medications, four had refused 
outright to take them, as they did not believe they were suitable. Twenty-one 
participants had initially accepted the offer of medication and, of that number, 17 
were still taking them at the point of interview, leaving four participants who had 
discontinued due to side effects. This is higher than the 50% expected adherence rate 
expressed by Poluzzi et al. (2008), however comment cannot be made about how 
regularly participants were taking their medications. Concerns about treatment 
options have been shown to negatively impact on medication adherence in previous 
studies with people who have long term conditions (Horne et al., 2013) Whilst the 
majority of participants who had started taking lipid lowering medications had 
continued to do so for at least one year post risk assessment, this sustained adherence 
could be attributed to a number of individuals being afforded the opportunity to 
change medications that were not suiting them. A number of participants had 
returned to their healthcare provider because they were experiencing side effects that 
they attributed to the commencement of treatment. Many people described a number 
of adverse effects of the treatment ranging in severity from mild and tolerable (such 
as gastric discomfort) to unbearable (such as severe muscular pains or heaviness of 
limbs). Side effects were cited as the reason for discontinuing with lipid lowering 
medications.  
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The way in which discussions about side effects were handled by the health 
professionals impacted greatly on people’s decision to carry on with treatment or 
discontinue altogether. This finding is consistent with (Martin et al., 2005) who 
highlighted the importance of open communication to increase adherence with 
medications, Upon experiencing side effects that were attributed to the lipid lowering 
medication, a number contacted their GP practice to discuss the side effects. Many 
participants were offered the chance to swap from one brand of medication to 
another that might be easier for them to tolerate. In these cases, participants noted 
that they were able to tolerate a different brand better and that they were happy to 
continue taking them indefinitely. However, the opportunity to reconfigure 
medication regimens was not consistent across all GP practices. When some 
participants approached their GP practice to discuss the intolerable side effects that 
they were experiencing, they had been turned away and informed that the current 
medication was the only brand they could be offered. In each of these cases the 
individual had made the decision to discontinue treatment with lipid lowering 
medication. This inconsistency between practices in the way in which side effects 
were dealt with represents the impact that individual health practitioners can have on 
the outcomes of the programme. Had the individual had the opportunity to try 
another brand of medication, and tolerated it, they may have adhered to it over the 
longer term, therefore reducing their risk.  
 
Testing for high cholesterol and trying to treat it through making dietary changes or 
by taking lipid lowering medications is a familiar concept in the UK, and it is 
regularly discussed in the media and national press. Cholesterol management was 
often discussed in interview and many participants emphasised that they had been 
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advised to take a drug that they assumed was normally promoted for cholesterol 
reduction for a new purpose – prevention, rather than cure. Lipid lowering 
medications were, in the eyes of participants, now being offered regardless of 
cholesterol levels or whether an individual’s cholesterol sat inside or outside of the 
current recommended thresholds. This apparent lack of regard for prescription 
according to measured cholesterol levels caused confusion and anxiety.  New 
concepts such as high-density lipoprotein level (HDL/ ‘good cholesterol’) and low-
density lipoprotein level (LDL/ ‘bad cholesterol’) were being introduced into 
discussion in consultations as a way of encouraging people to commence statins 
treatment. However, this only served to muddy people’s understanding of concepts 
they had previously thought they had a grasp on. 
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9 Conclusions, implications, and limitations 
The following chapter will draw together the salient points from the findings and 
discussion chapters to highlight the conclusions and then implications of the study 
for: theory; policy and practice; training, support, and education; and – finally – 
future research. Each will now be discussed in turn. 
 
9.1 Conclusions of the study 
Normalisation Process Theory has helped to surface important aspects of the 
NHSHC programme that influence participants’ engagement with the NHSHC and 
their subsequent journey throughout the process from: attending the assessment, 
being identified as at-risk, making sense of this ‘diagnosis’, and engaging in lifestyle 
changes and/or a pharmaceutically aided journey. Evidence from this study suggests 
that the at-risk individual should be viewed as a participant in a social system, and 
this wider social system is integral to engagement, both positively and negatively, 
with all aspects of the programme. The NHSHC programme places responsibility for 
CVR and lifestyle changes firmly at the door of the individual. Whilst it is the 
individual who is identified as at increased risk of CVR and it is the individual that 
ultimately makes changes to their lifestyle or adheres to prophylactic medications, 
their network of family, friends, and health professionals influence each stage of the 
journey. In this respect the individual is a single cog in a much wider system.  
 
Findings have shown how the engagement of the health professional delivering the 
CVR assessment is pivotal to the individual and how they perceive their CVR and its 
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potential impact on their life. The collective interpretation work that is undertaken 
between these parties has a huge influence on the individuals’ subsequent journey 
through the NHSHC. Health professionals have the opportunity to positively or 
negatively influence the individuals’ understanding of CVR. Those health 
professionals who are able to interpret and deliver CVR into something that is 
important to the individual have the capacity to help the individual to afford meaning 
and value to CVR and meaningfully engage in activities to reduce it. Those health 
professionals who are unable to meaningfully interpret CVR can likewise, negatively 
influence the individual’s perception.  
 
The role of family, friends, and anecdotal evidence about potential candidacy for 
CVD impacts individuals’ engagement with the NHSHC programme, and this 
influence cannot be underestimated. Provision of ‘scientific evidence’ based upon the 
calculation of surrogate markers for CVR is not necessarily sufficient to convince 
many people that they should engage with lifestyle changes or take lipid lowering 
medications prophylactically. To be effective, messages about CVR must be 
contextualised into the individuals’ specific circumstances. This may require 
involvement from at-risk individuals’ families, friends, and may require sustained 
engagement from health professionals.  
 
Social networks are called upon to make sense of, and engage with, the work of 
changing behaviours through modifying diet, increasing physical activity, monitoring 
alcohol consumption, and smoking cessation – all of which are social activities and 
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have social determinants. Harnessing the influence of these social networks is 
essential if impacts on health are to be seen from the NHSHC programme. 
 
Sustained interaction with health professionals was also shown to be important at 
stages of reconfiguration of treatment. For those individuals who had suffered 
adverse side effects from the prescribed medications, the relationship with the 
prescribing professional had the power to determine their continuation, or not, with 
medications. This demonstrates again the impacts of wider social networks on the 
individual’s journey. 
 
9.2 Implications arising from the study 
The following section considers the implications that arise from the study. In 
particular it considers: implications for theory; implications for policy and practice; 
implications for training, support, and education; and implications for future 
research.  
9.2.1 Implications for Theory 
 Normalisation Process Theory proved useful at all stages of the research 
project. Other researchers or those interested in exploring people’s 
engagement in health services and health intervention may also find NPT 
useful in guiding the construction and implementation of their project – 
especially relating to:   
a. In the planning phases NPT can act as a sensitisation tool to consider 
aspects of people’s engagement with services/ interventions. i.e. the 
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work undertaken to consider engaging with health interventions, 
organising resources, engaging with programme activities, and 
reflecting on the benefits or disadvantages of health services and 
interventions. 
b. When constructing interview schedules NPT provides a framework to 
inform the development of a comprehensive set of questions that 
consider aspects of engagement that may otherwise be overlooked. 
c. At the analysis stages of a project, NPT constructs can be used in a 
confirmatory manner. In this respect the constructs of NPT are helpful 
to abstract themes into higher order concepts. 
d. NPT is also helpful in providing a framework to discuss emergent 
themes and consider their implications. 
 Normalisation Process Theory was developed to explore the ways in which 
innovative practices were routinised in organisations. However, this study 
shows that NPT is a useful tool to explore people’s engagement with 
practices outside of an organisational setting. Normalisation Process Theory 
may be used to explore aspects of how individuals adopt (or reject) a 
diagnosis and subsequently engage with (or resist) lifestyle intervention and 
medication regimens.   
 Normalisation Process Theory is presented as a universal tool that can be 
applied to any context. Whilst this is helpful to demonstrate its utility in a 
variety of contexts and settings, it means that the constructs and underlying 
working mechanisms need to be interpreted on a case-by-case basis to be 
relevant. The work required to contextualise the theory to a particular 
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problem or setting by interpreting what the constructs are asking of the 
‘problem’ should not be underestimated, or avoided.  
 In the context of this study, the construct of making sense of it (coherence) 
was the most useful construct to explore, as findings relating to this construct 
acted as an indicator as to whether participants would actively take part in the 
programme or actively resist aspects of it. 
 A tension between the working mechanisms of making sense of it (coherence) 
– individual interpretation (individual specification) and collective 
interpretation (collective specification) was found, as the evidence 
underpinning each of these types of interpretation was often founded on 
contrary information. However, those delivering the programme may want to 
focus on the work of collective interpretation as it could influence 
engagement in programmes such as the NHSHC.   
 Findings from the study suggest that the processes explored in the construct 
making sense of it (coherence) have the power to provide rationale for both 
engagement in programmes such as the NHSHC and also rationale for active 
resistance with it, or parts of it i.e. lifestyle changes or medication. 
 Findings from this study suggest that the coming to a conclusion 
(internalisation) working mechanism is not a discrete process, like the other 
working mechanisms, rather it is a product of the other three working 
mechanisms of that construct. Therefore, those using NPT to explore how 
people make sense of a process or practice may want to focus on the 
processes involved in understanding the uniqueness of it (differentiation), 
collectively interpreting it (communal specification), and individually 
interpreting it (individual specification).  
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9.2.2 Implications for Policy and Practice 
Findings from this study have implications for the structuring and delivery of the 
NHSHC. 
 The way in which the NHSHC programme is expected to bring about change 
in a high-risk population could be developed and made explicit. Findings 
have highlighted that simply providing information about individual risk is 
not sufficient to spur adherence from individuals, over the longer term. 
Rather, there is significant work required to support patients to buy into the 
premise of the programme and the subsequent work they must engage in to 
reduce their CVR. 
 The NHSHC offer was not viewed as distinct. The offer – in terms of what is 
provided in the assessment, treatment, and advice – was not considered novel. 
There is an opportunity for those tasked with programme delivery to promote 
the unique aspects and offerings of the NHSHC to those attending 
assessment.  
 There is an opportunity to strengthen the relationship between healthcare 
provider and patient (collectively interpreting it (communal specification)) to 
encourage shared decision making and the implications of being identified as 
at high risk of CVR.  
 When this research was conducted there were few defined referral pathways 
for those identified as at high risk, meaning that individuals were informed of 
their high-risk status but there was no defined intervention to support changes 
in lifestyle. Further programme development would benefit from having clear 
referral pathways to community and individual lifestyle interventions.  
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 The study highlighted a possible unintended outcome of the NHSHC 
programme – the perception, for some, that being identified as high risk of 
CVR was reassuring as no physiological condition had been identified. There 
is an opportunity for those delivering the programme to work with patients to 
build an understanding of the implications of being at-risk. 
 The development of branded materials with healthy lifestyle advice 
specifically for those involved in the NHSHC programme could provide 
much needed support and a point of reference for people once they have left 
the GP surgery and are expected to manage dietary changes and increase 
physical activity levels.  
 The annual review process demonstrates a missed opportunity to re-engage 
individuals with the NHSHC programme. Risk reassessment would offer an 
opportunity to monitor progress.   
 Individuals who experienced debilitating side effects from the prophylactic 
medications they were prescribed often sought out opportunities to 
reconfigure their treatment options. However, in some cases alternative 
treatment was refused. In these cases, individuals discontinued their 
medications. Had the opportunity of treatment reconfiguration (to different 
types of statin that may cause less side effects) been offered – those patients 
may not have discontinued treatment altogether. 
 
9.2.3 Implications for Training, Support, and Education 
The delivery of the programme has been delegated in the GP setting to practice 
nurses and, in many cases, healthcare assistants, who do not have the depth of 
clinical knowledge to be able to sufficiently answer technical questions raised by 
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individuals. Findings from this study highlight some areas for increased training, 
support, and education. 
 Nurses are perceived as having difficulty explaining:  
a. complex concepts such as risk (absolute versus relative risk)  
b. how being at-risk of CVD interacts with pre-existing conditions 
Training specific to the communication of these complex concepts would be 
beneficial, perhaps accompanied by reference material that could be used in 
consultations. 
 The use of demonstration aides worked well in cases where they were used. 
The extension of their use is recommended. 
 Individuals do not make changes or decisions about their health in a vacuum. 
They include family and friends in their discussions, and utilise other forms 
of information to synthesise and come to a decision. Education of HPs should 
support this notion and facilitate the inclusion of the patient’s wider social 
network in decisions and participation in all aspects of the NHSHC 
programme. 
 Support and advice given to those identified as at high risk should be CVR 
specific. Dietary and physical activity advice was viewed as too generic. 
 
9.2.4 Implications for Future research  
The study has highlighted several areas for future research: 
 Further research could explore the need to develop new theories about ‘risk 
biographies’ or ‘risk narratives’ to build upon and extend the work of Bury 
(1984) and Karp (1994).  
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 Further research with high risk individuals in other geographically locations 
to explore if these findings are consistent in other locales. 
 Research with individuals who have not engaged with the programme to find 
out reasons why. 
 Research with those identified as low and medium risk to explore their 
experiences of engagement with the NHSHC programme. 
 Research with other, more diverse demographic groups to explore if these 
findings are consistent. 
 
9.3 Strengths and limitations of the study 
Findings from this thesis have been derived from a number of interviews with people 
who have been identified as at high risk of an adverse cardiovascular event in the 
next ten years. Much attention has been focussed on evaluating the impact of the 
NHSHC programme through monitoring the uptake of CVR assessment. However, a 
strength of this study is that it is one of a limited number that has explored the 
experiences of those people identified as at increased risk of CVD through the 
NHSHC programme. Studies such as this, which acknowledge the journey that those 
identified as at-risk undertake are essential to ensuring such offerings are appropriate 
and acceptable to the targeted population. Moreover, another strength of this study is 
that it is the first time (to my knowledge) that a theoretically driven approach (using 
NPT) to understanding the patient journey has been undertaken and the first time 
NPT has been used, prospectively, to understand the work patients do to interact with 
health provision. 
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Participants were sampled using a purposive approach – all needed to have 
undergone an NHSHC, been identified as at high risk of CVD, been given lifestyle 
advice and in most cases prescribed statins prophylactically, and attended at least one 
annual review. This sampling strategy enabled the inclusion of participants who 
shared common experiences to allow patterns and commonalities to be identified in 
the data (Gray, 2018). However, due to the sampling strategy and how it worked in 
practice (section 5.2.1) there were unintended limitations, (primarily homogeneity of 
the sample) which could impact on the transferability of these findings. This arose 
due to the type of people who agreed to be interviewed for the study. All participants 
in the study were White British – which reflects the particular catchment areas from 
which they were sampled. The majority of them were living in the least deprived 
quintiles of the Tees Valley (Table 21) and were over 55 years old, representing the 
older end of the possible spectrum of those offered an NHSHC (40-74 years old). 
Caution must therefore be taken when transferring these findings more widely to the 
population identified as at increased CVR through the NHSHC programme. Further 
research should aim to include additional investigation of patient adherence with the 
NHSHC programme by recruiting participants from more deprived communities, 
ethnically diverse participants, and younger participants.  
 
Qualitative studies do not seek to achieve large representative samples from which 
results can be generalised to other populations. Rather, we seek insights developed 
through looking at issues in-depth (Kelly, 2010). The analysis presented in this thesis 
is based upon responses from 26 individuals. This represents a very small sample 
size in relation to the population from which it was drawn and again caution must be 
taken when transferring these findings to the wider population. Further research 
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could explore, on a larger scale, the transferability of these findings to a wider 
population.  
 
Individuals were asked to recall many aspects of the assessment they had received 
from invitation, delivery of risk score, what lifestyle advice, and medical intervention 
which had occurred some time prior to interview. The lapse of at least one year 
(patients were contacted after their first annual review) may have affected the 
accuracy of their recall around what was offered in terms of lifestyle 
advice/intervention. However, their current behaviour is obviously determined by 
their memory and understanding of that encounter. 
 
Findings in this thesis were drawn from interviews with individuals who were 
already compliant, to some extent, with many aspects of the NHSHC programme. No 
data was collected from individuals who: 
1. were invited for assessment but decided not to attend (refusers), or  
2. attended assessment but did not attend an annual review (drop outs).  
Further qualitative research is needed to understand the experiences and needs of 
these two groups and any new study along these lines should include representation 
from ethnically diverse populations. 
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11.2 Appendix 2: UK National Screening Committee criteria 
 
Below are the UK National Screening Committee’s standardised criteria to assess the 
viability, effectiveness, and appropriateness of screening programmes. They are 
organised into four domains; the condition, the test, the treatment, and the screening 
programme (reference). 
 The condition 
1. The condition should be an important health problem 
2. The epidemiology and natural history of the condition, including 
development from latent to declared disease, should be adequately 
understood and there should be a detectable risk factor, disease marker, latent 
period or early symptomatic stage. 
3. All the cost-effective primary prevention interventions should have been 
implemented as far as practicable. 
4. If the carriers of a mutation are identified as a result of screening the natural 
history of people with this status should be understood, including the 
psychological implications. 
 The Test 
5. There should be a simple, safe, precise and validated screening test. 
6. The distribution of test values in the target population should be known and a 
suitable cut-off level defined and agreed. 
7.  The test should be acceptable to the population. 
8. There should be an agreed policy on the further diagnostic investigation of 
individuals with a positive test result and on the choices available to those 
individuals. 
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9. If the test is for mutations the criteria used to select the subset of mutations to 
be covered by screening, if all possible mutations are not being tested, should 
be clearly set out. 
 
 The Treatment 
10.  There should be an effective treatment or intervention for patients identified 
through early detection, with evidence of early treatment leading to better 
outcomes than late treatment. 
11. There should be agreed evidence based policies covering which individuals 
should be offered treatment and the appropriate treatment to be offered. 
12. Clinical management of the condition and patient outcomes should be 
optimised in all health care providers prior to participation in a screening 
programme. 
 The Screening Programme 
13. There should be evidence from high quality Randomised Controlled Trials 
that the screening programme is effective in reducing mortality or morbidity. 
Where screening is aimed solely at providing information to allow the person 
being screened to make an “informed choice” (e.g. Down’s syndrome, cystic 
fibrosis carrier screening), there must be evidence from high quality trials 
that the test accurately measures risk. The information that is provided about 
the test and its outcome must be of value and readily understood by the 
individual being screened. 
14. There should be evidence that the complete screening programme (test, 
diagnostic procedures, treatment/ intervention) is clinically, socially and 
ethically acceptable to health professionals and the public. 
15. The benefit from the screening programme should outweigh the physical and 
psychological harm (caused by the test, diagnostic procedures and treatment). 
16. The opportunity cost of the screening programme (including testing, 
diagnosis and treatment, administration, training and quality assurance) 
should be economically balanced in relation to expenditure on medical care 
as a whole (i.e. value for money). Assessment against this criteria should 
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have regard to evidence from cost benefit and/or cost effectiveness analyses 
and have regard to the effective use of available resource. 
17. All other options for managing the condition should have been considered 
(e.g. improving treatment, providing other services), to ensure that no more 
cost effective intervention could be introduced or current interventions 
increased within the resources available. 
18. There should be a plan for managing and monitoring the screening 
programme and an agreed set of quality assurance standards. 
19. Adequate staffing and facilities for testing, diagnosis, treatment and 
programme management should be available prior to the commencement of 
the screening programme. 
20. Evidence-based information, explaining the consequences of testing, 
investigation and treatment, should be made available to potential 
participants to assist them in making an informed choice. 
21. Public pressure for widening the eligibility criteria for reducing the screening 
interval, and for increasing the sensitivity of the testing process, should be 
anticipated. Decisions about these parameters should be scientifically 
justifiable to the public. 
22. If screening is for a mutation the programme should be acceptable to people 
identified as carriers and to other family members. 
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11.3 Appendix 3: Local clinical pathways (low, medium, and high risk) 
  
Indicative list/ opportunistic screening 
Risk assessment: 
 
 Age    Sex    Smoking status    Physical activity    Alcohol intake    Family history    Ethnicity    Body Mass Index    Cholesterol test  
 Blood pressure (if high follow a)    Diabetes Filter (if at risk follow b)   
 
High risk 
Over 20% 
Medium risk 
11% - 19% 
Hypertension pathway 
(a) 
Low risk 
0% - 10% 
Diabetic pathway 
(b) 
Risk Management 
 
 Smoking cessation 
 Exercise on 
prescription/ 
physical activity 
intervention 
 Weight 
management on 
referral 
 Lifestyle 
management 
advice 
 
Risk Management 
 
 Smoking cessation 
 Exercise on 
prescription/ 
physical activity 
intervention 
 Weight 
management on 
referral 
 Lifestyle 
management 
advice 
 
Risk Management 
 
 Smoking cessation 
 Exercise on 
prescription/ 
physical activity 
intervention 
 Weight 
management on 
referral 
 Lifestyle 
management 
advice 
 
5 year recall 5 year recall 
Offered statin and/ or 
antihypertensive 
Annual recall 
Please see flowchart 2 
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Assessment for 
hypertension 
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Serum 
creatinine  
Chronic Kidney 
disease assessment 
Offered 
antihypertensives 
Disease/ high 
risk register 
managed 
under QOF 
Diabetes 
confirmed? 
FPG  
HbA 1c  Disease/ high risk register 
managed under QOF 
IGR/IGT 
Lifestyle management 
advice 
Y 
N 
Risk Management 
 
 Smoking cessation 
 Exercise on 
prescription/ 
physical activity 
intervention 
 Weight 
management on 
referral 
 Lifestyle 
management 
advice 
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11.4 Appendix 4: Key information for staff 
 
 
Overview of evaluation project: 
 
1. We would like to speak with patients who have just had their first annual review 
 
2. We would like to hear how patients have felt over the last year about 
a. Making lifestyle changes 
b. Taking medications 
 
3. We would like to have an informal chat for about an hour at a place to suit them. 
 
4. Any travel costs will be reimbursed and a £20 high street voucher given at the end of 
the interview as a gesture of good will. 
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11.5 Appendix 5: Ethics approval letter 
 
 
 
 274 
 
 
 275 
 
11.6 Appendix 6: Participant information sheet 
 
 
 
 
 
Understanding patient experiences of the Healthy Heart Check Programme: First annual 
review 
Study information for patients 
You have been given this information sheet today because you have had an appointment for 
your first annual review since having a Healthy Heart Check assessment. We would like to 
invite you to take the time to give us your views about how you have felt since being told 
you are at high risk of cardiovascular disease. 
 
Why have I been chosen? 
You have been chosen because you have had a Healthy Heart Check and have been given 
either lifestyle advice to follow, medications to take or a combination of both. 
 
Why do you want to speak to me? 
The Healthy Heart Check programme is here to help people to know if they are at-risk of 
heart problems and provide advice and in some cases medication to reduce that risk. We 
would like to hear about your journey over the last year, since being told you were at-risk, so 
that we can understand if the Healthy Heart Check programme is working as well as it could. 
If you decide to take part, as a gesture of good will, you will receive a £20 high street 
voucher that can be used in many stores nationwide. 
 
What will I have to do if I take part? 
We would like to contact you and arrange a time to speak to you to ask you some questions 
about the Healthy Heart Check programme and the annual review you have just had. We 
would like to arrange this interview at a time and place that suits you – if you need to travel 
to a location to meet with us then your travel costs will be reimbursed. 
 
This interview should last around one hour and will, with your permission, be recorded. Only 
members of the research team will listen to these recordings. You can change your mind 
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about answering any of the questions and can stop the interview at any time and ask the 
researcher not to use your information. 
 
What happens to the information that is collected? 
The recording of your conversation (interview) with the researcher will be written up and 
used, along with other interviews to form the basis of a report. No personal details (name, 
address etc.) will be disclosed in the reports, so you can be assured that you will remain 
anonymous. The recordings of interviews and all paper documents relating to them will be 
held securely at Teesside University in accord with the data Protection Act (1998). Only staff 
directly involved in this evaluation will hear and see these. All data will be anonymised and 
held for a minimum of 20 years and may be used for future study but only in research 
projects that have received ethical approval from an appropriate committee. 
 
What happens next? 
You need not do anything. If you filled in your contact details to be passed to the research 
team, they will contact you soon to set up a time and place to hold the interview. If you 
would like to speak with the research team before then please contact Rebekah McNaughton 
on 01642 342755 or email her at R.McNaughton@tees.ac.uk  
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11.7 Appendix 7: Participant details form 
 
 
 
 
 
 
 
 
 
Understanding patient experiences of the Healthy Heart Check 
Programme: First annual review 
 
If you are happy to take part in the evaluation of the Healthy Heart 
Check programme please let us know the best way to get in contact 
with you by filling your details in below. Once it is completed, 
please hand it back to the nurse and she will make sure you have a 
printed information sheet to take away with you. 
 
 
Name 
 
...................................................... 
 
 
Address ...................................................... 
...................................................... 
...................................................... 
...................................................... 
 
 
Telephone number 
 
...................................................... 
 
 
Email address 
 
...................................................... 
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11.8 Appendix 8: Interview guide 
 
Interview schedule (Patients) 
Being invited for the HHC & results of assessment 
What happened when you were invited for a HHC? 
 Had you seen advertising/ read about the programme? 
 Did you think attendance was compulsory/ voluntary?  
 Were you told why you were invited for a HHC? 
o How did you feel about being identified for a HHC? 
(resentful/grateful/relieved/curious) 
 Do you know anyone else that had been invited/ attended? 
 Did you discuss the invitation with family/ friends? 
 Were you pleased/ anxious to be invited? 
 What made you decide to go for the check? 
 Did you already have concerns about your health? 
 Do you have a history of vascular disease in the family?  
 
Interpretation of risk 
 How did you feel when you were told you were high risk?  
 What does being ‘at-risk’ mean to you? 
o Does it feel ‘real’? 
o Does it feel ‘likely’ to happen? 
 
Making Changes 
 What advice were you given once you were told you were high risk? 
 Were you advised to make changes to the way you live your life? 
 What were these changes? 
a. smoking, drinking, eating, exercise, medication 
 
**At this point note down what changes they were asked to make for use later in interview** 
 How did it feel to be asked to make changes to the way you live your life based on a 
‘risk’ of being ill in the future? 
 Was making these changes important to you? 
o Did you start to feel ‘sick’ or ‘at-risk’? 
o Did you feel in control? 
o Did you get others on board with the changes? 
 
 Did making these changes seem achievable? 
o Family supportive, anxious, dismissive? 
o Other mentoring or support? 
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 Were you given professional help and advice to achieve this? 
o Did you understand why you were making the changes? 
(understand the ‘science’ behind the programme?) 
o Did you rely on the expertise of the HPs to implement the changes?  
 If there are things you are uncertain about (aspects of health/conditions/changes), 
how do you manage this?  
o Where would you turn? 
(peers, family, professionals, internet...) 
 How does it make you feel to be asked to take medications/make changes for life? 
o How do you fit it into your life? (extra job) 
o Remembering/coping strategies for taking medications? 
o Are the changes achievable in the long term? 
o Do you sometimes have to make compromises/ trade-offs to fit the changes 
into your lifestyle? 
 
 How did friends and family react to your new lifestyle (smoking, drinking, exercise, 
and meds)? 
o Were they supportive?  
o Did they try to derail your efforts? 
 
Making it happen 
 Been making these changes for a year now, which ones have managed to ‘stick’? 
 How have you achieved this? 
o Set reminders 
o Developed new habits 
o Aversion techniques? 
 Have there been moments of doubt about why you are doing this? 
o What triggered these? 
o How have you managed these? 
 Given help from the nurse/ GP that did the assessment? 
 Anything outside general practice that helps you manage the changes? 
o Support groups 
o Internet 
o Other HPs 
o Friends 
o Family 
o Colleagues 
*probe about access to these, how they get there, are they enjoyable* 
Reflecting on the past year 
 Have any noticeable changes happened to your health/ the way you feel mentally of 
physically since making all these changes? 
 What would you attribute them to? 
 How does that make you feel? 
(generally feeling healthier, weight loss, feedback from family and friends?) 
 Were there changes to be noted at the annual review? 
 What feedback did you receive from the nurse? 
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(happy with it? Sad? Frustrated?) 
 Do you feel that making the changes was worthwhile? 
 Do you feel you will be able to continue with the changes in the long term? 
 How do you feel about having review appointments annually? 
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11.9 Appendix 9: Consent form 
 
 
 
 
